[
  {
    "id": 3,
    "document_id": 49,
    "query": "1. exp psychotic disorders/\n2. Delusions/\n3. Hallucinations/\n4. Paranoid Disorders/\n5. Schizophrenia/\n6. (psychotic disorder$ or psychoses or psychosis).tw.\n7. (delusion$ or hallucination$ or paranoid$).tw.\n8. (schizoaffective disorder$ or schizophreniform disorder$ or schizophrenia).tw.\n9. exp mood disorders/\n10. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9\n11. Receptors, Steroid/\n12. Glucocorticoids/\n13. Receptors, Corticotropin-Releasing Hormone/\n14. Receptors, Corticotropin/\n15. Dexamethasone/\n16. Hydrocortisone/\n17. Adrenocorticotropic Hormone/\n18. Corticotrophs/\n19. Hydroxycorticosteroids/\n20. R 121919.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n21. ORG 34116.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n22. 3-acetoxyandrost-5-ene-7,17-dione.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n23. Dehydroepiandrosterone/\n24. Mifepristone/\n25. Mitotane/\n26. Aminoglutethimide/\n27. Spironolactone/\n28. Ketoconazole/\n29. Metyrapone/\n30. Corticotropin-Releasing Hormone/\n31. 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30\n31. 10 and 31\n32. clinical trial.pt\n33. clinical trial$.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n34. random$.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n35. placebo.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n36. placebo.ti,ab\n37. groups.ti,ab\n38. dt.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n39. trial.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n40. groups.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n41. 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40\n42. 31 and 41",
    "notes": "MEDLINE (OVID 1950 to August 2009)",
    "start_date": "1949-12-31",
    "end_date": "2009-07-31",
    "annotator_id": 1
  },
  {
    "id": 4,
    "document_id": 48,
    "query": "1. exp Dementia/\n\n2. Delirium/\n\n3. Wernicke Encephalopathy/\n\n4. Delirium, Dementia, Amnestic, Cognitive Disorders/\n\n5. dement*.mp.\n\n6. alzheimer*.mp.\n\n7. (lewy* adj2 bod*).mp.\n\n8. deliri*.mp.\n\n9. (chronic adj2 cerebrovascular).mp.\n\n10. (\"organic brain disease\" or \"organic brain syndrome\").mp.\n\n11. (\"normal pressure hydrocephalus\" and \"shunt*\").mp.\n\n12. \"benign senescent forgetfulness\".mp.\n\n13. (cerebr* adj2 deteriorat*).mp.\n\n14. (cerebral* adj2 insufficient*).mp.\n\n15. (pick* adj2 disease).mp.\n\n16. (creutzfeldt or jcd or cjd).mp.\n\n17. huntington*.mp.\n\n18. binswanger*.mp.\n\n19. korsako*.mp.\n\n20. or/1-19\n\n21. (statin or statins).ti,ab.\n\n22. atorvastatin.ti,ab.\n\n23. cerivastatin.ti,ab.\n\n24. fluvastatin.ti,ab.\n\n25. lovastatin.ti,ab.\n\n26. pravastatin.ti,ab.\n\n27. simvastatin.ti,ab.\n\n28. lipitor.ti,ab.\n\n29. baycol.ti,ab.\n\n30. lescol.ti,ab.\n\n31. mevacor.ti,ab.\n\n32. altocor.ti,ab.\n\n33. pravachol.ti,ab.\n\n34. lipostat.ti,ab.\n\n35. zocor.ti,ab.\n\n36. mevinolin.ti,ab.\n\n37. compactin.ti,ab.\n\n38. fluindostatin.ti,ab.\n\n39. rosuvastatin.ti,ab.\n\n40. Hydroxymethylglutaryl-CoA Reductase Inhibitors/ or Lovastatin/\n\n41. Simvastatin/\n\n42. or/21-41\n\n43. 20 and 42\n\n44. randomized controlled trial.pt.\n\n45. controlled clinical trial.pt.\n\n46. controlled clinical trial.pt.\n\n47. randomized.ab.\n\n48. placebo.ab.\n\n49. drug therapy.fs.\n\n50. randomly.ab.\n\n51. trial.ab.\n\n52. groups.ab.\n\n53. or/44-52\n\n54. (animals not (humans and animals)).sh.\n\n55. 53 not 54\n\n56. 43 and 55\n\n57. exp *Secondary Prevention/ or exp *Primary Prevention/\n\n58. (prevent or prevention).ti,ab.\n\n59. \"delay onset\".ti,ab.\n\n60. exp *Cognition/\n\n61. ((cognit* or cognition or memory or mental or brain) adj3 (impair* or decline* or deficit* or los* or stop* or reduc*)).ti,ab.\n\n62. (dementia or alzheimer*).ti,ab.\n\n63. Dementia/\n\n64. or/57-63\n\n65. 42 and 64\n\n66. 55 and 65",
    "notes": "MEDLINE In-process and other non-indexed citations and MEDLINE 1950-present (Ovid SP)",
    "start_date": "2014-11-30",
    "end_date": "2015-10-31",
    "annotator_id": 1
  },
  {
    "id": 5,
    "document_id": 42,
    "query": "1 exp Oxazolidinones/ (3454)\n2 exp Oxazolone/ (471)\n3 (linezolid$ or oxazolone$).ti,ab. (3313)\n4 or/1-3 (5205)\n5 exp Glycopeptides/ (24374)\n6 (vancomycin$ or glycopeptide$).ti,ab. (14989)\n7 or/5-6 (32269)\n8 exp Soft Tissue Infections/ (1969)\n9 exp Staphylococcal Skin Infections/ (2085)\n10 exp Cellulitis/ (2621)\n11 exp Erysipelas/ (360)\n12 exp Furunculosis/ (298)\n13 exp Abscess/ (17532)\n14 exp Wound Infection/ (15200)\n15 exp Fasciitis, Necrotizing/ (1891)\n16 exp Myositis/ (6975)\n17 exp Gas Gangrene/ (356)\n18 (soft tissue infection$ or skin infection$).ti,ab. (4702)\n19 (cellulitis or erysipelas or furuncul$ or abscess$ or absess$ or necrotizing fasciitis or myositis or gas gangrene or (wound$ adj2 infect$)).ti,ab. (44369)\n20 or/8-19 (69951)\n21 4 and 7 and 20 (216)\n22 randomized controlled trial.pt. (247475)\n23 controlled clinical trial.pt. (40136)\n24 randomized.ab. (201843)\n25 placebo.ab. (93559)\n26 clinical trials as topic.sh. (80952)\n27 randomly.ab. (138890)\n28 trial.ti. (75242)\n29 or/22-28 (558737)\n30 Animals/ (2530681)\n31 Humans/ (7027945)\n32 30 not 31 (1649878)\n33 29 not 32 (508211)\n34 21 and 33 (43)",
    "notes": "Ovid Medline",
    "start_date": null,
    "end_date": "2015-03-23",
    "annotator_id": 1
  },
  {
    "id": 6,
    "document_id": 1,
    "query": "1. MMSE*.ti,ab.\n\n2. sMMSE.ti,ab.\n\n3. Folstein*.ti,ab.\n\n4. MiniMental.ti,ab.\n\n5. \"mini mental stat*\".ti,ab.\n\n6. or/1-5",
    "notes": "We did not use search filters designed to retrieve diagnostic test accuracy studies (collections of terms aimed at reducing the number needed to screen by filtering out irrelevant records and retaining only those that are relevant) as a method to restrict the search overall, because available filters have not yet proved sensitive enough for systematic review searches (Beynon 2013; Whiting 2011). We did not apply any language restriction\n\nNote that though then say from 1946, in the query strategy for MEDLINE they say 1950-present.\nThey also report hit restrictions:\nNov 2012: 10048\nMay 2014: 1657",
    "start_date": "1949-12-31",
    "end_date": "2014-05-19",
    "annotator_id": 3
  },
  {
    "id": 7,
    "document_id": 2,
    "query": "--",
    "notes": "This review used the \"Cochrane Central Register of Controlled Trials\" and most pubmed references may have come from there - they also do pubmed searches; but because of the Cochrane Central Register of Controlled Trials, it may be an issue to correctly align search results. It is unclear how they combined the search terms:\n\"sing the following search terms: c(a)esarean section; tocolysis; betamimetics; glyceryl tri-nitrate; calcium channel blockers; birth injury; and birth trauma.\"\n\nThey focus on randomised controlled trials. Also, \"We excluded quasi-randomised trials (e.g. those randomised by date of birth or hospital number) from the analysis.\"",
    "start_date": "1965-12-31",
    "end_date": "2005-12-31",
    "annotator_id": 3
  },
  {
    "id": 8,
    "document_id": 3,
    "query": "[exp Infant, Newborn/ OR Premature Birth/ OR (neonat$ or neo nat$).ti,ab. OR (newborn$ or new born$ or newly born$).ti,ab. OR (preterm or preterms or pre term or pre terms).ti,ab. OR (preemie$ or premie or premies).ti,ab. OR (prematur$ adj3 (birth$ or born or deliver$)).ti,ab. OR (low adj3 (birthweight$ or birth weight$)).ti,ab. OR (lbw or vlbw or elbw).ti,ab. OR infan$.ti,ab. OR (baby or babies).ti,ab.] AND [emollients/ OR Skin cream/ OR Ointments/ OR Dermatological agents/ OR Plant oils/ OR emollient$.ti,ab. (skin adj6 (cream$ or oil$ or unguent$ or gel$ or moisturi$ or honey or humectant$ or ointment$ or foam$ or lotion$ or conditioner$)).ti,ab. OR (topical adj2 (agent$ or treatment$ or therap$)).ti,ab. OR skin care product$.ti,ab.]",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2015-08-30",
    "annotator_id": 3
  },
  {
    "id": 15,
    "document_id": 8,
    "query": "PubMed:\n\n((lumbar stenosis OR spine stenosis OR spinal stenosis) AND (pubstatusaheadofprint OR publisher[sb] OR pubmednotmedline[sb]))",
    "notes": "Pubmed query: how is it different from MEDLINE?",
    "start_date": "1945-12-31",
    "end_date": "2015-02-10",
    "annotator_id": 3
  },
  {
    "id": 13,
    "document_id": 7,
    "query": "1. exp Cardiovascular Diseases/\n2. cardio*.tw.\n3. cardia*.tw.\n4. heart*.tw.\n5. coronary*.tw.\n6. angina*.tw.\n7. ventric*.tw.\n8. myocard*.tw.\n9. pericard*.tw.\n10. isch?em*.tw.\n11. emboli*.tw.\n12. arrhythmi*.tw.\n13. thrombo*.tw.\n14. atrial fibrillat*.tw.\n15. tachycardi*.tw.\n16. endocardi*.tw.\n17. (sick adj sinus).tw.\n18. exp Stroke/\n19. (stroke or stokes).tw.\n20. cerebrovasc*.tw.\n21. cerebral vascular.tw.\n22. apoplexy.tw.\n23. (brain adj2 accident*).tw.\n24. ((brain* or cerebral or lacunar) adj2 infarct*).tw.\n25. exp Hypertension/\n26. hypertensi*.tw.\n27. peripheral arter* disease*.tw.\n28. ((high or increased or elevated) adj2 blood pressure).tw.\n29. exp Hyperlipidemias/\n30. hyperlipid*.tw.\n31. hyperlip?emia*.tw.\n32. hypercholesterol*.tw.\n33. hypercholester?emia*.tw.\n34. hyperlipoprotein?emia*.tw.\n35. hypertriglycerid?emia*.tw.\n36. exp Arteriosclerosis/\n37. exp Cholesterol/\n38. cholesterol.tw.\n39. \"coronary risk factor* \".tw.\n40. Blood Pressure/\n41. blood pressure.tw.\n42. or/1-41\n43. Mass Screening/\n44. Systematic risk assessment*.tw.\n45. Case finding.tw.\n46. ((screen* or assess* or test* or diagnos* or surveill* or identifi* or prevelence or incidence*) adj10 (structured or systematic or organised or organized or opportunistic or random)).tw.\n47. Risk Assessment/\n48. (risk* adj3 assess*).tw.\n49. or/43-48\n50. Primary Prevention/\n51. (prophylaxis or prevent*).tw.\n52. 50 or 51\n53. 42 and 49 and 52\n54. randomized controlled trial.pt.\n55. controlled clinical trial.pt.\n56. randomized.ab.\n57. placebo.ab.\n58. drug therapy.fs.\n59. randomly.ab.\n60. trial.ab.\n61. groups.ab.\n62. 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61\n63. exp animals/ not humans.sh.\n64. 62 not 63\n65. 53 and 64",
    "notes": "Types of studies: Randomised controlled trials (RCTs).",
    "start_date": "1945-12-31",
    "end_date": "2015-01-23",
    "annotator_id": 3
  },
  {
    "id": 11,
    "document_id": 6,
    "query": "1. exp ORTHODONTICS/\n2. orthodontic$.mp.\n3. or/1-2\n4. (retention or retain$).mp.\n5. (stabilise$ or stabilize$).mp.\n6. (fraenectom$ or frenectom$).mp.\n7. (fiberotom$ or fibreotom$).mp.\n8. \"interproximal stripping\".mp.\n9. pericision.mp.\n10. reproximat$.mp.\n11. ((gingiv$ or periodont$) adj4 surg$).mp.\n12. (retain or retention).mp.\n13. 11 and 12\n14. or/4-10\n15. 13 or 14\n16. 3 and 15",
    "notes": "Types of studies: Randomised controlled trials.",
    "start_date": "1945-12-31",
    "end_date": "2016-01-25",
    "annotator_id": 3
  },
  {
    "id": 12,
    "document_id": 6,
    "query": "1. randomized controlled trial.pt.\n2. controlled clinical trial.pt.\n3. randomized.ab.\n4. placebo.ab.\n5. drug therapy.fs.\n6. randomly.ab.\n7. trial.ab.\n8. groups.ab.\n9. or/1-8\n10. exp animals/ not humans.sh.\n11. 9 not 10",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2016-01-25",
    "annotator_id": 3
  },
  {
    "id": 14,
    "document_id": 8,
    "query": "randomized controlled trial.pt.\n\ncontrolled clinical trial.pt.\n\npragmatic clinical trial.pt.\n\nrandomized.ab.\n\nplacebo.ab,ti.\n\ndrug therapy.fs.\n\nrandomly.ab,ti.\n\ntrial.ab,ti.\n\ngroups.ab,ti.\n\nor/1-9\n\n(animals not (humans and animals)).sh.\n\n10 not 11\n\nexp Constriction, Pathologic/\n\nlimit 13 to yr=\"1976 - 1982\"\n\nexp Lumbar Vertebrae/\n\nlimit 15 to yr=\"1966 - 1982\"\n\nexp Spinal Canal/\n\nlimit 17 to yr=\"1966 - 1982\"\n\nexp Spinal Diseases/\n\nlimit 19 to yr=\"1966 - 1982\"\n\nexp Spinal Stenosis/\n\nspinal stenosis.mp.\n\n(lumbar adj5 stenosis).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n\n(spin* adj5 stenosis).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n\nneurogenic claudication.mp.\n\nexp Spinal Osteophytosis/\n\nexp Spondylosis/\n\n(lumb* adj5 spondyl*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n\nexp Cauda Equina/\n\nlumbar radicular pain.mp.\n\n28 or 26 or 29 or 22 or 27 or 18 or 21 or 16 or 23 or 25 or 14 or 20 or 24 or 30\n\n12 and 31\n\nlimit 32 to yr=2012-2015\n\nlimit 32 to ed=20121001-20150211\n\n33 or 34",
    "notes": "We considered for inclusion both randomised controlled trials (RCTs) and quasi-randomised controlled studies",
    "start_date": "1945-12-31",
    "end_date": "2015-02-10",
    "annotator_id": 3
  },
  {
    "id": 10,
    "document_id": 5,
    "query": "#1\tSearch Thrombosis[Mesh]\n#2\tSearch Thromboembolism[Mesh]\n#3\tSearch Venous Thromboembolism[Mesh]\n#4\tSearch Venous Thrombosis[Mesh]\n#5\tSearch thrombus*[tiab] OR thrombotic*[tiab] OR thrombolic*[tiab] OR thromboemboli*[tiab] OR thrombos*[tiab] OR embol*[tiab]\n#6\tSearch Pulmonary Embolism[Mesh]\n#7\tSearch PE[tiab] OR DVT[tiab] OR VTE[tiab]\n#8\tSearch vein thromb*[tiab] OR venous thromb*[tiab]\n#9\tSearch (vein*[ti] OR venous[ti]) AND thromb*[ti]\n#10\tSearch ((((((((#1) OR #2) OR #3) OR #4) OR #5) OR #6) OR #7) OR #8) OR #9\n#11\tSearch warfarin[MeSH]\n#12\tSearch warfarin[tiab] OR Jantoven[tiab] OR Marevan[tiab] OR Lawarin[tiab] OR Waran[tiab] OR Warfant[tiab] OR coumadin[tiab] OR coumarin[tiab] OR coumadin[tiab] OR coumarin[tiab]\n#13\tSearch vitamin k antagon*[tiab]\n#14\tSearch (vitamin k[ti] OR vit k[ti]) AND antagon*[ti]\n#15\tSearch (((#11) OR #12) OR #13) OR #14\n#16\tSearch Nomograms[MeSH]\n#17\tSearch nomogram*[tiab]\n#18\tSearch (initial[ti] OR initiation[ti] OR induction[ti] OR loading[ti]) AND (dose*[ti] OR dosage[ti])\n#19\tSearch (dosing[ti] OR dose*[ti] OR dosage*[ti]) AND (empirical[ti] OR regime*[ti] OR method[ti] OR protocol[ti] OR algorithm*[ti] OR Kovacs[ti] OR Fennerty[ti] OR Tait[ti])\n#20\tSearch (((#16) OR #17) OR #18) OR #19\n#21\tSearch ((#10) AND #15) AND #20",
    "notes": "Types of studies: Randomized controlled trials.",
    "start_date": null,
    "end_date": "2015-09-29",
    "annotator_id": 3
  },
  {
    "id": 9,
    "document_id": 4,
    "query": "1 exp Menorrhagia/ (3581)\n2 menorrhagia.tw. (2686)\n3 hypermenorrhoea.tw. (31)\n4 excessive menstrua$.tw. (163)\n5 dysfunctional uterine bleeding.tw. (779)\n6 heavy menstrua$.tw. (512)\n7 abnormal uterine bleeding.tw. (1382)\n8 abnormal menstrua$ bleeding.tw. (36)\n9 iron deficient anaemia.tw. (42)\n10 or/1-9 (6776)\n11 exp endometrial ablation techniques/ or exp hysterectomy/ or exp hysterectomy, vaginal/ or exp hysteroscopy/ (28277)\n12 hysterectom$.tw. (27351)\n13 endometrial ablation.tw. (976)\n14 hysteroscop$.tw. (4939)\n15 (TAH or LAVH or TCRE).tw. (1213)\n16 transcervical resection$.tw. (196)\n17 laser ablation.tw. (4581)\n18 exp Electrosurgery/ (3806)\n19 electrosurgery.tw. (1177)\n20 (rollerball or thermal balloon).tw. (305)\n21 (hyperthermia or thermotherap$).tw. (22084)\n22 photodynamic therap$.tw. (12018)\n23 exp Cryosurgery/ (11040)\n24 (cryoablation or microwave or laser$ or Cryosurger$).tw. (215571)\n25 surgical treatment$.tw. (118658)\n26 endometrial resection.tw. (270)\n27 Balloon.tw. (48789)\n28 (catheter ablation or radiofrequency or saline irrigation).tw. (26425)\n29 exp Catheter Ablation/ (22294)\n30 ablation.tw. (59556)\n31 or/11-30 (515895)\n32 (medical therap$ or medical treatment$).tw. (57246)\n33 prostaglandin synthetase inhibitor$.mp. or PGSI$.tw. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier] (667)\n34 exp Mefenamic Acid/ (942)\n35 Mefenamic Acid.tw. (1055)\n36 exp Anti-Inflammatory Agents, Non-Steroidal/ (159226)\n37 Nonsteroidal anti inflammator$.tw. (12422)\n38 NSAID$.tw. (18605)\n39 Non steroidal anti inflammator$.tw. (11856)\n40 flurbiprofen.tw. (1982)\n41 FLURBIPROFEN/ (1640)\n42 meclofenamic acid.tw. (284)\n43 Meclofenamic Acid/ (934)\n44 ibuprofen.tw. or IBUPROFEN/ (10885)\n45 naproxen.tw. or NAPROXEN/ (5489)\n46 diclofenac.tw. or DICLOFENAC/ (9539)\n47 gonadotrophin-releasing hormone analogue$.tw. (239)\n48 tranexamic acid.tw. or Tranexamic Acid/ (2823)\n49 progestogen.tw. or Progestins/ (11300)\n50 norethisterone.tw. or Norethindrone/ (4586)\n51 medroxyprogesterone acetate.tw. or Medroxyprogesterone 17-Acetate/ (6294)\n52 Contraceptives, Oral, Combined/ (4230)\n53 danazol.tw. or DANAZOL/ (2820)\n54 Levonorgestrel.tw. or Levonorgestrel/ (4851)\n55 LNG-IUS.tw. (471)\n56 mirena.tw. (229)\n57 antifibrinolytic.tw. or Antifibrinolytic Agents/ (5211)\n58 Combined oral contraceptive$.tw. (1951)\n59 or/32-58 (266223)\n60 59 and 10 and 31 (534)\n61 randomized controlled trial.pt. (385614)\n62 controlled clinical trial.pt. (88649)\n63 randomized.ab. (310509)\n64 placebo.tw. (162856)\n65 clinical trials as topic.sh. (170973)\n66 randomly.ab. (224859)\n67 trial.ti. (133531)\n68 (crossover or cross-over or cross over).tw. (62761)\n69 or/61-68 (959243)\n70 (animals not (humans and animals)).sh. (3896812)\n71 69 not 70 (883409)\n72 60 and 71 (113)",
    "notes": "Randomised controlled trials (RCTs)",
    "start_date": null,
    "end_date": "2016-01-13",
    "annotator_id": 3
  },
  {
    "id": 37,
    "document_id": 55,
    "query": "1. tomography/\n2. tomography, optical coherence/\n3. ophthalmoscopy/\n4. (optical$ adj2 coherence$ adj2 tomograph$).tw.\n5. OCT.tw.\n6. or/1-5\n7. exp macular edema/\n8. (macula$ adj3 oedema).tw.\n9. (macula$ adj3 edema).tw.\n10. maculopath$.tw.\n11. (CME or CSME or CMO or CSMO).tw.\n12. (DMO or DME).tw.\n13. or/7-12\n14. exp diabetes mellitus/\n15. diabetic retinopathy/\n16. diabetes complications/\n17. diabet$.tw.\n18. retinopath$.tw.\n19. or/14-18\n20. 6 and 13 and 19",
    "notes": " Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to June 2013)",
    "start_date": "1945-12-31",
    "end_date": "2013-06-29",
    "annotator_id": 1
  },
  {
    "id": 38,
    "document_id": 82,
    "query": "1. acoustic stimulation.mp. or exp Acoustic Stimulation/\n2. acupressure.mp. or exp Acupressure/\n3. exp Acupuncture/ or acupuncture.mp.\n4. exp Medicine, African Traditional/\n5. anthroposophy.mp. or exp Anthroposophy/\n6. antioxidants.mp. or exp Antioxidants/\n7. arabic medicine.mp. or exp Medicine, Arabic/\n8. aromatherapy.mp. or exp Aromatherapy/\n9. art therapy.mp. or exp Art Therapy/\n10. auricular therapy.mp.\n11. exp Medicine, Ayurvedic/\n12. ayurved$.mp.\n13. biofeedback.mp. or exp Biofeedback, Psychology/\n14. breathing exercise$.mp. or exp Breathing Exercises/\n15. exp Color Therapy/\n16. (color therap$ or colour therap$).mp. [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract, name of substance word, subject heading word, unique identifier]\n17. exp complementary therapies/ or exp acupuncture therapy/ or exp anthroposophy/ or exp auriculotherapy/ or exp holistic health/ or exp homeopathy/ or exp horticultural therapy/ or exp medicine, traditional/ or exp mesotherapy/ or exp mind-body therapies/ or exp musculoskeletal manipulations/ or exp naturopathy/ or exp organotherapy/ or exp phytotherapy/ or exp reflexotherapy/ or exp rejuvenation/ or exp sensory art therapies/ or exp speleotherapy/ or exp spiritual therapies/\n18. dance therapy.mp. or exp Dance Therapy/\n19. exp Medicine, East Asian Traditional/\n20. eclecticism.mp. or exp Eclecticism, Historical/\n21. electroacupuncture.mp. or exp Electroacupuncture/\n22. faith healing.mp. or exp Faith Healing/\n23. holistic health.mp.\n24. homeopathy.mp.\n25. horticultural therapy.mp.\n26. hypnosis.mp. or exp Hypnosis/\n27. exp \"Imagery (Psychotherapy)\"/\n28. kampo.mp. or exp Medicine, Kampo/\n29. exp Kinesiology, Applied/ or kinesiology.mp.\n30. laughter therapy.mp. or exp Laughter Therapy/\n31. magic.mp. or exp Magic/\n32. manipulation.mp. or exp Manipulation, Chiropractic/\n33. exp Massage/ or massage.mp.\n34. meditation.mp. or exp Meditation/\n35. mental healing.mp. or exp Mental Healing/\n36. mesotherapy.mp. or exp Mesotherapy/\n37. moxibustion.mp. or exp Moxibustion/\n38. music therapy.mp. or exp Music Therapy/\n39. exp Naturopathy/ or naturopath$.mp.\n40. natural remed$.mp. [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract, name of substance word, subject heading word, unique identifier]\n41. occultism.mp. or exp Occultism/\n42. exp Psychodrama/ or psychodrama.mp.\n43. drama therapy.mp.\n44. Psychology/ or psychology.mp.\n45. psychophysiology.mp. or exp Psychophysiology/\n46. mind body relation$.mp.\n47. radiesthesia.mp. or exp Radiesthesia/\n48. reflexotherapy.mp. or exp Reflexotherapy/\n49. rejuvenation.mp. or exp Rejuvenation/\n50. relaxation therapy.mp. or exp Relaxation Therapy/\n51. shamanism.mp. or exp Shamanism/\n52. speleotherapy.mp. or exp Speleotherapy/\n53. Tai Ji/\n54. tai chi.mp.\n55. therapeutic touch.mp. or exp Therapeutic Touch/\n56. exp Medicine, Unani/ or unani.mp.\n57. witchcraft.mp. or exp Witchcraft/\n58. yoga.mp. or exp Yoga/\n59. visualisation.mp.\n60. immunoaugmentation.mp.\n61. Tissue Therapy/\n62. Medicine, Chinese Traditional/\n63. tcm.mp.\n64. antineoplaston.mp.\n65. chelation.mp.\n66. shark.mp.\n67. electromagnetic$.mp.\n68. \"Tea Tree Oil\"/\n69. Aloe/\n70. reflexology.mp.\n71. reiki.mp.\n72. herb$.mp.\n73. physical therapy.mp.\n74. cupping therapy.mp.\n75. therapeutic exercise.mp.\n76. folk.mp.\n77. bioelectromagnetic$.mp.\n78. Diet/\n79. nutrition.mp.\n80. Diet, Macrobiotic/\n81. gerson.mp.\n82. support group.mp. or Self-Help Groups/\n83. or/1-82\n84. acne.mp. or exp Acne Vulgaris/\n85. randomized controlled trial.pt.\n86. controlled clinical trial.pt.\n87. randomized.ab.\n88. placebo.ab.\n89. clinical trials as topic.sh.\n90. randomly.ab.\n91. trial.ti.\n92. 85 or 86 or 87 or 88 or 89 or 90 or 91\n93. (animals not (humans and animals)).sh.\n94. 92 not 93\n95. 83 and 84 and 94",
    "notes": "All databases were searched up to 22 January 2014. MEDLINE searches started from 1946.",
    "start_date": "1945-12-31",
    "end_date": "2014-01-21",
    "annotator_id": 1
  },
  {
    "id": 26,
    "document_id": 9,
    "query": "1 exp Heart Failure/\n2 exp Ventricular Dysfunction/\n3 heart failure.tw.\n4 cardiac failure.tw.\n5 (ventric$ adj6 dysfunction$).tw.\n6 (ventric$ adj6 function$).tw.\n7 exp Heart Defects, Congenital/\n8 (congenital$ adj3 heart).tw.\n9 (congenital$ adj3 cardiac).tw.\n10 or/1-9\n11 exp Adrenergic beta-Antagonists/\n12 betablocker$.tw.\n13 (beta$ adj3 block$).tw.\n14 (beta and (adrenergic adj6 block$)).tw.\n15 Acebutolol.tw.\n16 atenolol.tw.\n17 alprenolol.tw.\n18 betaxolol.tw.\n19 bisoprolol.tw.\n20 bupranolol.tw.\n21 carvedilol.tw.\n22 carteolol.tw.\n23 celiprolol.tw.\n24 esmolol.tw.\n25 labetalol.tw.\n26 metoprolol.tw.\n27 nadolol.tw.\n28 oxprenolol.tw.\n29 penbutolol.tw.\n30 pindolol.tw.\n31 practolol.tw.\n32 propranolol.tw.\n33 sotalol.tw.\n34 timolol.tw.\n35 or/11-34\n36 10 and 35\n37 limit 36 to \"all child (0 to 18 years)\"\n38 (child$ or infant$ or pediatr$ or paediatr$ or adolesc$).tw.\n39 38 and 36\n40 37 or 39\n41 randomized controlled trial.pt.\n42 controlled clinical trial.pt.\n43 Randomized controlled trials/\n44 random allocation/\n45 double blind method/\n46 single-blind method/\n47 or/41-46\n48 exp animal/ not humans/\n49 47 not 48\n50 clinical trial.pt.\n51 exp Clinical trials as topic/\n52 (clin$ adj25 trial$).ti,ab.\n53 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ti,ab.\n54 placebos/\n55 placebo$.ti,ab.\n56 random$.ti,ab.\n57 research design/\n58 or/50-57\n59 58 not 48\n60 59 not 49\n61 comparative study.pt.\n62 exp evaluation studies/\n63 follow up studies/\n64 prospective studies/\n65 (control$ or prospectiv$ or volunteer$).ti,ab.\n66 or/61-65\n67 66 not 48\n68 67 not (49 or 60)\n69 49 or 60 or 68\n70 40 and 69",
    "notes": "MEDLINE (Ovid)\n\nAuthors notes:\nThe original review searched the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE (Ovid), EMBASE (Ovid), and LILACS up to January 2008 (Appendix 1). We updated the searches on 9 November 2015 (Appendix 2). We did not apply any language restrictions.",
    "start_date": null,
    "end_date": "2008-01-30",
    "annotator_id": 1
  },
  {
    "id": 27,
    "document_id": 10,
    "query": "#1 \"Middle Ear Ventilation\"[Mesh]\n\n#2 ((tympanostomy OR (middle AND ear) OR tympanic) AND tube*)\n\n#3(ear* AND (\"tube insert*\" OR \"tubes insert*\" OR \"ventilation tube*\" OR \"ventilating tube*\" OR \"tube ventilat*\" OR \"tubes ventilat*\"))\n\n#4 (grommet* OR tubulation OR (middle AND ear AND ventilat*))\n\n#5 (#1 OR #2 OR #3 OR #4)\n\n#6 \"Water\"[Mesh:NoExp]\n\n#7 \"Baths\"[Mesh]\n\n#8 \"Swimming\"[Mesh]\n\n#9 \"Fresh Water\"[Mesh]\n\n#10 \"Swimming Pools\"[Mesh]\n\n#11 \"Immersion\"[Mesh]\n\n#12 \"Oceans and Seas\"[Mesh]\n\n#13 \"Seawater\"[Mesh]\n\n#14 (water* or swim* or shower* or bath* or dry or wash* or clean* or dive or diving or rinsing or rinse or nonswim*)\n\n#15 (immers* or submers* or submerg* or lake* or pond* or creek* or pool* or river* or freshwater* or sea* or ocean* or seawater* or ingress)\n\n#16 \"Ear Protective Devices\"[Mesh]\n\n#17 ((ear and protect*) or \"ear mould*\" or \"ear mold*\" or \"ear plug*\" or earplug* or earmold* or earmould* or \"Canal occlusive devis*\" or \"physical barrier*\" or (cotton and (vaseline or \"petroleum jelly\")))\n\n#18 (#6 OR #7 OR #8 Or #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18)\n\n#19 (#5 AND #18)\n\n#20 \"Middle Ear Ventilation/adverse effects\"[Mesh]\n\n#21 (#19 OR #20)",
    "notes": "Search History:\nPubMed (1946 to 1 September 2015);",
    "start_date": "1945-12-31",
    "end_date": "2015-08-31",
    "annotator_id": 1
  },
  {
    "id": 28,
    "document_id": 43,
    "query": "1. randomized controlled trial.pt.\n2. controlled clinical trial.pt.\n3. randomized controlled trials.sh.\n4. random allocation.sh.\n5. double blind method.sh.\n6. single blind method.sh.\n7. or/1-6\n8. clinical trial.pt.\n9. exp clinical trials/\n10. (clin$ adj25 trial$).ti,ab.\n11. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.\n12. placebos.sh.\n13. placebo$.ti,ab.\n14. random$.ti,ab.\n15. research design.sh.\n16. or/10-15\n17. comparative study.sh.\n18. exp evaluation studies/\n19. follow up studies.sh.\n20. prospective studies.sh.\n21. (control$ or prospectiv$ or volunteer$).ti,ab.\n22. or/17-21\n23. 7 or 16 or 22\n24. abdomen/su\n25. (abdomin$ or abdomen).ti,ab,sh.\n26. (surgery or operat$).ti,ab,sh.\n27. 25 and 26\n28. 24 or 27\n29. analgesia epidural/\n30. exp anesthesia epidural/\n31. (epidural adj2 (analgesi$ or an?esthe$)).ti,ab.\n32. 29 or 30 or 31\n33. 28 and 32\n34. 23 and 33",
    "notes": "Search History:\nOvid MEDLINE (from inception to week 1, November 2014);\nThe search strategy for Ovid MEDLINE (1966 to July 2004) and Ovid CENTRAL (2004, Issue 3). The original search was performed in 2004 and updated in 2010 and in 2014.",
    "start_date": "2003-12-31",
    "end_date": "2014-12-30",
    "annotator_id": 1
  },
  {
    "id": 29,
    "document_id": 101,
    "query": "exp osteoarthritis/\n\nosteoarthr$.tw.\n\n(degenerative adj2 arthritis).tw.\n\narthrosis.tw.\n\nor/1-4\n\nKnee/\n\nexp Knee Joint/\n\nknee$.tw.\n\nor/6-8\n\nexp EXERCISE/\n\nexp exertion/\n\nexp Physical Fitness/\n\nexp Exercise Test/\n\nexp Exercise Tolerance/\n\nexp Sports/\n\nexp PLIABILITY/\n\nexp Physical Endurance/\n\nexertion$.tw.\n\nexercis$.tw.\n\nsport$.tw.\n\n((physical or motion) adj5 (fitness or therap$)).tw.\n\n(physical$ adj2 endur$).tw.\n\n((strength$ or isometric$ or isotonic$ or isokinetic$ or aerobic$ or endurance or  weight$) adj5 (exercis$ or train$)).tw.\n\nexp physical therapy modalities/\n\nphysiotherap$.tw.\n\nmanipulat$.tw.\n\nkinesiotherap$.tw.\n\nexp Rehabilitation/\n\nrehab$.tw.\n\n(skate$ or skating).tw.\n\nrun$.tw.\n\njog$.tw.\n\ntreadmill$.tw.\n\nswim$.tw.\n\nbicycl$.tw.\n\n(cycle$ or cycling).tw.\n\nwalk$.tw.\n\n(row or rows or rowing).tw.\n\nmuscle strength$.tw.\n\nor/10-39\n\nrandomized controlled trial.pt.\n\ncontrolled clinical trial.pt.\n\nrandomized.ab.\n\nplacebo.ab.\n\ndrug therapy.fs.\n\nrandomly.ab.\n\ntrial.ab.\n\ngroups.ab.\n\n41 or 42 or 43 or 44 or 45 or 46 or 47 or 48\n\nhumans.sh.\n\n49 and 50\n\nand/5,9,40,51",
    "notes": "Five electronic databases were searched from inception to May 2013",
    "start_date": null,
    "end_date": "2003-05-30",
    "annotator_id": 1
  },
  {
    "id": 30,
    "document_id": 11,
    "query": "1 (discharge and (plan* or service? or program* or intervention?)).ti.\n2 *Patient Discharge/ \n3 (patient* adj2 discharge*).ti,ab.\n4 (hospital adj2 discharge*).ti,ab.\n5 (discharge adj2 plan*).ti,ab. \n6 (discharge adj service?).ti,ab. \n7 (discharge adj program*).ti,ab. \n8 (discharge adj procedure*).ti,ab. \n9 2 or 3 or 4 or 5 or 6 or 7 or 8 \n10 *\"Continuity of Patient Care\"/\n11 *\"Length of Stay\"/\n12 Patient Readmission/ \n13 (readmission or readmitted or re-admission or re-admitted).ti,ab. \n14 (rehospitali?ation* or re-hospitali?ation* or rehospitali?ed or re-hospitali?ed).ti,ab. (4530)\n15 length of stay.ti,ab. \n16 length of hospital stay.ti,ab. \n17 ((hospital or hospitali?ed or bed) adj2 days).ti,ab. \n18 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17\n19 9 and 18 \n20 1 or 19\n21 randomized controlled trial.pt. \n22 controlled clinical trial.pt.\n23 randomized.ab. \n24 placebo.ab. \n25 drug therapy.fs. \n26 randomly.ab.\n27 trial.ab. \n28 groups.ab. \n29 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 \n30 exp animals/ not humans.sh. \n31 29 not 30 \n32 20 and 31 \n33 (2012* or 2013* or 2014* or 2015* or 2016*).ed,dp,yr. \n34 32 and 33",
    "notes": "Electronic search history:\nMEDLINE via OvidSP (1946 to October 2015)\n\nMEDLINE(R) In-Process & Other Non-Indexed Citations and MEDLINE(R) (OvidSP) [1946 to Present]\nDate searched: 05 October November 2015\n\n(I think here they made a mistake but really it's October)",
    "start_date": "1945-12-31",
    "end_date": "2015-10-04",
    "annotator_id": 1
  },
  {
    "id": 31,
    "document_id": 12,
    "query": "1. exp Colchicine/\n2. colcemid*.tw.\n3. demecolcine.tw.\n4. colchamine.tw.\n5. lumicolchicine*.tw.\n6. gamma-lumicolchicine*.tw.\n7. beta-lumicolchicine.tw.\n8. colchicin*.tw.\n9. colchichine.tw.\n10. aqua colchin.tw.\n11. colchicum.tw.\n12. colchily.tw.\n13. colchimedio.tw.\n14. colchiquim.tw.\n15. colchisol.tw.\n16. colchysat.tw.\n17. colcine.tw.\n18. colcrys.tw.\n19. colgout.tw.\n20. goutichine.tw.\n21. goutnil.tw.\n22. kolkicin.tw.\n23. nsc 757.tw.\n24. tolchicine.tw.\n25. or/1-24\n26. randomized controlled trial.pt.\n27. controlled clinical trial.pt.\n28. randomized.ab.\n29. placebo.ab.\n30. clinical trials as topic.sh.\n31. randomly.ab.\n32. trial.ti.\n33. 26 or 27 or 28 or 29 or 30 or 31 or 32\n34. exp animals/ not humans.sh.\n35. 33 not 34\n36. 25 and 35\n37. (trial* or random*).tw.\n38. 33 or 37\n39. 38 not 34\n40. 25 and 39",
    "notes": "MEDLINE electronic search details:\nMEDLINE In-Process & Other Non-Indexed Citations, MEDLINE Daily, MEDLINE and OLDMEDLINE (Ovid, 1946 to 30 January 2015)\n\n\"We identified trials through systematic searches of the following bibliographic databases on 30 January 2015:\"",
    "start_date": "1945-12-31",
    "end_date": "2015-01-29",
    "annotator_id": 1
  },
  {
    "id": 32,
    "document_id": 83,
    "query": "1. randomized controlled trial.pt.\n2. controlled clinical trial.pt.\n3. randomized.ab.\n4. placebo.ab.\n5. clinical trials as topic.sh.\n6. randomly.ab.\n7. trial.ti.\n8. 1 or 2 or 3 or 4 or 5 or 6 or 7\n9. (animals not (human and animals)).sh.\n10. 8 not 9\n11. exp Dermatitis, Atopic/\n12. atopic dermatitis.mp.\n13. atopic eczema.mp.\n14. exp NEURODERMATITIS/\n15. neurodermatitis.mp.\n16. infantile eczema.mp.\n17. childhood eczema.mp.\n18. Besniers' Prurigo.mp.\n19. exp Eczema/ or eczema.mp.\n20. 16 or 11 or 19 or 14 or 13 or 17 or 12 or 15 or 18\n21. 10 and 20\n22. exp Pyroglyphidae/\n23. (house dust mite$ or housedust mite$).mp. \n24. Dermatophagoide$.mp. \n25. Euroglyphus.mp.\n26. Blomia.mp.\n27. dust mite$.mp.\n28. exp Mites/\n29. 22 or 23 or 24 or 25 or 26 or 27 or 28\n30. 21 and 29",
    "notes": "Databases were searched up to 14 August 2014;\nMEDLINE via Ovid (from 1946) using the strategy in Appendix 2;\n",
    "start_date": "1945-12-31",
    "end_date": "2014-08-13",
    "annotator_id": 1
  },
  {
    "id": 33,
    "document_id": 98,
    "query": "1\tLymphoma/\n2\texp Hodgkin Disease/\n3\tGerminoblastom$.tw,kf,ot.\n4\tReticulolymphosarcom$.tw,kf,ot.\n5\tHodgkin$.tw,kf,ot.\n6\t(malignan$ adj2 (lymphogranulom$ or granulom$)).tw,kf,ot.\n7\tor/1-6\n8\texp Positron-Emission Tomography/\n9\t(pet$ or petscan$ or (Positron$ and emission$) or (Positron$ and tomography$)).tw,kf,ot.\n10\t(pet$ and (deoxy$ or fluor$ or 18fluor$ or fdg$ or 18fdg$ or fludeoxy$)).tw,kf,ot.\n11\texp Tomography, Emission-Computed/\n12\t(pet$ or petscan$).tw,kf,ot.\n13\t(tomograph$ or tomographs$ or tomographic$ or tomography$ or tomographies$).tw,kf,ot.\n14\temission$.tw,kf,ot.\n15\t13 and 14\n16\t8 or 9 or 10 or 11 or 12 or 15\n17\t7 and 16\n18\trandomized controlled trial.pt.\n19\tcontrolled clinical trial.pt.\n20\trandomi?ed.ab.\n21\tplacebo.ab.\n22\tclinical trials as topic.sh.\n23\trandomly.ab.\n24\ttrial.ti.\n25\tor/18-24\n26\thumans.sh.\n27\t25 and 26\n28\t17 and 27",
    "notes": "MEDLINE (Ovid) (1990 to 22.09.2014) (for search strategy see Appendix 2).",
    "start_date": "1989-12-31",
    "end_date": "2014-09-21",
    "annotator_id": 1
  },
  {
    "id": 34,
    "document_id": 13,
    "query": "1. exp angiotensin-converting-enzyme-inhibitors/ or (alacepril or benazepril* or captopril or ceranapril or cilazapril*or delapril or enalapril* or fosinopril* or imidapril or libenzapril or quinaprilat or ramipril* or rentiapril or saralasin or spirapril or temocapril hydrochloride or teprotide or trandolapril or zofenopril or cozaar or valsartan or diovan or telmisartan or micardis or candesartan or tasosartan or verdia or eprosartan or irbesartan).mp. or exp ramipril/ or exp receptors, angiotensin/ or exp losartan/\n2. (surg* or perioperative or preoperative or intraoperative or postoperative).mp.\n3. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) not (animals not (humans and animals)).sh.\n4. 1 and 2 and 3",
    "notes": "Ovid MEDLINE (1966 to 8 December 2014)",
    "start_date": "1965-12-31",
    "end_date": "2014-12-07",
    "annotator_id": 1
  },
  {
    "id": 35,
    "document_id": 99,
    "query": "1. cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or brain ischemia/ or exp brain infarction/ or hypoxia-ischemia, brain/ or carotid artery diseases/ or carotid artery thrombosis/ or carotid artery, internal, dissection/ or intracranial arterial diseases/ or cerebral arterial diseases/ or infarction, anterior cerebral artery/ or infarction, middle cerebral artery/ or infarction, posterior cerebral artery/ or exp \"intracranial embolism and thrombosis\"/ or exp stroke/ or vertebral artery dissection/\n2. (isch?emi$ adj6 (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or attack$)).tw.\n3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle cerebr$ or mca$ or anterior circulation) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.\n4. 1 or 2 or 3\n5. (mailuoning or mai-luo-ning or mai luo ning).mp.\n6. (ayapin or scoparone).mp.\n7. 5 or 6\n8. 4 and 7\n9. exp animals/ not humans.sh.\n10. 8 not 9",
    "notes": "MEDLINE (Ovid) (1966 to May 2014) (Appendix 2)",
    "start_date": "1965-12-31",
    "end_date": "2004-05-30",
    "annotator_id": 1
  },
  {
    "id": 36,
    "document_id": 32,
    "query": "#1 Search fitness for work[tw] OR fitness for duty[tw] OR fitness to work[tw] OR occupational fitness[tw] OR fitness for employment[tw] OR job fitness[tw] OR pre-employ*[tw] OR preemploy*[tw] OR pre-place*[tw] OR preplace*[tw] OR ((pre-work[tw] OR prework[tw]) AND screen*[tw]) OR employment screen*[tw] OR employment test*[tw] OR employee screen*[tw] OR employee test*[tw] OR (post-offer[tw] AND (screen*[tw] OR test[tw] OR tests[tw] OR testing[tw]))\n\n#2 Search \"Randomized Controlled Trial\" [Publication Type] OR \"Controlled Clinical Trial\" [Publication Type] OR \"Randomized Controlled Trials as Topic\"[Mesh] OR \"Random Allocation\"[Mesh] OR \"Double-Blind Method\"[Mesh] OR \"Single-Blind Method\"[Mesh]\n\n#3 Search \"Clinical Trial\" [Publication Type] OR \"Clinical Trials as Topic\"[Mesh] OR \"Placebos\"[Mesh] OR \"Research Design\"[Mesh] OR \"Epidemiologic Research Design\"[Mesh] OR (clinical*[tw] AND trial*[tw]) OR ((singl*[tw] OR doubl*[tw] OR trebl*[tw]) AND (blind*[tw] OR mask*[tw])) OR (placebo*[tw] OR random*[tw])\n\n#4 Search \"Comparative Study\" [Publication Type] OR \"Evaluation Studies\" [Publication Type] OR \"Evaluation Studies as Topic\"[Mesh] OR \"Follow-Up Studies\"[Mesh] OR \"Prospective Studies\"[Mesh] OR control*[tw] OR perspectiv*[tw] OR volunteer*[tw]\n\n#5 Search #1 AND (#2 OR #3 OR #4)\n\n#6 Search #5 NOT (\"Animals\"[Mesh] NOT \"Humans\"[Mesh])\n\n#7 Search (#6) AND (\"2008/03/01\"[Date - Create] : \"3000\"[Date - Create])\n\n#8 Search (#6) AND (\"2008/03/01\"[Date - Completion] : \"3000\"[Date - Completion])\n\n#9 Search (#6) AND (\"2008/03/01\"[Date - Entrez] : \"3000\"[Date - Entrez])\n\n#10 Search (#6) AND (\"2008/03/01\"[Date - MeSH] : \"3000\"[Date - MeSH])\n\n#11 Search #7 OR #8 OR #9 OR #10",
    "notes": "For the update of this Cochrane review, we searched the following databases: CENTRAL, MEDLINE, EMBASE, Pedro, CINAHL and PsycINFO from 2008 to 31 March 2015 with help from the clinical librarian of the research institute of the primary author (FS) of the review.\n\n(MEDLINE/PUBMED (update 31 March 2015)",
    "start_date": "2007-12-31",
    "end_date": "2015-03-30",
    "annotator_id": 1
  },
  {
    "id": 39,
    "document_id": 34,
    "query": "1 exp Infant, Newborn/\n\n2 Premature Birth/\n\n3 (neonat$ or neo nat$).ti,ab.\n\n4 (newborn$ or new born$ or newly born$).ti,ab.\n\n5 (preterm or preterms or pre term or pre terms).ti,ab.\n\n6 (preemie$ or premie or premies).ti,ab.\n\n7 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab.\n\n8 (low adj3 (birthweight$ or birth weight$)).ti,ab.\n\n9 (lbw or vlbw or elbw).ti,ab.\n\n10 infan$.ti,ab.\n\n11 (baby or babies).ti,ab.\n\n12 Enterocolitis, Necrotizing/\n\n13 enterocolitis.ti,ab.\n\n14 NEC.ti,ab.\n\n15 or/1-14\n\n16 Glutamine/\n\n17 glutam$.ti,ab.\n\n18 levoglutam$.ti,ab.\n\n19 16 or 17 or 18\n\n20 15 and 19\n\n21 randomized controlled trial.pt.\n\n22 controlled clinical trial.pt.\n\n23 randomized.ab.\n\n24 placebo.ab.\n\n25 drug therapy.fs.\n\n26 randomly.ab.\n\n27 trial.ab.\n\n28 groups.ab.\n\n29 or/21-28\n\n30 exp animals/ not humans.sh.\n\n31 29 not 30\n\n32 15 and 19 and 31\n\n33 limit 32 to ed=20111101-20140911",
    "notes": "Cochrane notified me that this was not the most recent version of the review. I clicked the button that took me to the recent version.\n\n--\n\nWe searched: the Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE (OvidSP), Maternity and Infant Care (OvidSP), MEDLINE & MEDLINE in process (OvidSP) and PubMed (until December 2015 updated from previous search in November 2011)\n\n--\n\nThe Cochrane highly sensitive search strategy for identifying randomized trials in MEDLINE (sensitivity-maximizing version) was used to limit retrieval to clinical trials (lines 21-31) (Lefebvre 2011).\n\n--\n\nKey:\n/ = indexing term (MeSH heading)\nexp = exploded MeSH heading\n$ = truncation\n.ti,ab. = terms in either title or abstract fields\nadj3 = terms within three words of each other (any order)\n.pt. = publication type\n.fs. = floating subheading\n.sh.= subject heading\n.ed. = entry date - date added to the database\n",
    "start_date": "2011-10-31",
    "end_date": "2015-12-30",
    "annotator_id": 1
  },
  {
    "id": 40,
    "document_id": 34,
    "query": "1 exp Infant, Newborn/\n\n2 Premature Birth/\n\n3 (neonat$ or neo nat$).ti,ab.\n\n4 (newborn$ or new born$ or newly born$).ti,ab.\n\n5 (preterm or preterms or pre term or pre terms).ti,ab.\n\n6 (preemie$ or premie or premies).ti,ab.\n\n7 (prematur$ adj3 (birth$ or born or deliver$)).ti,ab.\n\n8 (low adj3 (birthweight$ or birth weight$)).ti,ab.\n\n9 (lbw or vlbw or elbw).ti,ab.\n\n10 infan$.ti,ab.\n\n11 (baby or babies).ti,ab.\n\n12 Enterocolitis, Necrotizing/\n\n13 enterocolitis.ti,ab.\n\n14 NEC.ti,ab.\n\n15 or/1-14\n\n16 Glutamine/\n\n17 glutam$.ti,ab.\n\n18 levoglutam$.ti,ab.\n\n19 16 or 17 or 18\n\n20 15 and 19\n\n21 limit 20 to ed=20111101-20140918",
    "notes": "See the previous notes section for details.\n\n--\nMEDLINE In-Process & Other Non-Indexed Citations (OvidSP http://ovidsp.ovid.com/)",
    "start_date": "2011-10-31",
    "end_date": "2015-12-30",
    "annotator_id": 1
  },
  {
    "id": 41,
    "document_id": 34,
    "query": "Search ((((((((((((((((((((((\"Infant, Newborn\"[Mesh])) OR (\"Premature Birth\"[Mesh])) OR (((neonat*[Title/Abstract]) OR neo nat*[Title/Abstract]) OR neo-nat*[Title/Abstract])) OR (((((newborn*[Title/Abstract]) OR new born*[Title/Abstract]) OR new-born*[Title/Abstract]) OR newly born*[Title/Abstract]) OR newly-born*[Title/Abstract])) OR ((((((preterm[Title/Abstract]) OR preterms[Title/Abstract]) OR pre term[Title/Abstract]) OR pre-term[Title/Abstract]) OR pre terms[Title/Abstract]) OR pre-terms[Title/Abstract])) OR (((preemie*[Title/Abstract]) OR premie[Title/Abstract]) OR premies[Title/Abstract])) OR ((prematur*[Title/Abstract]) AND birth*[Title/Abstract])) OR ((prematur*[Title/Abstract]) AND born[Title/Abstract])) OR ((prematur*[Title/Abstract]) AND deliver*[Title/Abstract])) OR ((low[Title/Abstract]) AND birthweight*[Title/Abstract])) OR ((low[Title/Abstract]) AND birth weight*[Title/Abstract])) OR ((low[Title/Abstract]) AND birth-weight*[Title/Abstract])) OR (((lbw[Title/Abstract]) OR vlbw[Title/Abstract]) OR elbw[Title/Abstract])) OR (infan*[Title/Abstract])) OR ((baby[Title/Abstract]) OR babies[Title/Abstract])) OR (\"Enterocolitis, Necrotizing\"[Mesh:noexp]) OR (enterocolitis[Title/Abstract]) OR (NEC[Title/Abstract]))) AND (((levoglutam*[Title/Abstract]) OR glutam*[Title/Abstract]) OR \"Glutamine\"[Mesh:noexp]))) AND (((((((((((randomized controlled trial[Publication Type])) OR (controlled clinical trial[Publication Type])) OR (randomized[Title/Abstract])) OR (placebo[Title/Abstract])) OR (drug therapy[MeSH Subheading])) OR (randomly[Title/Abstract])) OR (trial[Title/Abstract])) OR (groups[Title/Abstract]))) NOT (animals[mh] NOT humans[mh])))) AND (\"2011/11/01\"[Date - Entrez] : \"3000\"[Date - Entrez])",
    "notes": "See the previous notes section for details.\n\nThis is another document that seems to search both \"PubMed\" and \"MEDLINE\"\n--\nhttp://www.ncbi.nlm.nih.gov/pubmed/\n\nThe Cochrane highly sensitive search strategy for identifying randomized trials in PubMed (sensitivity-maximizing version) was used to limit retrieval to clinical trials (Lefebvre 2011).\n\n--\n[Mesh] = exploded Medical Subject heading (MeSH)\n[mh] = exploded MeSH\n[Mesh:noexp] = MeSH not exploded\n* = truncation\n[Title/Abstract] = terms in either title or abstract fields\n[Date - Entrez] = entry date - date added to the database",
    "start_date": "2011-10-31",
    "end_date": "2015-12-30",
    "annotator_id": 1
  },
  {
    "id": 42,
    "document_id": 8,
    "query": "randomized controlled trial.pt.\n\ncontrolled clinical trial.pt.\n\npragmatic clinical trial.pt.\n\nrandomized.ab.\n\nplacebo.ab,ti.\n\ndrug therapy.fs.\n\nrandomly.ab,ti.\n\ntrial.ab,ti.\n\ngroups.ab,ti.\n\nor/1-9\n\n(animals not (humans and animals)).sh.\n\n10 not 11\n\nexp Constriction, Pathologic/\n\nlimit 13 to yr=\"1976 - 1982\"\n\nexp Lumbar Vertebrae/\n\nlimit 15 to yr=\"1966 - 1982\"\n\nexp Spinal Canal/\n\nlimit 17 to yr=\"1966 - 1982\"\n\nexp Spinal Diseases/\n\nlimit 19 to yr=\"1966 - 1982\"\n\nexp Spinal Stenosis/\n\nspinal stenosis.mp.\n\n(lumbar adj5 stenosis).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n\n(spin* adj5 stenosis).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n\nneurogenic claudication.mp.\n\nexp Spinal Osteophytosis/\n\nexp Spondylosis/\n\n(lumb* adj5 spondyl*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n\nexp Cauda Equina/\n\nlumbar radicular pain.mp.\n\n28 or 26 or 29 or 22 or 27 or 18 or 21 or 16 or 23 or 25 or 14 or 20 or 24 or 30\n\n12 and 31",
    "notes": "MEDLINE In-Process & Other Non-Indexed Citations",
    "start_date": "1945-12-31",
    "end_date": "2015-02-10",
    "annotator_id": 1
  },
  {
    "id": 43,
    "document_id": 14,
    "query": "1. exp Bronchiectasis/\n\n2. bronchiect$.mp.\n\n3. bronchoect$.mp.\n\n4. kartagener$.mp.\n\n5. (ciliary adj3 dyskinesia).mp.\n\n6. (bronchial$ adj3 dilat$).mp.\n\n7. or/1-6",
    "notes": "Bronchiectasis search\n\n--\n\nThe previously published version included searches up to October 2009. The search period for this update is October 2009 through September 2015.\n\nMEDLINE searches started from 1966.\n\n--\n\nFor MEDLINE, OLDMEDLINE and EMBASE, we combined the topic search strategy with the RCT search filter as outlined in the Airways Group module.",
    "start_date": "1965-12-31",
    "end_date": "2009-10-30",
    "annotator_id": 1
  },
  {
    "id": 44,
    "document_id": 14,
    "query": "1. exp \"clinical trial [publication type]\"/\n\n2. (randomized or randomised).ab,ti.\n\n3. placebo.ab,ti.\n\n4. dt.fs.\n\n5. randomly.ab,ti.\n\n6. trial.ab,ti.\n\n7. groups.ab,ti.\n\n8. or/1-7\n\n9. Animals/\n\n10. Humans/\n\n11. 9 not (9 and 10)\n\n12. 8 not 11",
    "notes": "See previous query notes for more details.\n\n--\n\nFilter to identify RCTs",
    "start_date": "1965-12-31",
    "end_date": "2009-10-30",
    "annotator_id": 1
  },
  {
    "id": 45,
    "document_id": 113,
    "query": "1. exp Dementia/\n\n2. Dementia, Multi-Infarct/\n\n3. Dementia, Vascular/\n\n4. Alzheimer Disease/\n\n5. Lewy Body Disease/\n\n6. Delirium/\n\n7. Huntington Disease/\n\n8. \"Pick Disease of the Brain\"/\n\n9. Kluver-Bucy Syndrome/\n\n10. Wernicke Encephalopathy/\n\n11. Creutzfeldt-Jakob Syndrome/\n\n12. Delirium, Dementia, Amnestic, Cognitive Disorders/\n\n13. dement*.mp.\n\n14. Alzheimer*.mp.\n\n15. (lewy* adj2 bod*).mp.\n\n16. deliri*.mp.\n\n17. ((cognit* or memory* or mental*) adj3 (declin* or impair* or los* or deteriorat*)).mp.\n\n18. (chronic adj2 cerebrovascular).mp.\n\n19. (\"organic brain disease\" or \"organic brain syndrome\").mp.\n\n20. \"supranuclear palsy\".mp.\n\n21. (\"normal pressure hydrocephalus\" and \"shunt*\").mp.\n\n22. \"benign senescent forgetfulness\".mp.\n\n23. (cerebr* adj2 deteriorat*).mp.\n\n24. (cerebral* adj2 insufficient*).mp.\n\n25. (confusion* or confused).mp.\n\n26. (pick* adj2 disease).mp.\n\n27. (creutzfeldt or jcd or cjd).mp.\n\n28. huntington*.mp.\n\n29. binswanger*.mp.\n\n30. korsako*.mp.\n\n31. (mci or \"subjective memory complaint\" or \"episodic memory\").mp.\n\n32. (\"incipient dementia\" or \"pre-clinical ad\" or \"pre-clinical alzheimer*\").mp.\n\n33. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32\n\n34. Patient Care Management/\n\n35. \"Case manag*\".ti,ab.\n\n36. Case Management/\n\n37. Managed Care Programs/\n\n38. \"Managed care\".ti,ab.\n\n39. \"Care pathway\".ti,ab.\n\n40. Outreach.ti,ab.\n\n41. \"Crisis resolution\".ti,ab.\n\n42. Disease Management/\n\n43. \"Disease management\".ti,ab.\n\n44. Intermediate Care Facilities/\n\n45. Care coordination.ti,ab.\n\n46. Community mental health.ti,ab.\n\n47. Community Mental Health Services/\n\n48. Community Mental Health Centers/\n\n49. Home Nursing/\n\n50. Health Services for the Aged/\n\n51. \"Geriatric health service*\".ti,ab.\n\n52. Home Care Services/\n\n53. Patient Care Team/\n\n54. Admiral nursing.ti,ab.\n\n55. (carer* or caregiver*).mp. adj2 support.ti,ab.\n\n56. Family-based therapy.ti,ab.\n\n57. or/34-56\n\n58. randomized controlled trial.pt.\n\n59. controlled clinical trial.pt.\n\n60. (Randomized or randomised).ti,ab.\n\n61. Randomly.ti,ab.\n\n62. Comparative Study/\n\n63. \"Interrupted time series\".ti,ab.\n\n64. \"ITS design\".ti,ab.\n\n65. Intervention*.ti,ab.\n\n66. Evaluat*.ti,ab.\n\n67. Placebo*.ti,ab.\n\n68. Groups.ti,ab.\n\n69. or/58-68\n\n70. 69 and 57 and 33\n\n71. (2010* or 2011* or 2012*).ed.\n\n72. 70 and 71",
    "notes": "MEDLINE In-process and other non-indexed citations and MEDLINE 1950-present (Ovid SP)",
    "start_date": "1949-12-31",
    "end_date": "2017-02-27",
    "annotator_id": 1
  },
  {
    "id": 46,
    "document_id": 92,
    "query": "1. exp Tracheostomy/ or tracheo?tom*.af. \n2. Respiration, Artificial/ or Laryngeal Masks/ or Positive-Pressure Respiration/ or Pulmonary Ventilation/ or Ventilators, Mechanical/ or High-Frequency Ventilation/ or ((early or precocious or premature) and (late or tardy)).ti,ab. or artificial respiration*.ti,ab. or (ventilat* adj3 (mechanical or high?frequency or oscillation or positive pressure or jet or weaning or pulmonary)).mp. or (respirat* or ventilator*).ti,ab. or chest tube*.ti,ab. or ((airway* or laryngeal) adj3 mask*).mp.\n3. (randomized controlled trial.pt. or controlled clinical trial.pt.or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) not (animals.sh not (humans.sh and animals.sh))\n4. 1 and 2 and 3",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2013-08-30",
    "annotator_id": 1
  },
  {
    "id": 47,
    "document_id": 33,
    "query": "1    exp Ovarian Neoplasms/\n2    (ovar* adj5 (cancer* or neoplasm* or malignan* or tumor* or tumour* or carcinom*)).mp.\n3    1 or 2˜\n4    exp Infusions, Parenteral/\n5    Injections, Intraperitoneal/\n6    intraperitoneal.mp.\n7    intra-peritoneal.mp.\n8    peritone*.mp.\n9    regional.mp.\n10 parenteral.mp.\n11 4 or 5 or 6 or 7 or 8 or 9 or 10\n12 drug therapy.fs.\n13 exp Antineoplastic Agents/\n14 exp Antineoplastic Combined Chemotherapy Protocols/\n15 exp Chemotherapy, Adjuvant/\n16 chemotherap*.mp.\n17 cisplatin.mp.\n18 carboplatin.mp.\n19 cyclophosphamide.mp.\n20 etoposide.mp.\n21 paclitaxel.mp.\n22 doxorubicin.mp.\n23 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22\n24 3 and 11 and 23\n25 randomized controlled trial.pt.\n26 controlled clinical trial.pt.\n27 randomized.ab.\n28 placebo.ab.\n29 drug therapy.fs.\n30 randomly.ab.\n31 trial.ab.\n32 25 or 26 or 27 or 28 or 29 or 30 or 31\n33 24 and 32",
    "notes": "",
    "start_date": "1950-12-31",
    "end_date": "2015-08-30",
    "annotator_id": 1
  },
  {
    "id": 48,
    "document_id": 50,
    "query": "1. Lewy Bodies/\n\n2. dement*.ti,ab.\n\n3. (LDB or DLB or LBD).ti,ab.\n\n4. (lewy* adj2 bod*).ti,ab.\n\n5. Lewy Body Disease/\n\n6. or/1-5\n\n7. DAT scan*.ti,ab.\n\n8. Dopamine Plasma Membrane Transport Proteins/\n\n9. \"dopamine transporter\".ti,ab.\n\n10. Dopaminergic Neurons/\n\n11. FP-CIT.ti,ab.\n\n12. DaTSCAN.ti,ab.\n\n13. (\"123I-β-CIT\" or \"[123I]β-CIT\" or \"[123I]beta-CIT\").ti,ab.\n\n14. \"123I-FP-CIT\".ti,ab.\n\n15. SPECT.ti,ab.\n\n16. \"[99mTc]TRODAT-1\".ti,ab.\n\n17. \"[123I]PE2I\".ti,ab.\n\n18. \"[123I]altropane\".ti,ab.\n\n19. \"[11C]cocaine\".ti,ab.\n\n20. \"[3H]WIN\".ti,ab.\n\n21. \"[11C]altropane\".ti,ab.\n\n22. (\"[11C]/[18F]beta-CFT\" or \"[11C]/[18F]β-CFT\").ti,ab.\n\n23. \"[11C]FE-CIT\".ti,ab.\n\n24. \"[11C]dMP\".ti,ab.\n\n25. Tomography, Emission-Computed, Single-Photon/\n\n26. SPET.ti,ab.\n\n27. \"single photon emission tomography\".ti,ab.\n\n28. \"single photon emission computed tomography\".ti,ab.\n\n29. or/7-28\n\n30. 6 and 29",
    "notes": "We searched MEDLINE (1946 to February 2013)\n\nMEDLINE In-process and other non-indexed citations and MEDLINE 1946 to present (OvidSP)\n\n--\n\n1586 hits retrieved",
    "start_date": "1945-12-31",
    "end_date": "2013-02-27",
    "annotator_id": 1
  },
  {
    "id": 49,
    "document_id": 70,
    "query": "1 randomized controlled trial.pt.\n2 controlled clinical trial.pt.\n3 randomized controlled trials.sh.\n4 random allocation.sh.\n5 double blind method.sh.\n6 single blind method.sh.\n7 or/1-6\n8 (animals not human).sh.\n9 7 not 8\n10 clinical trial.pt.\n11 exp Clinical Trials/\n12 (clin$ adj25 trial$).ab,ti.\n13 ((singl$ or doubl$ or trebl$) adj25 (blind$ or mask$)).ab,ti.\n14 placebo$.sh.\n15 placebo$.ab,ti.\n16 random$.ab,ti.\n17 research design.sh.\n18 or/10-17\n19 18 not 8\n20 19 not 9\n21 comparative study.sh.\n22 exp evaluation studies/\n23 follow up studies.sh.\n24 prospective studies.sh.\n25 (control$ or prospectiv$ or volunteer$).ab,ti.\n26 or/21-25\n27 26 not 8\n28 27 not (9 or 20)\n29 9 or 20 or 28\n30 exp amputation/\n31 amput$.mp.\n32 exp amputees/\n33 30 or 31 or 32\n34 exp artificial limbs/\n35 exp artificial leg/\n36 prosthe$.mp.\n37 34 or 35 or 36\n38 exp rehabilitation/ or exp rehabilitation nursing/ or exp rehabilitation centers/ or exp rehabilitation, vocational/\n39 exp exercise therapy/ or exp exercise/ or exp exercise test/ or exp exercise movement techniques/ or exp exercise tolerance/\n40 exp \"physical education and training\"/\n41 exp physical therapy techniques/\n42 exp physical fitness/\n43 exp movement/ or exp exercise movement techniques/\n44 exp gait/\n45 exp locomotion/\n46 exp walking/\n47 exp musculoskeletal equilibrium/\n48 exp contracture/ or exp posture/ or exp movement/\n49 exp exertion/ or exp muscle, skeletal/ or exp muscle contraction/ or exp muscles/ or exp leg/ or exp isometric contraction/\n50 exp weight bearing/\n51 exp weight perception/\n52 exp biomechanics/\n53 exp energy metabolism/ or exp energy intake/\n54 exp efficiency/\n55 exp kinetics/\n56 or exp muscles/ or exp tarsal joints/ or exp ankle/ or exp electromyography/ or exp kinesiology, applied/ or exp foot/\n57 (patient adj satisfaction).mp.\n58 exp physician's practice patterns/ or exp practice guidelines/\n59 exp clinical protocols/\n60 exp treatment outcome/\n61 exp aptitude/\n62 exp feedback/\n63 or/38-62\n64 29 and 33 and 37 and 63",
    "notes": "This one is formatted really weirdly. They break the search strategy into 5 rows in a table but I can't see why they would do this. I just combined them all into the same query above.",
    "start_date": "1965-12-31",
    "end_date": "2005-12-30",
    "annotator_id": 1
  },
  {
    "id": 50,
    "document_id": 17,
    "query": "1. randomized controlled trial.pt.\n\n2. controlled clinical trial.pt.\n\n3. randomized.ab.\n\n4. placebo.ab.\n\n5. drug therapy.fs.\n\n6. randomly.ab.\n\n7. trial.ab.\n\n8. groups.ab.\n\n9. or/1-8\n\n10. (animals not (humans and animals)).sh.\n\n11. 9 not 10\n\n12. esophag$.mp.\n\n13. oesophag$.mp.\n\n14. 12 or 13\n\n15. Neoplasms/\n\n16. cancer$.mp.\n\n17. exp Adenocarcinoma/\n\n18. carcino$.mp.\n\n19. exp Carcinoma, Squamous Cell/\n\n20. or/15-19\n\n21. 14 and 20\n\n22. exp Medicine, Chinese Traditional/\n\n23. exp Drugs, Chinese Herbal/ or exp Plant Extracts/\n\n24. exp Herbal Medicine/ or exp Plants, Medicinal/\n\n25. exp Complementary Therapies/\n\n26. alternative medicine.ab,ti.\n\n27. artemisinin.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n\n28. milkvetch root.mp.\n\n29. wolfberry fruit.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n\n30. yam rhizome.mp.\n\n31. indian bread.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n\n32. hedyotis.mp. [mp=title, original title, abstract, name of substance word, subject heading word]\n\n33. or/22-32\n\n34. 11 and 21 and 33",
    "notes": "MEDLINE (1950 to September 2015; Appendix 2).",
    "start_date": "1949-12-31",
    "end_date": "2015-09-29",
    "annotator_id": 1
  },
  {
    "id": 52,
    "document_id": 64,
    "query": "1 oscillococcinum.tw,nm.\n2 \"anas barbariae hepatis et cordis extractum\".tw,nm.\n3 Homeopathy/\n4 homeopath*.tw.\n5 homoeopath*.tw.\n6 oscillo*.tw,nm.\n7 or/3-6\n8 Influenza, Human/\n9 exp Influenzavirus A/\n10 exp Influenzavirus B/\n11 influenza*.tw.\n12 flu.tw.\n13 Cough/\n14 cough*.tw.\n15 sore throat*.tw.\n16 exp Viruses/\n17 virus*.tw.\n18 Respiratory Tract Infections/\n19 Respiratory System/\n20 exp Infection/\n21 infection*.tw.\n22 (respiratory adj3 (infection* or tract or acute or symptom*)).tw.\n23 exp Fever/\n24 fever*.tw.\n25 runny nose*.tw.\n26 Headache/\n27 headache*.tw.\n28 (pain adj2 (limb* or joint*)).tw.\n29 or/8-28\n30 7 and 29\n31 1 or 2 or 30",
    "notes": "More recent searches (MEDLINE (Ovid))\n\n--\nMEDLINE (July 2012 to August week 4, 2014)",
    "start_date": "2012-06-30",
    "end_date": "2014-08-30",
    "annotator_id": 1
  },
  {
    "id": 55,
    "document_id": 105,
    "query": "1. Imidazoles/ or Benzyl Compounds/ or hypnomidate.mp. or amidate.af. or exp Etomidate/ or et?omidat$.af. or (r?26?490 or R?16659).mp. or radenar?on.mp.\n2. ((Intubation, Intratracheal/ or Intubation/ or intubat$.ti,ab. or anesthesia/ or anesthesia, intravenous/ or an?esthesia.ti,ab. or anesthesia, general/ or anesthetics/ or an?esthetic$.ti,ab. or (airway adj5 protect$).mp. or Laryngoscopy/ or laryngoscop$.mp. or sedat$.mp. or Hypnotics.mp.) and Sedatives/) or Deep Sedation/ or single bolus dose.mp. or induction.mp. or Conscious Sedation/ or intensive care units/ or burn units/ or coronary care units/ or recovery room/ or respiratory care units/ or Intensive Care/ or Critical Care/ or Emergencies/ or emergenc$.mp. or Emergency Treatment/ or ambulanc$.mp. or emergency service, hospital/ or trauma centers/ or Emergency medical services/ or trauma.ti,ab. or Critical Illness/ or ((intensive or critical$ or serious$) adj5 (ill$ or care or sick$)).mp. or ICU.mp. or shock$.ti,ab.\n3. 1 and 2\n4. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or drug therapy.fs. or randomly.ab. or trial.ab. or groups.ab.) not (animals not (humans and animals)).sh.\n5. 3 and 4",
    "notes": "MEDLINE via OvidSP (1950 to 8 February 2013)",
    "start_date": "1949-12-31",
    "end_date": "2013-02-07",
    "annotator_id": 1
  },
  {
    "id": 51,
    "document_id": 64,
    "query": "#1. exp HOMEOPATHY/\n#2. homeopath$.mp.\n#3. homoeopath$.mp.\n#4. oscillococcinum.mp.\n#5. or/1-4\n#6. exp INFLUENZA/\n#7. influenza.mp.\n#8. flu.mp.\n#9. exp COUGH/\n#10. cough$.mp.\n#11. exp VIRUSES/\n#12. virus$.mp.\n#13. exp Respiratory Tract Infections/\n#14. exp Respiratory System/\n#15. respiratory tract$.mp.\n#16. exp INFECTION/\n# 17. infection$.mp.\n# 18. exp FEVER/\n# 19. fever$.mp.\n# 20. or/6-19\n# 21. 5 and 20\n# 22. limit 21 to yr=2003-2006",
    "notes": "MEDLINE (Ovid)\n--\n\nThese queries come from the first search done.",
    "start_date": "1965-12-31",
    "end_date": "2003-06-29",
    "annotator_id": 1
  },
  {
    "id": 53,
    "document_id": 64,
    "query": "1 oscillo*.tw.\n2 \"anas barbariae\".tw.\n3 (homeopath* or homoeopath*).tw.\n4 or/1-3\n5 influenza.tw.\n6 flu.tw.\n7 influenzavirus.tw.\n8 cough*.tw.\n9 sore throat*.tw.\n10 virus*.tw.\n11 respiratory tract infection*.tw.\n12 respiratory infection*.tw.\n13 fever*.tw.\n14 runny nose*.tw.\n15 headache*.tw.\n16 (pain adj2 (limb* or joint*)).tw.\n17 infection*.tw.\n18 or/5-17\n19 4 and 18",
    "notes": "MEDLINE In-Process & Other Non-Indexed Citations (Ovid)\n\n--\nMEDLINE In-Process & Other Non-Indexed Citations (4 September 2014)",
    "start_date": "2012-06-30",
    "end_date": "2014-08-30",
    "annotator_id": 1
  },
  {
    "id": 54,
    "document_id": 65,
    "query": "#7\tSearch #3 AND #4 AND #5 Limits: Publication Date from 1996/01/01 to 2008/08/29\n\n#6\tSearch #3 AND #4 AND #5 Limits: Publication Date from 1996/01/01 to 2008\n\n#5\tSearch STAVUDINE OR D4T OR ZERIT OR STAVIR\n\n#4\tSearch randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random allocation [mh] OR double-blind method [mh] OR single-blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR (\"clinical trial\" [tw]) OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR ( placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp] OR comparative study [mh] OR evaluation studies [mh] OR follow-up studies [mh] OR prospective studies [mh] OR control* [tw] OR prospectiv* [tw] OR volunteer* [tw]) NOT (animals [mh] NOT human [mh])\n\n#3\tSearch #1 OR #2\n\n#2\tSearch Antiretroviral Therapy, Highly Active[MeSH] OR Anti-Retroviral Agents[MeSH] OR Antiviral Agents[MeSH:NoExp] OR ((anti) AND (hiv[tw])) OR antiretroviral*[tw] OR ((anti) AND (retroviral*[tw])) OR HAART[tw] OR ((anti) AND (acquired immunodeficiency[tw])) OR ((anti) AND (acquired immunedeficiency[tw])) OR ((anti) AND (acquired immuno-deficiency[tw])) OR ((anti) AND (acquired immune-deficiency[tw])) OR ((anti) AND (acquired immun*) AND (deficiency[tw]))\n\n#1\tSearch HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tw] OR hiv-1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw] OR hiv infect*[tw] OR human immunodeficiency virus[tw] OR human immunedeficiency virus[tw] OR human immuno-deficiency virus[tw] OR human immune-deficiency virus[tw] OR ((human immun*) AND (deficiency virus[tw])) OR acquired immunodeficiency syndrome[tw] OR acquired immunedeficiency syndrome[tw] OR acquired immuno-deficiency syndrome[tw] OR acquired immune-deficiency syndrome[tw] OR ((acquired immun*) AND (deficiency syndrome[tw])) OR \"sexually transmitted diseases, viral\"[MH]",
    "notes": "Types of studies: Randomised, controlled blinded and non-blinded clinical trials.\n\nMy feeling is that each of the #number search should be treated as a different query",
    "start_date": "1995-12-31",
    "end_date": "2008-08-28",
    "annotator_id": 3
  },
  {
    "id": 57,
    "document_id": 97,
    "query": "((randomized controlled trial [pt]) OR (controlled clinical trial [pt]) OR (clinical trial [pt]) OR (random allocation [mh]) OR (randomized controlled trials [mh])) AND ((herpes OR herpetic OR simplex) AND (cornea OR corneal OR keratitis OR ocular))",
    "notes": "PubMed (January 1946 to 31 December 2014)",
    "start_date": "1945-12-31",
    "end_date": "2014-12-30",
    "annotator_id": 1
  },
  {
    "id": 58,
    "document_id": 65,
    "query": "#1\tSearch (HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tiab] OR hiv-1*[tiab] OR hiv-2*[tiab] OR hiv1[tiab] OR hiv2[tiab] OR hiv infect*[tiab] OR human immunodeficiency virus[tiab] OR human immunedeficiency virus[tiab] OR human immuno-deficiency virus[tiab] OR human immune-deficiency virus[tiab] OR ((human immun*[tiab]) AND (deficiency virus[tiab])) OR acquired immunodeficiency syndrome[tiab] OR acquired immunedeficiency syndrome[tiab] OR acquired immuno-deficiency syndrome[tiab] OR acquired immune-deficiency syndrome[tiab] OR ((acquired immun*[tiab]) AND (deficiency syndrome[tiab])) OR \"sexually transmitted diseases, Viral\"[MeSH:NoExp])\n\n#2\tSearch (antiretroviral therapy, highly active[MeSH] OR anti-retroviral agents[MeSH] OR antiviral agents[MeSH:NoExp] OR ((anti[tiab]) AND (hiv[tiab])) OR antiretroviral*[tiab] OR ((anti[tiab]) AND (retroviral*[tiab])) OR HAART[tiab] OR ((anti[tiab]) AND (acquired immunodeficiency[tiab])) OR ((anti[tiab]) AND (acquired immuno-deficiency[tiab])) OR ((anti[tiab]) AND (acquired immune-deficiency[tiab])) OR ((anti[tiab]) AND (acquired immun*[tiab]) AND (deficiency[tiab])))\n\n#3\tSearch (#1 AND #2)\n\n#4\tSearch (randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals [mh] NOT humans [mh]))\n\n#5\tSearch (stavudine OR d4T OR zerit OR stavir)\n\n#6\tSearch (#3 AND #4 AND #5)\n\n#7\tSearch ((#3 AND #4 AND #5)) AND (\"2009/06/01\"[Date - Publication] : \"2012/11\"[Date - Publication])",
    "notes": "Types of studies: Randomised, controlled blinded and non-blinded clinical trials.\n\nMy feeling is that each of the #number search should be treated as a different query",
    "start_date": "2009-05-31",
    "end_date": "2012-11-29",
    "annotator_id": 3
  },
  {
    "id": 61,
    "document_id": 86,
    "query": "1 exp Vitamin B Complex/\n2 vitamin b.tw.\n3 folic acid.tw.\n4 folate$.tw.\n5 ((homocystein$ or homocystin$) adj3 (low$ or reduc$)).tw.\n6 pyridoxin$.tw.\n7 cobalamin$.tw.\n8 cyanocobalamin$.tw.\n9 pyridoxol$.tw.\n10 Vitamins/\n11 or/1-10\n12 Cardiovascular Diseases/\n13 exp Myocardial Ischemia/\n14 exp Brain Ischemia/\n15 Cerebrovascular Disorders/\n16 (coronary adj3 disease$).tw.\n17 angina.tw.\n18 myocardial infarct$.tw.\n19 heart infarct$.tw.\n20 heart attack$.tw.\n21 (stroke or strokes).tw.\n22 (cerebr$ adj3 (accident$ or infarct$)).tw.\n23 (brain adj3 infarct$).tw.\n24 apoplexy.tw.\n25 (cardiovascular adj2 (disease$ or event$)).tw.\n26 Hyperhomocysteinemia/\n27 hyperhomocyst?in?emi$.tw.\n28 or/12-27\n29 11 and 28\n30 randomized controlled trial.pt.\n31 controlled clinical trial.pt.\n32 Randomized controlled trials/\n33 random allocation/\n34 double blind method/\n35 single-blind method/\n36 or/30-35\n37 exp animal/ not humans/\n38 36 not 37\n39 clinical trial.pt.\n40 exp Clinical Trials as Topic/\n41 (clin$ adj25 trial$).ti,ab.\n42 ((singl$ or doubl$ or trebl$ or tripl$) adj (blind$ or mask$)).ti,ab.\n43 placebos/\n44 placebo$.ti,ab.\n45 random$.ti,ab.\n46 research design/\n47 or/39-46\n48 47 not 37\n49 38 or 48\n50 49 and 29",
    "notes": "",
    "start_date": "2004-12-31",
    "end_date": "2008-12-30",
    "annotator_id": 1
  },
  {
    "id": 63,
    "document_id": 86,
    "query": "1 exp Vitamin B Complex/\n2 vitamin b.tw.\n3 folic acid.tw.\n4 folate$.tw.\n5 ((homocystein$ or homocystin$) adj3 (low$ or reduc$)).tw.\n6 pyridoxin$.tw.\n7 cobalamin$.tw.\n8 cyanocobalamin$.tw.\n9 pyridoxol$.tw.\n10 Vitamins/\n11 or/1-10\n12 Cardiovascular Diseases/\n13 exp Myocardial Ischemia/\n14 exp Brain Ischemia/\n15 Cerebrovascular Disorders/\n16 (coronary adj3 disease$).tw.\n17 angina.tw.\n18 myocardial infarct$.tw.\n19 heart infarct$.tw.\n20 heart attack$.tw.\n21 (stroke or strokes).tw.\n22 (cerebr$ adj3 (accident$ or infarct$)).tw.\n23 (brain adj3 infarct$).tw.\n24 apoplexy.tw.\n25 (cardiovascular adj2 (disease$ or event$)).tw.\n26 Hyperhomocysteinemia/\n27 hyperhomocyst?in?emi$.tw.\n28 or/12-27\n29 11 and 28\n30 randomized controlled trial.pt.\n31 controlled clinical trial.pt.\n32 randomized.ab.\n33 placebo.ab.\n34 drug therapy.fs.\n35 randomly.ab.\n36 trial.ab.\n37 groups.ab.\n38 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37\n39 exp animals/ not humans.sh. (3663238)\n40 38 not 39\n41 29 and 40\n42 (2012* or 2013* or 2014*).ed.\n43 41 and 42",
    "notes": "",
    "start_date": "2004-12-31",
    "end_date": "2014-02-11",
    "annotator_id": 1
  },
  {
    "id": 69,
    "document_id": 59,
    "query": "neuroblastoma OR neuroblastomas OR neuroblast* OR ganglioneuroblastoma OR ganglioneuroblastomas OR ganglioneuroblast* OR neuroepithelioma OR neuroepitheliomas OR neuroepitheliom* OR esthesioneuroblastoma OR esthesioneuroblastomas OR esthesioneuroblastom* OR schwannian",
    "notes": "For Neuroblastoma the following MeSH headings and text words were used",
    "start_date": "1945-12-31",
    "end_date": "2014-09-30",
    "annotator_id": 1
  },
  {
    "id": 87,
    "document_id": 112,
    "query": "1 exp Orthognathic Surgery/ (87)\n2 exp Orthognathic Surgical Procedures/ (1052)\n3 exp Osteotomy, Le Fort/ (1454)\n4 (orthognathic adj5 surg*).tw. (2516)\n5 (maxillary osteotom* or Le Fort osteotom* or (mandibular adj5 osteotom*) or vertical ramus osteotom* or genioplast*).tw. (2160)\n6 or/1-5 (5695)\n7 exp Antibiotic Prophylaxis/ (8683)\n8 exp Anti-Bacterial Agents/ (527266)\n9 (antibiotic* or cephalosporin* or cefazolin or cefuroxime or amox?cillin* or clindam?cin or penicillin* or levofloxacin).tw. (260904)\n10 or/7-9 (629847)\n11 6 and 10 (65)\n12 randomized controlled trial.pt. (374960)\n13 controlled clinical trial.pt. (88427)\n14 randomi?ed.ab. (327203)\n15 placebo.ab. (146420)\n16 clinical trials as topic.sh. (170264)\n17 randomly.ab. (193925)\n18 trial.ti. (117951)\n19 or/12-18 (878362)\n20 exp animals/ not humans.sh. (3947165)\n21 19 not 20 (807587)\n22 11 and 21 (13)",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2014-05-30",
    "annotator_id": 1
  },
  {
    "id": 56,
    "document_id": 65,
    "query": "#1\tSearch HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tw] OR hiv-1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw] OR hiv infect*[tw] OR human immunodeficiency virus[tw] OR human immunedeficiency virus[tw] OR human immuno-deficiency virus[tw] OR human immune-deficiency virus[tw] OR ((human immun*) AND (deficiency virus[tw])) OR acquired immunodeficiency syndrome[tw] OR acquired immunedeficiency syndrome[tw] OR acquired immuno-deficiency syndrome[tw] OR acquired immune-deficiency syndrome[tw] OR ((acquired immun*) AND (deficiency syndrome[tw])) OR \"sexually transmitted diseases, viral\"[MH]\n\n#2\tSearch Antiretroviral Therapy, Highly Active[MeSH] OR Anti-Retroviral Agents[MeSH] OR Antiviral Agents[MeSH:NoExp] OR ((anti) AND (hiv[tw])) OR antiretroviral*[tw] OR ((anti) AND (retroviral*[tw])) OR HAART[tw] OR ((anti) AND (acquired immunodeficiency[tw])) OR ((anti) AND (acquired immunedeficiency[tw])) OR ((anti) AND (acquired immuno-deficiency[tw])) OR ((anti) AND (acquired immune-deficiency[tw])) OR ((anti) AND (acquired immun*) AND (deficiency[tw]))\n\n#3\tSearch #1 OR #2\n\n#4\tSearch randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized controlled trials [mh] OR random allocation [mh] OR double-blind method [mh] OR single-blind method [mh] OR clinical trial [pt] OR clinical trials [mh] OR (\"clinical trial\" [tw]) OR ((singl* [tw] OR doubl* [tw] OR trebl* [tw] OR tripl* [tw]) AND (mask* [tw] OR blind* [tw])) OR ( placebos [mh] OR placebo* [tw] OR random* [tw] OR research design [mh:noexp] OR comparative study [mh] OR evaluation studies [mh] OR follow-up studies [mh] OR prospective studies [mh] OR control* [tw] OR prospectiv* [tw] OR volunteer* [tw]) NOT (animals [mh] NOT human [mh])\n\n#5\tSearch STAVUDINE OR D4T OR ZERIT OR STAVIR\n\n#6\tSearch #3 AND #4 AND #5\n\n#7\tSearch #3 AND #4 AND #5 Limits: Publication Date from 2008/08/29 to 2009/06/05",
    "notes": "Types of studies: Randomised, controlled blinded and non-blinded clinical trials.\n\nMy feeling is that each of the #number search should be treated as a different query",
    "start_date": "2008-08-28",
    "end_date": "2009-06-04",
    "annotator_id": 3
  },
  {
    "id": 59,
    "document_id": 18,
    "query": "1 exp Surgical Wound Infection/ \n2 exp Surgical Wound Dehiscence/ \n3 (surg* adj5 infect*).tw. \n4 (surg* adj5 wound*).tw. \n5 (surg* adj5 site*).tw. \n6 (surg* adj5 incision*).tw. \n7 (surg* adj5 dehiscen*).tw. \n8 ((post-operative or postoperative) adj5 wound infection*).tw. \n9 exp Preoperative Care/ \n10 exp Perioperative Care/ \n11 ((preoperative or pre-operative) adj care).tw. \n12 or/1-11 \n13 exp Skin/ \n14 exp Antisepsis/ \n15 and/13-14 \n16 skin antisep*.tw. \n17 exp Anti-Infective Agents, Local/ \n18 exp Iodophors/ \n19 exp Povidone-Iodine/ \n20 exp Chlorhexidine/ \n21 exp Alcohols/ \n22 exp Soaps/ \n23 (iodophor* or povidone-iodine or betadine or chlorhexidine or triclosan or hexachlorophene or benzalkonium or alcohol or alcohols or antiseptic* or soap*).tw. \n24 exp Disinfectants/ \n25 13 and 24 \n26 (skin adj5 disinfect*).tw. \n27 exp Detergents/ \n28 13 and 27 \n29 (skin adj5 detergent*).tw. \n30 or/15-23,25-26,28-29 \n31 exp Handwashing/ \n32 exp Hand/ \n33 (hand or hands or handwash* or surgical scrub*).tw. \n34 or/31-33 \n35 12 and 30 and 34",
    "notes": "Ovid MEDLINE (2005 to May Week 5 2007);",
    "start_date": "2004-12-31",
    "end_date": "2007-05-30",
    "annotator_id": 1
  },
  {
    "id": 60,
    "document_id": 65,
    "query": "#6\t Search: (((((HIV INFECTIONS) OR HIV OR HIV OR HIV-1* OR HIV-2* OR HIV1 OR HIV2 OR (HIV INFECT*) OR (HUMAN IMMUNODEFICIENCY VIRUS) OR (HUMAN IMMUNEDEFICIENCY VIRUS) OR (HUMAN IMMUNO-DEFICIENCY VIRUS) OR (HUMAN IMMUNE-DEFICIENCY VIRUS) OR ((HUMAN IMMUN*) AND (DEFICIENCY VIRUS)) OR (ACQUIRED IMMUNODEFICIENCY SYNDROME))) OR (((ACQUIRED IMMUNEDEFICIENCY SYNDROME) OR (ACQUIRED IMMUNO-DEFICIENCY SYNDROME) OR (ACQUIRED IMMUNE-DEFICIENCY SYNDROME) OR ((ACQUIRED IMMUN*) AND (DEFICIENCY SYNDROME)) OR (SEXUALLY TRANSMITTED DISEASES, VIRAL)))) OR ((Antiretroviral Therapy, Highly Active[MeSH] OR Anti-Retroviral Agents[MeSH] OR Antiviral Agents[MeSH:NoExp] OR ((anti) AND (hiv[tw])) OR antiretroviral*[tw] OR ((anti) AND (retroviral*[tw])) OR HAART[tw] OR ((anti) AND (acquired immunodeficiency[tw]))) OR (((anti) AND (acquired immunedeficiency[tw])) OR ((anti) AND (acquired immuno-deficiency[tw])) OR ((anti) AND (acquired immune-deficiency[tw])) OR ((anti) AND (acquired immun*) AND (deficiency[tw]))))) AND ((((RANDOMIZED CONTROLLED TRIAL) OR (CONTROLLED CLINICAL TRIAL) OR (RANDOMIZED CONTROLLED TRIALS) OR (RANDOM ALLOCATION) OR (DOUBLE-BLIND METHOD) OR (SINGLE-BLIND METHOD) OR (CLINICAL TRIAL) OR (CLINICAL TRIALS) OR (CLINICAL TRIAL) OR ((SINGL* OR DOUBL* OR TREBL* OR TRIPL*) AND (MASK* OR BLIND* )))) OR ((PLACEBOS OR PLACEBO* OR RANDOM* OR (COMPARATIVE STUDY) OR (EVALUATION STUDIES) OR (FOLLOW-UP STUDIES) OR (PROSPECTIVE STUDIES) OR CONTROL* OR PROSPECTIV* OR VOLUNTEER*))) AND (STAVUDINE OR D4T OR ZERIT OR STAVIR) Limit: 2008/08/29:2009/06/05\n\n\n#5\t Search: STAVUDINE OR D4T OR ZERIT OR STAVIR\n\n\n#4\t Search: (((RANDOMIZED CONTROLLED TRIAL) OR (CONTROLLED CLINICAL TRIAL) OR (RANDOMIZED CONTROLLED TRIALS) OR (RANDOM ALLOCATION) OR (DOUBLE-BLIND METHOD) OR (SINGLE-BLIND METHOD) OR (CLINICAL TRIAL) OR (CLINICAL TRIALS) OR (CLINICAL TRIAL) OR ((SINGL* OR DOUBL* OR TREBL* OR TRIPL*) AND (MASK* OR BLIND* )))) OR ((PLACEBOS OR PLACEBO* OR RANDOM* OR (COMPARATIVE STUDY) OR (EVALUATION STUDIES) OR (FOLLOW-UP STUDIES) OR (PROSPECTIVE STUDIES) OR CONTROL* OR PROSPECTIV* OR VOLUNTEER*))\n\n\n#3\t Search: ((((HIV INFECTIONS) OR HIV OR HIV OR HIV-1* OR HIV-2* OR HIV1 OR HIV2 OR (HIV INFECT*) OR (HUMAN IMMUNODEFICIENCY VIRUS) OR (HUMAN IMMUNEDEFICIENCY VIRUS) OR (HUMAN IMMUNO-DEFICIENCY VIRUS) OR (HUMAN IMMUNE-DEFICIENCY VIRUS) OR ((HUMAN IMMUN*) AND (DEFICIENCY VIRUS)) OR (ACQUIRED IMMUNODEFICIENCY SYNDROME))) OR (((ACQUIRED IMMUNEDEFICIENCY SYNDROME) OR (ACQUIRED IMMUNO-DEFICIENCY SYNDROME) OR (ACQUIRED IMMUNE-DEFICIENCY SYNDROME) OR ((ACQUIRED IMMUN*) AND (DEFICIENCY SYNDROME)) OR (SEXUALLY TRANSMITTED DISEASES, VIRAL)))) OR ((Antiretroviral Therapy, Highly Active[MeSH] OR Anti-Retroviral Agents[MeSH] OR Antiviral Agents[MeSH:NoExp] OR ((anti) AND (hiv[tw])) OR antiretroviral*[tw] OR ((anti) AND (retroviral*[tw])) OR HAART[tw] OR ((anti) AND (acquired immunodeficiency[tw]))) OR (((anti) AND (acquired immunedeficiency[tw])) OR ((anti) AND (acquired immuno-deficiency[tw])) OR ((anti) AND (acquired immune-deficiency[tw])) OR ((anti) AND (acquired immun*) AND (deficiency[tw]))))\n\n\n#2\t Search: (Antiretroviral Therapy, Highly Active[MeSH] OR Anti-Retroviral Agents[MeSH] OR Antiviral Agents[MeSH:NoExp] OR ((anti) AND (hiv[tw])) OR antiretroviral*[tw] OR ((anti) AND (retroviral*[tw])) OR HAART[tw] OR ((anti) AND (acquired immunodeficiency[tw]))) OR (((anti) AND (acquired immunedeficiency[tw])) OR ((anti) AND (acquired immuno-deficiency[tw])) OR ((anti) AND (acquired immune-deficiency[tw])) OR ((anti) AND (acquired immun*) AND (deficiency[tw])))\n\n\n#1\t Search: (((HIV INFECTIONS) OR HIV OR HIV OR HIV-1* OR HIV-2* OR HIV1 OR HIV2 OR (HIV INFECT*) OR (HUMAN IMMUNODEFICIENCY VIRUS) OR (HUMAN IMMUNEDEFICIENCY VIRUS) OR (HUMAN IMMUNO-DEFICIENCY VIRUS) OR (HUMAN IMMUNE-DEFICIENCY VIRUS) OR ((HUMAN IMMUN*) AND (DEFICIENCY VIRUS)) OR (ACQUIRED IMMUNODEFICIENCY SYNDROME))) OR (((ACQUIRED IMMUNEDEFICIENCY SYNDROME) OR (ACQUIRED IMMUNO-DEFICIENCY SYNDROME) OR (ACQUIRED IMMUNE-DEFICIENCY SYNDROME) OR ((ACQUIRED IMMUN*) AND (DEFICIENCY SYNDROME)) OR (SEXUALLY TRANSMITTED DISEASES, VIRAL)))",
    "notes": "Types of studies: Randomised, controlled blinded and non-blinded clinical trials.\n\nThis is a PubMed query",
    "start_date": "2007-12-31",
    "end_date": "2009-12-30",
    "annotator_id": 3
  },
  {
    "id": 62,
    "document_id": 86,
    "query": "1 exp Vitamin B Complex/\n2 vitamin b.tw.\n3 folic acid.tw.\n4 folate$.tw.\n5 ((homocystein$ or homocystin$) adj3 (low$ or reduc$)).tw.\n6 pyridoxin$.tw.\n7 cobalamin$.tw.\n8 cyanocobalamin$.tw.\n9 pyridoxol$.tw.\n10 Vitamins/\n11 or/1-10\n12 Cardiovascular Diseases/\n13 exp Myocardial Ischemia/\n14 exp Brain Ischemia/\n15 Cerebrovascular Disorders/\n16 (coronary adj3 disease$).tw.\n17 angina.tw.\n18 myocardial infarct$.tw.\n19 heart infarct$.tw.\n20 heart attack$.tw.\n21 (stroke or strokes).tw.\n22 (cerebr$ adj3 (accident$ or infarct$)).tw.\n23 (brain adj3 infarct$).tw.\n24 apoplexy.tw.\n25 (cardiovascular adj2 (disease$ or event$)).tw.\n26 Hyperhomocysteinemia/\n27 hyperhomocyst?in?emi$.tw.\n28 or/12-27\n29 11 and 28\n30 randomized controlled trial.pt.\n31 controlled clinical trial.pt.\n32 randomized.ab.\n33 placebo.ab.\n34 drug therapy.fs.\n35 randomly.ab.\n36 trial.ab.\n37 groups.ab.\n38 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37\n39 exp animals/ not humans.sh. (3663238)\n40 38 not 39\n41 29 and 40\n42 (200808* or 200809* or 20081* or 2009* or 2010* or 2011* or 2012*).ed.\n43 41 and 42",
    "notes": "",
    "start_date": "2004-12-31",
    "end_date": "2012-12-30",
    "annotator_id": 1
  },
  {
    "id": 64,
    "document_id": 35,
    "query": "1. exp Nicotine/  or exp Nicotinic Agonists/  or exp Receptors, Nicotinic/ or  nicotin*.af.\n2. exp Analgesics/ or exp Analgesia/ or  analges*.mp. or  exp Pain, Postoperative/ or exp pain/dt or exp Surgical Procedures, Operative/ or su.fs. or  (pain* adj5 ((post or follow* or after*) adj3 (surger* or surgic* or operat* or procedur*))).mp.\n3. 1 and 2\n4. (randomized controlled trial.pt. or controlled clinical trial.pt. or randomized.ab. or placebo.ab. or drug therapy.fs. or randomly.ab. or trial.ab. or groups.ab.) not (animals.sh not (humans.sh and animals.sh))\n5. 3 and 4",
    "notes": "We searched MEDLINE (1966 to 20 March 2014)",
    "start_date": "1965-12-31",
    "end_date": "2014-03-19",
    "annotator_id": 1
  },
  {
    "id": 65,
    "document_id": 115,
    "query": "1\texp health promotion/ or residence characteristics/\n2\tcommunity health planning/ or exp community health services/\n3\t(national adj (policy or policies or strateg$ or program$)).ti,ab.\n4\texp mass media/\n5\tcommunity networks/\n6\tcommunity health centers/\n7\t\"marketing of health services\"/\n8\tcities/\n9\trural population/ or rural health/\n10\turban population/\n11\tcommunity-institutional relations/\n12\texp environment design/\n13\tcity planning/\n14\tenvironmental planning.ti,ab.\n15\tsocial environment/\n16\turban health/\n17\tsocial marketing/ or \"health education\"/\n18\t((state or county or town or city or village or nation*) adj2 (wide or whole or communit*)).ti,ab.\n19\t((combined$ or multiple or multi or multifactorial or partner$) adj2 (program$ or strateg$ or intervention$ or organi?ation$)).ti,ab.\n20\t(media intervention* or whole community or community intervention* or community organsai?ation$1).ti,ab.\n21\t(community adj2 (design or action or program* or partner$)).ti,ab.\n22\t((health or community or environment*) adj (policy or policies)).ti,ab.\n23\t(urban design or \"land use policies\" or \"land use policy\").ti,ab.\n24\t((transportation or travel) adj (policy or policies)).ti,ab.\n25\thealth planning.ti,ab.\n26\t((neighbo?rhood* or city or cities or community) adj2 (development or regeneration or renewal or design* or plan* or polic*)).ti,ab.\n27\t(community wide or community setting$ or community group$ or organi?ation$ level$1).ti,ab.\n28\t(Communit$ adj2 base$).ti,ab.\n29\t((built environment* or urban environment* or environmental) adj (change* or intervention*)).ti,ab.\n30\t(environment$ adj2 infrastructure).ti,ab.\n31\t(urban adj2 (regeneration or renewal or plan* or design* or policy or policies or strateg* or program$)).ti,ab.\n32\t(urban adj2 (regeneration or renewal or plan* or design* or policy or policies or strateg* or program$)).ti,ab.\n33\tsocial marketing.ti,ab.\n34\t(\"point of decision\" adj3 (stair* or travel*)).ti,ab.\n35\t(health counsel* or individual counsel*).ti,ab.\n36\t(community adj3 (collaborati* or coalition)).ti,ab.\n37\t((school* or work?place* or employer* or classroom or college) adj2 (strateg$ or program$ or policy or policies)).ti,ab.\n38\t((public or community) adj2 (information or education or campaign or intervention or strateg$ or program$ or policy or policies)).ti,ab.\n39\t(policy change* or fiscal change*).ti,ab.\n40\t(policy adj3 (interven$ or change or introduce$ or modif$ or alter$)).ti,ab.\n41\tphysical infrastructure.ti,ab.\n42\t((road or land) adj us*).ti,ab.\n43\t(Legislation or legislative).ti,ab.\n44\t((Voluntary or volunteer or charities or charity or non-government or government or \"not for profit\") adj2 (group$1 or organisation$ or department$1 or club$1)).ti,ab.\n45\tor/1-44\n46\texp exercise/\n47\trunning/\n48\twalking/\n49\tphysical fitness/\n50\tswimming/\n51\t(fitness adj class*).ti,ab.\n52\tgardening/\n53\texp \"physical education and training\"/\n54\texp dancing/\n55\texp sports/\n56\texp yoga/ or exp fitness centers/ or recreation/ or \"play and playthings\"/ or exp motor activity/\n57\t(fitness adj (regime* or program*)).ti,ab.\n58\tcardiorespiratory fitness.ti,ab.\n59\taerobic capacity.ti,ab.\n60\t((moderate or vigorous*) adj activ*).ti,ab.\n61\t(led walk* or health walk*).ti,ab.\n62\t(physical adj5 (fit* or train* or activ* or endur*)).ti,ab.\n63\t(exercis* adj5 (fit* or train* or activ* or endur*)).ti,ab.\n64\t((leisure or fitness) adj5 (centre* or center* or facilit*)).ti,ab.\n65\t((promot* or uptak* or encourag* or increas* or start* or adher* or sustain* or maintain*) adj5 gym*).ti,ab.\n66\t((promot* or uptak* or encourag* or increas* or start* or adher* or sustain* or maintain*) adj5 physical activ*).ti,ab.\n67\t((promot* or uptak* or encourag* or increas* or start* or adher* or sustain* or maintain*) adj5 (circuit* or aqua*)).ti,ab.\n68\t((promot* or uptak* or encourag* or increas* or start* or adher* or sustain* or maintain*) adj5 (exercis* or exertion or keep fit or fitness class or yoga or aerobic*)).ti,ab.\n69\t((decreas* or reduc* or discourag*) adj5 (sedentary or deskbound or \"physical* inactiv*\")).ti,ab.\n70\tsport*3.ti,ab.\n71\twalk*3.ti,ab.\n72\trunning.ti,ab.\n73\tjogging.ti,ab.\n74\tpilates.ti,ab.\n75\tyoga.ti,ab.\n76\t((cycle or cycling) adj5 (school$ or work or workplace or commut$ or travel$ or equipment or facilit$ or rack$1 or store$1 or storing or park$ or friendly or infrastructure)).ti,ab.\n77\tbicycl*.ti,ab.\n78\t(bike*1 or biking).ti,ab.\n79\t(swim*1 or swimming).ti,ab.\n80\t(exercis*3 adj5 aerobic*).ti,ab.\n81\trollerblading.ti,ab.\n82\trollerskating.ti,ab.\n83\tskating.ti,ab.\n84\texertion*1.ti,ab.\n85\tstrength training.ti,ab.\n86\tresilience training.ti,ab.\n87\tweight lifting.tw.\n88\ttravel mode*1.tw.\n89\t(active adj (travel*4 or transportation or commut$)).tw.\n90\t(multimodal transportation or alternative transport* or alternative travel*).ti,ab.\n91\trecreation*1.ti,ab.\n92\t(\"use\" adj3 stair*).ti,ab.\n93\t(pedestrianis* or pedestrianiz*).ti,ab.\n94\tor/46-93\n95\trandomized controlled trial.pt.\n96\tcontrolled clinical trial.pt.\n97\t(randomized or randomised or placebo or randomly or trial).ab.\n98\trandom allocation/ or clinical trial/ or single-blind method/ or double-blind method/ or control groups/\n99\tIntervention studies/\n100\tevaluation studies/\n101\tprogram evaluation/\n102\tComparative study.pt.\n103\tquasi-experiment$.ti,ab.\n104\t(pre test or pretest or (posttest or post test)).ti,ab.\n105\ttrial.ti.\n106\t(time adj series).ti,ab.\n107\t(pre test or pretest or (posttest or post test)).ti,ab.\n108\t((evaluat$ or intervention or interventional) adj8 (control or controlled or study or program$ or comparison or \"before and after\" or comparative)).ti,ab.\n109\t((intervention or interventional) adj8 (effect* or evaluat* or outcome*)).ti,ab.\n110\t((process or program*) adj3 (effect* or evaluat*)).ti,ab.\n111\t(controlled before or \"before and after stud$\" or follow up assessment).ti,ab.\n112\tor/95-111\n113\t45 and 94 and 112\n114\tanimals/ not (humans/ and animals/)\n115\t113 not 114",
    "notes": "MEDLINE (Ovid) January 1995 to 9 November 2009 [Medline/Medline in Process 5691 hits]; November 2009 to 17 January 2014 [3370 hits]; Total = 9061 hits\n\nlimited by year\n\n--\n\nsame search was done for MEDLINE In-process",
    "start_date": "1994-12-31",
    "end_date": "2014-01-16",
    "annotator_id": 1
  },
  {
    "id": 66,
    "document_id": 58,
    "query": "1. Glaucoma/cn [Congenital]\n2. ((congenital or neonat$ or pediatric$ or paediatric$ or child$) adj5 glaucoma$).tw.\n3. or/1-2\n4. exp trabeculectomy/\n5. goniotom$.tw.\n6. trabeculotom$.tw.\n7. trabeculectom$.tw.\n8. trabectom$.tw.\n9. exp filtering surgery/\n10. ((surg$ or operat$) adj3 filtrat$).tw.\n11. exp sclerostomy/\n12. sclerostom$.tw.\n13. sclerectom$.tw.\n14. viscocanalostom$.tw.\n15. (glaucoma$ adj4 surg$).tw.\n16. exp glaucoma drainage implants/\n17. (molteno or ahmed or baerveldt or krupin or schocket or joseph or optimed).tw.\n18. ((tube$ or device$ or drain$ or shunt$ or implant$ or seton$) adj6 glaucoma$).tw.\n19. laser coagulation/\n20. cyclophotocoagulat$.tw.\n21. cyclocryotherap$.tw.\n22. or/4-21\n23. 3 and 22",
    "notes": "Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to June 2014)",
    "start_date": "1945-12-31",
    "end_date": "2014-07-30",
    "annotator_id": 1
  },
  {
    "id": 67,
    "document_id": 58,
    "query": "#1 (glaucoma*[tw] AND (congenital[tw] OR neonat*[tw] OR pediatric*[tw] OR paediatric*[tw] OR child*[tw])) NOT Medline[sb]\n#2 goniotom*[tw] NOT Medline[sb]\n#3 trabeculotom*[tw] NOT Medline[sb]\n#4 trabeculectom*[tw] NOT Medline[sb]\n#5 trabectom*[tw] NOT Medline[sb]\n#6 (filtrat*[tw] AND (surg*[tw] OR operat*[tw])) NOT Medline[sb]\n#7 sclerostom*[tw] NOT Medline[sb]\n#8 sclerectom*[tw] NOT Medline[sb]\n#9 viscocanalostom*[tw] NOT Medline[sb]\n#10 (glaucoma*[tw] AND surg*[tw]) NOT Medline[sb]\n#11 (molteno[tw] OR ahmed[tw] OR baerveldt[tw] OR krupin[tw] OR schocket[tw] OR joseph[tw] OR optimed[tw]) NOT Medline[sb]\n#12 (glaucoma*[tw] AND (tube*[tw] OR device*[tw] OR drain*[tw] OR shunt*[tw] OR implant*[tw] OR seton*[tw]) NOT Medline[sb]\n#13 cyclophotocoagulat*[tw] NOT Medline[sb]\n#14 cyclocryotherap*[tw] NOT Medline[sb]\n#15 (#2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14)\n#16 (#1 AND #15)",
    "notes": "PubMed search strategy\n\nPubMed (January 1946 to June 2014)",
    "start_date": "1945-12-31",
    "end_date": "2014-06-29",
    "annotator_id": 1
  },
  {
    "id": 68,
    "document_id": 59,
    "query": "retinoic acid OR retinoic acids OR Retinoid* OR Retinoid OR Retinoids OR tretinoin OR Vitamin A Acid OR Acid, Vitamin A OR trans-Retinoic Acid OR Acid, trans-Retinoic OR trans Retinoic Acid OR all-trans-Retinoic Acid OR Acid, all-trans-Retinoic OR all trans Retinoic Acid OR beta-all-trans-Retinoic Acid OR beta all trans Retinoic Acid OR 3-cis-RA OR 13-cis-retinoic acid OR 4759-48-2 OR Retin-A OR Retin A OR Vesanoid OR isotretinoin OR ATRA OR Accutane OR Airol OR Dermairol",
    "notes": "For Retinoic acid the following MeSH headings and text words were used",
    "start_date": "1945-12-31",
    "end_date": "2014-09-30",
    "annotator_id": 1
  },
  {
    "id": 70,
    "document_id": 59,
    "query": "((randomized controlled trial[pt]) OR (controlled clinical trial[pt]) OR (randomized[tiab]) OR (placebo[tiab]) OR (drug therapy[sh]) OR (randomly[tiab]) OR (trial[tiab]) OR (groups[tiab])) AND (humans[mh])\n\nFinal search 1 and 2 and 3",
    "notes": "For RCTs and CCTs the following MeSH headings and text words were used",
    "start_date": "1945-12-31",
    "end_date": "2014-09-30",
    "annotator_id": 1
  },
  {
    "id": 71,
    "document_id": 96,
    "query": "1. (zentralveno?s* kathet* or (venostrom* or venenkathe*) or hickman line* or central line* insertion* or pulmonary arter* flotation* or ((venous or vein*) adj4 (cannulation or access or catheter* puncture)) or central venous line* or central venous pressure).mp. or exp Venous Cutdown/ or Central Venous Pressure/ or exp Catheterization Central Venous/ \n2. (ultrasound* or ultrasonic* or Doppler or echography or ultrasonograpgh*).mp. or exp Ultrasonography Doppler Color/ or exp Echocardiography Doppler/ or exp Ultrasonography/ or exp Ultrasonics/\n3. 1 and 2 \n4. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or drug therapy.fs. or randomly.ab. or trial.ab. or groups.ab.) not (animals not (humans and animals)).sh. \n5. 3 and 4",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2013-01-14",
    "annotator_id": 1
  },
  {
    "id": 72,
    "document_id": 76,
    "query": "1. exp Extracorporeal Membrane Oxygenation/ or ((extracor* or extra-cor*) and membra* and oxygen*).mp. or ECMO.ti,ab. or ((carbon dioxide or CO2) adj3 remov*).mp. or ((pump?free or pumpless or interventional) adj3 lung?assist*).mp. or (PECLA or iLA).ti,ab.\n2. ((lung adj5 assist*) or (severe adj3 (respiratory or cardiac or lung or heart) adj3 (insufficiency or failure))).af.\n3. (lung adj5 assist*).ti,ab.\n4. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or drug therapy.fs. or randomly.ab. or trial.ab. or groups.ab.) not (animals not (humans and animals)).sh.\n5. ((1 and 2) or 3) and 4",
    "notes": "",
    "start_date": "1970-12-31",
    "end_date": "2014-08-17",
    "annotator_id": 1
  },
  {
    "id": 74,
    "document_id": 103,
    "query": "1 Pneumonia, Mycoplasma/\n2 (mycoplasma adj3 pneumonia*).tw.\n3 primary atypical pneumonia.tw.\n4 or/1-3\n5 Mycoplasma pneumoniae/\n6 (mycoplasma pneumoniae or \"M. pneumoniae\").tw.\n7 Mycoplasma Infections/\n8 mycoplasma.tw.\n9 or/5-8\n10 exp Pneumonia/\n11 (pneumon* or bronchopneumon* or pleuropneumon*).tw.\n12 exp Bronchitis/\n13 (bronchit* or tracheobronchit*).tw.\n14 Respiratory Sounds/\n15 wheez*.tw.\n16 exp Respiratory Tract Infections/\n17 (respiratory tract infection* or acute respiratory infection* or lower respiratory infection* or lower respiratory tract infection* or lrti).tw.\n18 or/10-17\n19 9 and 18\n20 4 or 19\n21 exp Anti-Bacterial Agents/\n22 exp Macrolides/\n23 exp Quinolones/\n24 exp Tetracyclines/\n25 antibiotic*.tw,nm.\n26 (macrolide* or erythromycin* or roxithromycin* or clarithromycin* or azithromycin*).tw,nm.\n27 or/21-26\n28 20 and 27",
    "notes": "Previously we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2012, Issue 2) (accessed 13 March 2012), which contains the Acute Respiratory Infection Group's Specialised Register, MEDLINE (1966 to February Week 5, 2012)",
    "start_date": "1965-12-31",
    "end_date": "2012-02-28",
    "annotator_id": 1
  },
  {
    "id": 76,
    "document_id": 103,
    "query": "1 exp MYCOPLASMA/\n2 exp Mycoplasma pneumoniae/\n3 mycoplasma\n4 or/1-3\n5 exp BRONCHITIS/\n6 exp PNEUMONIA/\n7 exp Respiratory Tract Infections/\n8 bronchitis\n9 pneumonia\n10 atypical pneumonia\n11 respiratory tract infection$\n12 acute respiratory infection$\n13 or/5-12\n14 exp Anti-Bacterial Agents/\n15 exp MACROLIDES/\n16 exp QUINOLONES/\n17 exp TETRACYCLINES/\n18 antibiotic$\n19 (macrolide$ or erythromycin or roxithromycin or clarithromycin or azithromycin)\n20 or/14-19\n21 exp CHILD/\n22 (child or children)\n23 (paediatric or pediatric)\n24 or/21-23\n25 4 and 13 and 20 and 24",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2005-02-27",
    "annotator_id": 1
  },
  {
    "id": 81,
    "document_id": 19,
    "query": "1. exp \"clinical trial [publication type]\"/\n\n2. (randomized or randomised).ab,ti.\n\n3. placebo.ab,ti.\n\n4. dt.fs.\n\n5. randomly.ab,ti.\n\n6. trial.ab,ti.\n\n7. groups.ab,ti.\n\n8. or/1-7\n\n9. Animals/\n\n10. Humans/\n\n11. 9 not (9 and 10)\n\n12. 8 not 11\n\n",
    "notes": "Filter to identify RCTs\n\n--\nThe MEDLINE strategy and RCT filter are adapted to identify trials in other electronic databases.",
    "start_date": null,
    "end_date": "2016-01-30",
    "annotator_id": 1
  },
  {
    "id": 82,
    "document_id": 81,
    "query": "1. Alcohol-Related Disorders [mesh]\n2. alcohol* [tiab]\n3. dependen* or disorder* or drink* or misuse or abuse* or consumption [tiab]\n4. #2 AND #3\n5. alcoholism [mesh]\n6. exp drinking behaviour\n7. #1 or #4 or #5 or #6\n8. Anxiety* [tiab]\n9. Anxiety Disorders [mesh]\n10. #8 OR #9\n11. randomized controlled trial [pt]\n12. controlled clinical trial [pt]\n13. random* [tiab]\n14. placebo [tiab]\n15. drug therapy [mesh]\n16. trial [tiab]\n17. groups [tiab]\n18. #11 or #12 or #13 or #14 or #15 or #16 or #17\n19. Animals[mesh] NOT humans [mesh]\n20. #18 NOT #19\n21. #4 AND #10 AND #20",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2013-08-30",
    "annotator_id": 1
  },
  {
    "id": 83,
    "document_id": 74,
    "query": "1 (climacteric or menopaus$).tw. (37286)\n2 (postmenopaus$ or perimenopaus$).tw. (42140)\n3 vasomotor.tw. (10342)\n4 exp Menopause, Premature/ or exp Menopause/ (44481)\n5 exp Climacteric/ (47888)\n6 exp Perimenopause/ (748)\n7 exp Postmenopause/ (18274)\n8 exp Hot Flashes/ (2212)\n9 (hot flash$ or hot flush$).tw. (3446)\n10 night sweat$.tw. (1409)\n11 Nocturnal diaphoresis.tw. (7)\n12 vagina$ dry$.tw. (617)\n13 sexual function$.tw. (8686)\n14 sexual satisfaction.tw. (1342)\n15 vagina$ atrophy.tw. (309)\n16 or/1-15 (101033)\n17 exp Dehydroepiandrosterone Sulfate/ or exp Dehydroepiandrosterone/ (10083)\n18 Dehydroepiandrosterone.tw. (9609)\n19 DHEA$.tw. (6434)\n20 androstenedione.tw. (8040)\n21 Prasterone.tw. (82)\n22 dehydroisoandrosterone.tw. (220)\n23 dha sulfate.tw. (54)\n24 androstenolone.tw. (59)\n25 or/17-24 (19764)\n26 16 and 25 (1887)\n27 randomized controlled trial.pt. (360999)\n28 controlled clinical trial.pt. (87042)\n29 randomized.ab. (281866)\n30 randomised.ab. (55469)\n31 placebo.tw. (153268)\n32 clinical trials as topic.sh. (166848)\n33 randomly.ab. (205060)\n34 trial.ti. (120220)\n35 (crossover or cross-over or cross over).tw. (58959)\n36 or/27-35 (912453)\n37 exp animals/ not humans.sh. (3871615)\n38 36 not 37 (841156)\n39 26 and 38 (281)",
    "notes": "Database: Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) <1946 to Present>",
    "start_date": "1945-12-31",
    "end_date": "2014-02-09",
    "annotator_id": 1
  },
  {
    "id": 88,
    "document_id": 110,
    "query": "1.     exp Adrenergic alpha-Agonists/ or exp Dexmedetomidine/ or exp Clonidine/ or alpha?2 adrenergic agonist*.af. or (dexmed*or precede* or clonidin* or catapresan* or isoglancon or ST-155).mp.\n\n2.     exp Respiration, Artificial/ or Ventilation/ or ((invasive or intubat* or mechanical or artificial) adj3 (ventilat* or respire*)).mp. or ventilat*.ti,ab.\n\n3.     1 and 2\n\n4.     ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) not (animals not (humans and animals)).sh.\n\n5.     3 and 4",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2014-10-08",
    "annotator_id": 1
  },
  {
    "id": 89,
    "document_id": 104,
    "query": "exp PAIN/ (306193)\n\nexp PERIPHERAL NERVOUS SYSTEM DISEASES/ (115068)\n\nexp SOMATOSENSORY DISORDERS/ (16091)\n\n((pain* or discomfort*) adj10 (central or complex or nerv* or neuralg* or neuropath*)).mp. (38237)\n\n((neur* or nerv*) adj6 (compress* or damag*)).mp. (47759)\n\n1 or 2 or 3 or 4 or 5 (449361)\n\nNortriptyline/ (2043)\n\n(nortriptyline or Allegron or Aventyl or Noritren or Norpress or Nortrilen or Pamelor or Sensoval).mp. (2781)\n\n7 or 8 (2781)\n\nrandomized controlled trial.pt. (376175)\n\ncontrolled clinical trial.pt. (88531)\n\nrandomized.ab. (274544)\n\nplacebo.ab. (146796)\n\ndrug therapy.fs. (1708719)\n\nrandomly.ab. (194627)\n\ntrial.ab. (284610)\n\ngroups.ab. (1250317)\n\nor/10-17 (3208598)\n\n6 and 9 and 18 (107)",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2015-01-06",
    "annotator_id": 1
  },
  {
    "id": 109,
    "document_id": 27,
    "query": "1. exp Antifungal Agents/ or exp Mycoses/ or (micafungin or anidulafungin or fung* or fluconazole or diflucan or itraconazole or sporanox or ketoconazole or nizoral or voriconazole or amphotericin or ambisome or amphotec or abelcet or flucytosine or nystatin or miconazole or echinocandin* or caspofungin or (select* adj3 decontam*)).mp.\n\n2. exp Intensive Care Units/ or (intensive care or critical* or surg*).mp.\n\n3. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) not (animals not (humans and animals)).sh.\n\n4. 1 and 2 and 3",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2005-09-01",
    "annotator_id": 1
  },
  {
    "id": 75,
    "document_id": 103,
    "query": "1 exp MYCOPLASMA/\n2 exp Mycoplasma pneumoniae/\n3 mycoplasma.tw.\n4 \"m. pneumoniae\".tw.\n5 or/1-4\n6 exp BRONCHITIS/\n7 exp PNEUMONIA/\n8 exp Respiratory Tract Infections/\n9 bronchit*.tw.\n10 pneumon*.tw.\n11 wheez*.tw.\n12 tracheobronchit*.tw.\n13 respiratory tract infection*.tw.\n14 acute respiratory infection*.tw.\n15 or/6-14\n16 exp Anti-Bacterial Agents/\n17 exp MACROLIDES/\n18 exp QUINOLONES/\n19 exp TETRACYCLINES/\n20 antibiotic*.tw,nm.\n21 (macrolide* or erythromycin or roxithromycin or clarithromycin or azithromycin).tw,nm.\n22 or/16-21\n23 5 and 15 and 22\n24 exp Infant/\n25 (infant* or infancy or newborn* or baby* or babies or neonat* or preterm* or prematur*).tw.\n26 exp Child/\n27 (child* or schoolchild* or school age* or preschool* or kid or kids or toddler*).tw.\n28 Adolescent/\n29 (adoles* or teen* or boy* or girl*).tw.\n30 Minors/\n31 Puberty/\n32 (minor* or pubert* or pubescen*).tw.\n33 exp Pediatrics/\n34 (pediatric* or paediatric*).tw.\n35 exp Schools/\n36 (nursery school* or kindergar* or primary school* or secondary school* or elementary school* or high school* or highschool*).tw.\n37 or/24-36\n38 37 and 23",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2010-02-11",
    "annotator_id": 1
  },
  {
    "id": 77,
    "document_id": 103,
    "query": "1 Pneumonia, Mycoplasma/\n2 (mycoplasma adj3 pneumon*).tw.\n3 primary atypical pneumonia.tw.\n4 or/1-3\n5 Mycoplasma pneumoniae/\n6 (mycoplasma pneumoniae or \"M. pneumoniae\").tw.\n7 Mycoplasma Infections/\n8 mycoplasma.tw.\n9 or/5-8\n10 exp Pneumonia/\n11 (pneumon* or bronchopneumon* or pleuropneumon*).tw.\n12 exp Bronchitis/\n13 (bronchit* or tracheobronchit*).tw.\n14 Respiratory Sounds/\n15 wheez*.tw.\n16 exp Respiratory Tract Infections/\n17 (respiratory tract infection* or acute respiratory infection* or lower respiratory infection* or lower respiratory tract infection* or lrti).tw.\n18 or/10-17\n19 9 and 18\n20 4 or 19\n21 exp Anti-Bacterial Agents/\n22 exp Macrolides/\n23 exp Quinolones/\n24 exp Tetracyclines/\n25 antibiotic*.tw,nm.\n26 (macrolide* or erythromycin* or roxithromycin* or clarithromycin* or azithromycin*).tw,nm.\n27 or/21-26\n28 20 and 27",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2012-02-27",
    "annotator_id": 1
  },
  {
    "id": 78,
    "document_id": 109,
    "query": "1. (protocol* or non?protocol* or directed or guide* or algorithm* or manage* or ((standar* or regular*) adj3 assess*)).mp. or algorithms/ or exp Guideline/ or exp Clinical Protocols/ or exp Medication Therapy Management/ \n2. exp Conscious Sedation/ or exp Analgesia, Patient-Controlled/ or exp Analgesics/ or exp \"Hypnotics and Sedatives\"/ or sedat*.af. or analge*.ti,ab.\n3. 1 and 2 \n4. (((mechanical* or artificial) adj4 (ventil* or wean* or respirat*)) or ((crtical* or intens* or emergency) adj5 (care or ill* or patient* or unit* or ward*)) or (length adj3 stay) or ICU).mp. or exp Intensive Care/ or exp Intensive Care Units/ or exp Critical Care/ or exp Critical Illness/ or exp Respiration, Artificial/ or exp Ventilator Weaning/ or \"Length of Stay\"/\n5. 3 and 4 \n6. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) not (animals not (humans and animals)).sh. \n7. 5 and 6",
    "notes": "",
    "start_date": "1989-12-31",
    "end_date": "2013-11-29",
    "annotator_id": 1
  },
  {
    "id": 79,
    "document_id": 57,
    "query": "1 Noise/\n2 Acoustic Stimulation/\n3 hearing loss/ or deafness/ or hearing loss, bilateral/ or hearing loss, conductive/ or hearing loss, functional/ or hearing loss, high-frequency/ or hearing loss, noise-induced/ (26183)\n4 Sound/ (\n5 1 or 2 or 3 or 4\n6 Intensive Care, Neonatal/\n7 intensive care units/ or intensive care units, neonatal/\n8 6 or 7\n9 exp Infant, Newborn, Diseases/\n10 8 or 9\n11 5 and 10\n12 limit 11 to (\"newborn infant (birth to 1 month)\" and randomised controlled trial)\n13 limit 11 to randomised controlled trial\n14 13 not 12\n15 from 12 keep 5,8\n16 limit 11 to (\"newborn infant (birth to 1 month)\" and controlled clinical trial)\n17 limit 11 to (\"newborn infant (birth to 1 month)\" and clinical trial)\n18 17 not (16 or 12)\n19 limit 5 to (\"newborn infant (birth to 1 month)\" and (clinical trial or controlled clinical trial or randomised controlled trial)) (58)\n20 19 not (12 or 16 or 17)\n21 from 20 keep 4,21,29-32,35,37,40\n22 exp infant, low birth weight/ or infant, premature/\n23 5 and 22\n24 limit 23 to (clinical trial or controlled clinical trial or randomised controlled trial)\n25 24 not (12 or 16 or 17 or 19)\n26 21 or 15",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2014-12-30",
    "annotator_id": 1
  },
  {
    "id": 80,
    "document_id": 19,
    "query": "1. exp Asthma/\n\n2. asthma$.mp.\n\n3. (antiasthma$ or anti-asthma$).mp.\n\n4. Respiratory Sounds/\n\n5. wheez$.mp.\n\n6. Bronchial Spasm/\n\n7. bronchospas$.mp.\n\n8. (bronch$ adj3 spasm$).mp.\n\n9. bronchoconstrict$.mp.\n\n10. exp Bronchoconstriction/\n\n11. (bronch$ adj3 constrict$).mp.\n\n12. Bronchial Hyperreactivity/\n\n13. Respiratory Hypersensitivity/\n\n14. ((bronchial$ or respiratory or airway$ or lung$) adj3 (hypersensitiv$ or hyperreactiv$ or allerg$ or insufficiency)).mp.\n\n15. ((dust or mite$) adj3 (allerg$ or hypersensitiv$)).mp.\n\n16. or/1-15",
    "notes": "Asthma search",
    "start_date": null,
    "end_date": "2016-01-30",
    "annotator_id": 1
  },
  {
    "id": 85,
    "document_id": 116,
    "query": "1   exp Central Nervous System Depressants/\n\n2   exp Anesthesia/\n\n3   exp Benzodiazepines/\n\n4   exp Barbiturates/\n\n5   exp Histamine Antagonists/\n\n6   exp Psychotropic Drugs/\n\n7   (benzodiazepine* or barbiturate* or anaesthesia or anesthesia or opioid* or antipsychotic* or anti-psychotic* or antihistamine* or anti-histamine* or hypnotic* or sedat* or tranquil*).mp.\n\n8   (symptom* adj6 (relie* or control*)).mp.\n\n9   1 or 2 or 3 or 4 or 5 or 6 or 7 or 8\n\n10 Palliative Care/\n\n11 exp Terminal Care/\n\n12 Terminally Ill/\n\n13 palliat*.mp.\n\n14 (terminal* adj6 (care or caring or ill*)).mp.\n\n15 (terminal-stage* or terminal stage* or dying or (close adj6 death)).mp.\n\n16 (end adj3 life).mp.\n\n17 hospice*.mp.\n\n18 ((end-stage* or end stage*) adj6 (disease* or ill* or care or caring)).mp.\n\n19 ((incurable or advanced) adj6 (ill* or disease*)).mp.\n\n20 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19\n\n21 9 and 20\n\n22 randomized controlled trial.pt.\n\n23 controlled clinical trial.pt.\n\n24 randomized.ab.\n\n25 placebo.ab.\n\n26 clinical trials as topic.sh.\n\n27 randomly.ab.\n\n28 trial.ti.\n\n29 exp Cohort Studies/\n\n30 (cohort* or observational* or comparative* or quantitative* or (before and after) or (interrupted and time)).mp.\n\n31 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30\n\n32 21 and 31",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2014-11-29",
    "annotator_id": 1
  },
  {
    "id": 86,
    "document_id": 88,
    "query": "1. exp lung neoplasms/\n\n2. carcinoma, non-small-cell lung/\n\n3. (lung adj2 cancer).tw.\n\n4. (lung adj2 carcinoma$).tw.\n\n5. (lung adj2 neoplas$).tw.\n\n6. (pulmonary adj2 neoplas$).tw.\n\n7. (lung$ adj2 metast$).tw.\n\n8. exp carcinoma,bronchogenic/\n\n9. exp bronchial neoplasms/\n\n10. (bronch$ adj2 cancer$).tw.\n\n11. (bronch$ adj2 carcinoma$).tw.\n\n12. exp pleural neoplasms/\n\n13. or/1-12\n\n14. (lung$ or bronch$ or pulmonary).tw.\n\n15. exp carcinoma, squamous cell/\n\n16. exp adenocarcinoma/\n\n17. ((round adj cell) and (carcinoma$ or cancer$)).tw.\n\n18. ((reserve adj cell) and (carcinoma$ or cancer$)).tw.\n\n19. ((large adj cell) and (carcinoma$ or cancer$)).tw.\n\n20. ((squamous adj cell) and (carcinoma$ or cancer$)).tw.\n\n21. adenocarcinoma$.tw.\n\n22. carcinoma, large cell/\n\n23. or/15-22\n\n24. 14 and 23\n\n25. 13 or 24\n\n26. exp radiotherapy/\n\n27. exp radiotherapy, computer-assisted/\n\n28. exp radiation dosage/\n\n29. exp radiotherapy dosage/\n\n30. exp radiotherapy, high-energy/\n\n31. exp radiotherapy,adjuvant/\n\n32. exp dose fractionation/\n\n33. exp brachytherapy/\n\n34. exp radiation oncology/\n\n35. radiotherap$.tw.\n\n36. (thorac$ adj2 radiotherap$).mp.\n\n37. (radiat$ adj2 therap$).mp.\n\n38. (thorac$ adj2 radiat$).mp.\n\n39. irradiation.tw.\n\n40. (endobronch$ adj2 brachytherap$).mp.\n\n41. or/26-40\n\n42. exp palliative care/\n\n43. exp terminal care/\n\n44. exp quality of life/\n\n45. (symptom$ adj2 control$).mp.\n\n46. (symptom$ adj2 relief).mp.\n\n47. (symptom$ adj2 manag$).mp.\n\n48. (palliat$ adj2 manag$).mp.\n\n49. exp appetite/\n\n50. exp fatigue/\n\n51. exp cough/\n\n52. exp dyspnea/\n\n53. dyspnoea.tw.\n\n54. exp hemoptysis/\n\n55. haemoptysis.tw.\n\n56. exp chest pain/\n\n57. exp deglutition disorders/\n\n58. exp nausea/\n\n59. exp weight loss/\n\n60. tiredness.tw.\n\n61. exp hoarseness/\n\n62. breathlessness.tw.\n\n63. (symptom$ adj2 palliat$).mp.\n\n64. (palliat$ adj2 radiat$).mp.\n\n65. (palliat$ adj2 intent$).mp.\n\n66. or/42-65\n\n67. 41 and 66\n\n68. 25 and 67\n\n69. randomized controlled trial.pt.\n\n70. controlled clinical trial.pt.\n\n71. randomized.ab.\n\n72. placebo.ab.\n\n73. drug therapy.fs.\n\n74. randomly.ab.\n\n75. trial.ab.\n\n76. groups.ab.\n\n77. or/69-76\n\n78. exp animals/ not humans.sh.\n\n79. 77 not 78\n\n80. 68 and 79\n\n81 (201112* or 2012* or 2013* or 2014*).em.\n\n80 and 81",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2014-01-30",
    "annotator_id": 1
  },
  {
    "id": 110,
    "document_id": 36,
    "query": " pneumothorax AND ((infant, newborn[MeSH] OR newborn OR neonate OR neonatal OR premature OR low birth weight OR VLBW OR LBW or infan* or neonat*) AND (randomized controlled trial [pt] OR controlled clinical trial [pt] OR Clinical Trial[ptyp] OR randomized [tiab] OR placebo [tiab] OR clinical trials as topic [mesh: noexp] OR randomly [tiab] OR trial [ti]) NOT (animals [mh] NOT humans [mh]))",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2015-11-29",
    "annotator_id": 1
  },
  {
    "id": 90,
    "document_id": 51,
    "query": "1. exp Dementia/\n\n2. Cognition Disorders/\n\n3. (alzheimer$ or dement$).ti,ab.\n\n4. ((cognit$ or memory or cerebr$ or mental$) adj3 (declin$ or impair$ or los$ or deteriorat$ or degenerat$ or complain$ or disturb$ or disorder$)).ti,ab.\n\n5. (forgetful$ or confused or confusion).ti,ab.\n\n6. MCI.ti,ab.\n\n7. ACMI.ti,ab.\n\n8. ARCD.ti,ab.\n\n9. SMC.ti,ab.\n\n10. CIND.ti,ab.\n\n11. BSF.ti,ab.\n\n12. AAMI.ti,ab.\n\n13. MD.ti,ab.\n\n14. LCD.ti,ab.\n\n15. QD.ti,ab.\n\n16. AACD.ti,ab.\n\n17. MNCD.ti,ab.\n\n18. MCD.ti,ab.\n\n19. (\"N-MCI\" or \"A-MCI\" or \"M-MCI\").ti,ab.\n\n20. or/1-19\n\n21. \"Positron emission tomography\".ti,ab.\n\n22. *Positron-Emission Tomography/\n\n23. PET.ti,ab.\n\n24. \"FDG-PET\".ti,ab.\n\n25. (\"PET-FDG\" or \"18f-fdg\" or \"fdg uptake\").ti,ab.\n\n26. fluodeoxyglucose*.ti,ab.\n\n27. fluorodexyglucose*.ti,ab.\n\n28. Fluorodeoxyglucose F18/\n\n29. or/21-28\n\n30. glucose metabolism.ti,ab.\n\n31. hypometabolism.ti,ab.\n\n32. cerebral metabolic rate.ti,ab.\n\n33. metabolic activity.ti,ab.\n\n34. hypoperfusion.ti,ab.\n\n35. (CMRgl or rCMRGlu).ti,ab.\n\n36. or/30-35\n\n37. 20 and 29 and 36\n\n38. disease progression/\n\n39. (dement* or alzheimer* or AD or MCI).ti,ab.\n\n40. exp *Dementia/\n\n41. 39 or 40\n\n42. 41 and 38\n\n43. 29 and 42\n\n44. 37 or 43\n\n45. exp Dementia/di\n\n46. 36 and 45\n\n47. 44 or 46",
    "notes": "1. MEDLINE In-process and other non-indexed citations and MEDLINE 1950-present (January 2013) (Ovid SP)\n--\n\nhits retrieved\nJuly 2012: 1480\nJanuary 2013: 120",
    "start_date": "1949-12-31",
    "end_date": "2013-01-30",
    "annotator_id": 1
  },
  {
    "id": 91,
    "document_id": 16,
    "query": "1. exp Ovarian Neoplasms/\n2. (ovar* adj5 (cancer* or tumor* or tumour* or neoplas* or carcinoma* or adenocarcinoma* or malignan*)).mp.\n3. 1 or 2\n4. surgery.fs.\n5. exp Gynecologic Surgical Procedures/\n6. (cytoreduct* or debulk*).mp.\n7. 4 or 5 or 6\n8. Tranexamic Acid/\n9. (tranexamic acid or amchafibrin or anvitoff or cyclokapron or cyklokapron or exacyl or kabi 2161 or lysteda or spotof or t-amcha or tranhexamic acid or transamin or ugurol or xp12b).mp\n10. 8 or 9\n11. 3 and 7 and 10",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2015-05-30",
    "annotator_id": 1
  },
  {
    "id": 92,
    "document_id": 47,
    "query": "1 exp Gastrointestinal Neoplasms/\n\n2 exp Genital Neoplasms, Female/\n\n3 exp Ovarian Neoplasms/\n\n4 (gynaecological or gynecological).mp.\n\n5 (gastrointestin$ or gastro-intestin$ or intestin$ or bowel$ or colon$ or colorectal or rectal$ or stomach$ or gastric$).mp.\n\n6 (ovarian or ovary or ovaries).mp.\n\n7 (endometrial or endometrium).mp.\n\n8 (uterine or uterus or vaginal or vulvar or vagina$).mp.\n\n9 (cervix or cervical).mp.\n\n10 or/4-9\n\n11 Neoplasms/\n\n12 (neoplasm$ or cancer$ or carcinoma$ or tumor$ or tumour$).mp.\n\n13 or/11-12\n\n14 10 and 13\n\n15 1 or 2 or 3 or 14\n\n16 exp Intestinal Obstruction/\n\n17 ((bowel$ or intestin$ or gastrointestin$ or gastro-intestin$ or colon$ or colorect$ or retrosigmoid$) and (obstruct$ or blockage)).mp.\n\n18 or/16-17\n\n19 Colorectal Surgery/\n\n20 Surgical Procedures, Elective/\n\n21 (surgery or surgical$ or resect$).mp.\n\n22 19 or 20 or 21\n\n23 18 and 22",
    "notes": "",
    "start_date": "1996-12-31",
    "end_date": "2015-06-29",
    "annotator_id": 1
  },
  {
    "id": 93,
    "document_id": 39,
    "query": "1 Pneumonia, Ventilator-Associated/\n2 vap.tw.\n3 exp Pneumonia/\n4 pneumon*.tw.\n5 3 or 4\n6 exp Respiration, Artificial/\n7 exp Ventilators, Mechanical/\n8 (ventilat* or respirat*).tw.\n9 or/6-8\n10 5 and 9\n11 1 or 2 or 10\n12 exp Posture/\n13 posture*.tw.\n14 Patient Positioning/\n15 position*.tw.\n16 Supine Position/\n17 supine*.tw.\n18 (semi-recumbent* or semi-recumbent*).tw.\n19 (semi-reclin* or semireclin*).tw.\n20 (semisupin* or semi-supin*).tw.\n21 half-sitting.tw.\n22 ((head* or bed or backrest) adj5 (elevat* or rais* or inclin* or angle)).tw.\n23 or/12-22\n24 11 and 23",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2015-10-30",
    "annotator_id": 1
  },
  {
    "id": 94,
    "document_id": 79,
    "query": "1 Patellofemoral Pain Syndrome/ (453)\n2 Patella/ or exp Knee Joint/ or Knee/ (56364)\n3 Arthralgia/ or Pain/ (112939)\n4 2 and 3 (3290)\n5 anterior knee pain.tw. (1003)\n6 ((patell* or femoropatell* or femoro-patell* or retropatell*) adj2 (pain or syndrome or dysfunction)).tw. (1766)\n7 ((lateral compression or lateral facet or lateral pressure or odd facet) adj2 syndrome).tw. (20)\n8 ((chondromalac* or chondropath* or chondrosis) adj2 (knee*1 or patell* or femoropatell* or femoro-patell* or retropatell*)).tw. (513)\n9 Chondromalacia Patellae/ (59)\n10 or/1,4-9 (5753)\n11 exp Exercise Therapy/ or exp Exercise/ (140226)\n12 (exercis* or strengthen* or stretch* or train* or physiotherapy or physical therap*).tw. (595688)\n13 or/11-12 (655179)\n14 Randomized controlled trial.pt. (373732)\n15 Controlled clinical trial.pt. (88369)\n16 randomized.ab. (293610)\n17 placebo.ab. (153908)\n18 Drug therapy.fs. (1698370)\n19 randomly.ab. (212608)\n20 trial.ab. (304899)\n21 groups.ab. (1353578)\n22 or/14-21 (3335964)\n23 exp Animals/ not Humans/ (3938734)\n24 22 not 23 (2860785)\n25 and/10,13,24 (343)",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2014-05-10",
    "annotator_id": 1
  },
  {
    "id": 95,
    "document_id": 45,
    "query": "1. exp Myocardial Ischemia/\n\n2. (myocard* adj5 (ischaemia or ischemia)).tw.\n\n3. (isch?emi* adj5 heart).tw.\n\n4. exp Coronary Artery Bypass/\n\n5. (myocard* adj5 infarct*).tw.\n\n6. (heart adj5 infarct*).tw.\n\n7. angina.tw.\n\n8. (coronary adj5 (disease* or bypass or thrombo* or angioplast*)).tw.\n\n9. exp Percutaneous Coronary Intervention/\n\n10. (percutaneous coronary adj2 (interven* or revascular*)).tw.\n\n11. exp Angioplasty/\n\n12. angioplast*.tw.\n\n13. ((coronary or arterial) adj4 dilat*).tw.\n\n14. endoluminal repair*.tw.\n\n15. exp Stents/\n\n16. stent*.tw.\n\n17. (pci or ptca).tw.\n\n18. exp Atherectomy/\n\n19. atherectom*.tw.\n\n20. acute coronary syndrom*.tw.\n\n21. or/1-8\n\n22. or/1-20\n\n23. exp Exercise Therapy/\n\n24. Sports/\n\n25. Physical Exertion/\n\n26. rehabilitat*.mp.\n\n27. (physical* adj5 (fit* or train* or therap* or activit*)).mp.\n\n28. exp Exercise/\n\n29. (train* adj5 (strength* or aerobic* or exercise*)).tw.\n\n30. ((exercise* or fitness) adj3 (treatment or intervent* or program*)).tw.\n\n31. exp Rehabilitation/\n\n32. kinesiotherap*.tw.\n\n33. \"Physical Education and Training\"/\n\n34. Patient Education as Topic/\n\n35. (patient* adj5 educat*).tw.\n\n36. ((lifestyle or life-style) adj5 (interven* or program* or treatment*)).tw.\n\n37. Self Care/\n\n38. (self adj5 (manag* or care or motivate*)).tw.\n\n39. exp Psychotherapy/\n\n40. psychotherap*.tw.\n\n41. (psycholog* adj5 intervent*).tw.\n\n42. Counseling/\n\n43. (counselling or counseling).tw.\n\n44. ((behavior* or behaviour*) adj5 (modify or modificat* or therap* or change)).tw.\n\n45. (psycho-educat* or psychoeducat*).tw.\n\n46. (motivat* adj5 (intervention or interv*)).tw.\n\n47. Health Education/\n\n48. (health adj5 educat*).tw.\n\n49. (psychosocial or psycho-social).tw.\n\n50. (cognitive adj2 behav*).tw.\n\n51. or/23-33\n\n52. or/23-50\n\n53. 21 and 51\n\n54. 22 and 52\n\n55. randomized controlled trial.pt.\n\n56. controlled clinical trial.pt.\n\n57. randomized.ab.\n\n58. placebo.ab.\n\n59. drug therapy.fs.\n\n60. randomly.ab.\n\n61. trial.ab.\n\n62. groups.ab.\n\n63. 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62\n\n64. exp animals/ not humans.sh.\n\n65. 63 not 64\n\n66. 53 and 65\n\n67. 54 and 65\n\n68. 67 not 66\n\n69. (200912* or 2010* or 2011* or 2012* or 2013* or 2014*).ed.\n\n70. 66 and 69\n\n71. 68 or 70",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2014-07-01",
    "annotator_id": 1
  },
  {
    "id": 96,
    "document_id": 38,
    "query": "randomized controlled trial.pt.\n\ncontrolled clinical trial.pt.\n\nclinical trial.pt.\n\nexp clinical trial/\n\nRandom Allocation/\n\nDouble-Blind Method/\n\nSingle-Blind Method/\n\nComparative Study/\n\nevaluation studies/\n\nFollow-Up Studies/\n\ncross-over studies/\n\nResearch Design/\n\nPlacebos/\n\n(clinic$ adj25 trial$).tw.\n\n((single$ or double$ or treble$ or triple$) adj (mask$ or blind$)).tw.\n\n(control$ or prospective$ or volunteer$).tw.\n\n(latin adj square).tw.\n\nplacebo$.tw.\n\nrandom$.tw.\n\nor/1-19\n\n(animals not (humans and animals)).sh.\n\n20 not 21\n\ndorsalgia.ti,ab.\n\nexp Back Pain/\n\nbackache.ti,ab.\n\n(lumbar adj pain).ti,ab.\n\ncoccyx.ti,ab.\n\ncoccydynia.ti,ab.\n\nsciatica.ti,ab.\n\nexp sciatic neuropathy/\n\nspondylosis.ti,ab.\n\nlumbago.ti,ab.\n\nlow back pain.mp.\n\nor/23-33\n\n22 and 34\n\nexp Exercise/\n\nexercise$.mp.\n\ntrain$.mp.\n\n36 or 37 or 38\n\nspecific.mp.\n\nstabili$.mp.\n\nsegment$.mp.\n\nmultifidus.mp.\n\ntransversus.mp.\n\nmotor control.mp.\n\nor/40-45\n\n39 and 46\n\n35 and 47\n\nlimit 48 to yr=2014-2015\n\nlimit 48 to ed=20140516-20150402\n\n49 or 50",
    "notes": "MEDLINE",
    "start_date": "1945-12-31",
    "end_date": "2014-04-01",
    "annotator_id": 1
  },
  {
    "id": 111,
    "document_id": 75,
    "query": "(zonisamid* or Exceglan or Excegram or Excegran or Zonegran).mp.\n\nexp Pain/\n\n(pain* or analges*).mp.\n\n2 or 3\n\n1 and 4\n\nrandomized controlled trial.pt.\n\nrandomized.ab.\n\nplacebo.ab.\n\ndrug therapy.fs.\n\nrandomly.ab.\n\ntrial.ab.\n\ngroups.ab.\n\n6 or 7 or 8 or 9 or 10 or 11 or 12\n\n5 and 13 (43)",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2014-07-31",
    "annotator_id": 1
  },
  {
    "id": 97,
    "document_id": 38,
    "query": "randomized controlled trial.pt.\n\ncontrolled clinical trial.pt.\n\nclinical trial.pt.\n\nexp clinical trial/\n\nRandom Allocation/\n\nDouble-Blind Method/\n\nSingle-Blind Method/\n\nComparative Study/\n\nevaluation studies/\n\nFollow-Up Studies/\n\ncross-over studies/\n\nResearch Design/\n\nPlacebos/\n\n(clinic$ adj25 trial$).tw.\n\n((single$ or double$ or treble$ or triple$) adj (mask$ or blind$)).tw.\n\n(control$ or prospective$ or volunteer$).tw.\n\n(latin adj square).tw.\n\nplacebo$.tw.\n\nrandom$.tw.\n\nor/1-19\n\n(animals not (humans and animals)).sh.\n\n20 not 21\n\ndorsalgia.ti,ab.\n\nexp Back Pain/\n\nbackache.ti,ab.\n\n(lumbar adj pain).ti,ab.\n\ncoccyx.ti,ab.\n\ncoccydynia.ti,ab.\n\nsciatica.ti,ab.\n\nexp sciatic neuropathy/\n\nspondylosis.ti,ab.\n\nlumbago.ti,ab.\n\nlow back pain.mp.\n\nor/23-33\n\n22 and 34\n\nexp Exercise/\n\nexercise$.mp.\n\ntrain$.mp.\n\n36 or 37 or 38\n\nspecific.mp.\n\nstabili$.mp.\n\nsegment$.mp.\n\nmultifidus.mp.\n\ntransversus.mp.\n\nmotor control.mp.\n\nor/40-45\n\n39 and 46\n\n35 and 47",
    "notes": "MEDLINE In-Process & Other Non-Indexed Citations",
    "start_date": "1945-12-31",
    "end_date": "2014-04-01",
    "annotator_id": 1
  },
  {
    "id": 98,
    "document_id": 67,
    "query": "1. RANDOMIZED CONTROLLED TRIAL.pt.\n2. CONTROLLED CLINICAL TRIAL.pt.\n3. RANDOMIZED CONTROLLED TRIALS.sh.\n4. RANDOM ALLOCATION. sh.\n5. DOUBLE BLIND METHOD. sh.\n6. SINGLE BLIND METHOD. sh.\n7. or/1 6\n8. ANIMALS. sh. not HUMAN. sh.\n9. 7 not 8",
    "notes": "It was stated that this was not the most recent version of the article and so I clicked the button at the top of the review to view the current version. This is the same for any further queries (if any)",
    "start_date": "1965-12-31",
    "end_date": "2008-03-30",
    "annotator_id": 1
  },
  {
    "id": 99,
    "document_id": 67,
    "query": "10. CLINICAL TRIAL.pt.\n11. exp CLINICAL TRIALS/\n12. (clin$ adj25 trial$).ti,ab.\n13. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.\n14. PLACEBOS.sh.\n15. placebo$.ti,ab.\n16. random$.ti,ab.\n17. RESEARCH DESIGN. sh.\n18. or /10- 17\n19. 18 not 8\n20. 19 not 9\n21. 9 or 20",
    "notes": "Phase 2",
    "start_date": "2008-03-30",
    "end_date": "2015-07-30",
    "annotator_id": 1
  },
  {
    "id": 100,
    "document_id": 67,
    "query": "22. Brief intervention$.mp. [mp=title, subject heading word, abstract, instrumentation]\n23. Social norms intervention$.mp. [mp=title, subject heading word, abstract, instrumentation]\n24. (Social$ adj1 norms$).ti,ab.\n25. (norm$ adj1 feedback$).ti,ab.\n26. (person$ adj1 feedback$).ti,ab.\n27. (individual$ adj1 feedback$).ti,ab.\n28. (computer$ adj1 feedback$).ti,ab.\n29. (market$ adj1 campaign$).ti,ab.\n30. normative$.ti,ab.\n31. or/ 22 - 30\n32. Alcohol$.mp. [mp=title, subject heading word, abstract, instrumentation]\n33. Alcohol intervention$.mp. [mp=title, subject heading word, abstract, instrumentation]\n34. (alcohol$ adj1use$).ti,ab.\n35. (alcohol$ adj1 abuse$).ti,ab.\n36. (alcohol$ adj1 misuse$).ti,ab.\n37. (binge$ adj1 drink$).ti,ab.\n38. binge drink$.mp. [mp=title, subject heading word, abstract, instrumentation]\n39. alcohol use$.mp. [mp=title, subject heading word, abstract, instrumentation]\n40. alcohol abuse$.mp. [mp=title, subject heading word, abstract, instrumentation]\n41. alcohol misuse$.mp. [mp=title, subject heading word, abstract, instrumentation]\n42. (alcohol$ adj1 problems$).ti,ab.\n43. or/ 32-42\n44. Student$.mp[mp=title, subject heading word, abstract, instrumentation]\n45. (university$ adj1 student$).ti,ab.\n46. (college$ adj1 student$).ti,ab.\n47. education$.mp[mp=title, subject heading word, abstract, instrumentation]\n48. or/ 44-47\n44. 21 and 31 and 43 and 48",
    "notes": "Alcohol, social norms and student terms",
    "start_date": "2008-03-30",
    "end_date": "2015-07-30",
    "annotator_id": 1
  },
  {
    "id": 101,
    "document_id": 78,
    "query": "incontinence, urinary, male, postprostatectomy, stimulation, electrical stimulation, biofeedback, pelvic muscle exercises, Kegel exercises, behavioural, behaviour, behavior, therapy, behaviour modification, therapy, physiotherapy, lifestyle, weight loss, caffeine, smoking, extracorporeal magnetic innervation, external penile compression devices, continence, bladder control, quality of life, randomised (randomized) controlled trial, evaluation, effectiveness, efficacy, outcomes",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2006-01-30",
    "annotator_id": 1
  },
  {
    "id": 102,
    "document_id": 25,
    "query": "1. exp Fluorides, topical/\n\n(fluoride$ or fluor or \"PPM F\" or PPMF or APF or NAF or \"Sodium F\" or \"Amine F\" or SNF2 or \"Stannous F\" or \"phosphat$ F\" or \"acidulat$ F\" or \"acidulat$ fluor$\" or \"phosphat$ fluor$\" or fluorphosphat$ or \"amin$ fluor$\" or \"sodium$ fluor$\" or \"stannous$ fluor$\" or SMFP or MFP or monofluor$).mp.\n\n(varnish$ or lacquer$ or laquer$ or lacker$ or lakk$ or polyurethane$).mp.\n\n2 and 3\n\n1 or 4\n\n\"Pit and fissure sealants\"/\n\n(fiss$ adj6 seal$).mp.\n\n(dental adj3 seal$).mp.\n\n(compomer$ adj4 seal$).mp.\n\n(composite$ adj4 seal$).mp.\n\nexp Glass ionomer cements/\n\nexp Resin cements/\n\n(\"glass ionomer$\" or glassionomer$ or \"cermet cement$\" or \"resin cement$\").mp.\n\nor/6-13\n\n5 and 14",
    "notes": "MEDLINE via Ovid search strategy",
    "start_date": "1945-12-31",
    "end_date": "2016-12-17",
    "annotator_id": 1
  },
  {
    "id": 103,
    "document_id": 60,
    "query": "(third stage OR post partum OR postpartum OR postnatal* OR post natal* OR \"Delivery, Obstetric/methods\"[MeSH]) AND (cord AND traction)",
    "notes": "PubMed search strategy",
    "start_date": "1965-12-31",
    "end_date": "2014-01-28",
    "annotator_id": 1
  },
  {
    "id": 105,
    "document_id": 114,
    "query": "1 inflammatory demyelinating.tw. (3256)\n2 (polyradiculoneuropath$3 or polyneuropath$3).tw. (11425)\n3 polyneuropathies/ or Polyradiculoneuropathy/ (7927)\n4 (polyneuritis or polyradiculoneuritis).tw. (1715)\n5 2 or 3 or 4 (17287)\n6 Chronic disease/ or \"chronic disease\".mp. (239755)\n7 1 and 5 and 6 (322)\n8 chronic inflammatory demyelinating polyradiculoneuropathy.mp. or Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/ (1215)\n9 cidp.tw. (1080)\n10 7 or 8 or 9 (1655)\n11 randomized controlled trial.pt. (397325)\n12 controlled clinical trial.pt. (90482)\n13 randomized.ab. (292700)\n14 placebo.ab. (154093)\n15 drug therapy.fs. (1776484)\n16 randomly.ab. (205493)\n17 trial.ab. (304804)\n18 groups.ab. (1306164)\n19 or/11-18 (3347080)\n20 exp animals/ not humans.sh. (4079851)\n21 19 not 20 (2851539)\n22 10 and 21 (508)\n23 Adrenocorticotropic Hormone/ (44964)\n24 exp Adrenal Cortex Hormones/ (345255)\n25 exp Steroids/ (722046)\n26 (prednisone$ or prednisolone$ or dexamethasone$ or corticosteroid$).mp. (195435)\n27 or/23-26 (854879)\n28 22 and 27 (221)\n29 remove duplicates from 28 (203)",
    "notes": "The number after each query looks like the number of hits returned (and so shouldn't be included in the annotation).",
    "start_date": "1965-12-31",
    "end_date": "2014-10-30",
    "annotator_id": 1
  },
  {
    "id": 106,
    "document_id": 23,
    "query": "Renal Insufficiency/\n\nexp Renal Insufficiency, Chronic/\n\nKidney Diseases/\n\n(chronic kidney or chronic renal).tw.\n\n(CKF or CKD or CRF or CRD).tw.\n\n(pre-dialy$ or predialy$).tw.\n\nexp Uremia/\n\nur$emi$.tw.\n\nor/1-8\n\nexp Anemia/\n\n(anemia or anaemia).tw.\n\nor/10-11\n\nexp Erythropoietin/\n\n(EPO or darbepoetin$ or epoetin or erythropoietin).tw.\n\nor/13-14\n\nand/9,12,15",
    "notes": "",
    "start_date": null,
    "end_date": "2015-06-28",
    "annotator_id": 1
  },
  {
    "id": 107,
    "document_id": 63,
    "query": "1. exp Hypothermia Induced/ or Circulatory Arrest Deep Hypothermia Induced/ or exp Hypothermia/ or exp Cryotherapy/ or exp Cryosurgery/ or (Cooling or Cryotherapy or Hypotherm*).mp. or (cryo* or cold).ti,ab.\n2. exp Neurosurgical Procedures/ or exp Neurosurgery/ or exp Brain Injuries/ or exp Intracranial Aneurysm/ or exp Intracranial Arterial Diseases/ or exp Cerebrovascular Disorders/ or exp Cerebrovascular Trauma/ or ((operat* or surg* or procedur*) adj5 (brain* or neuro*)).mp. or ((Brain or Cerebro*) adj5 (disord* or trauma* or damage)).mp. or Intracranial.mp.\n3. 1 and 2\n4. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) not (animals not (humans and animals)).sh.\n5. 3 and 4",
    "notes": "",
    "start_date": "1949-12-31",
    "end_date": "2011-05-30",
    "annotator_id": 1
  },
  {
    "id": 108,
    "document_id": 93,
    "query": "exp Vitamin B Complex/\n\nthiamin$.tw.\n\nniacin$.tw.\n\nriboflavin$.tw.\n\nfolic acid.tw.\n\nfolate$.tw.\n\ncobalamin$.tw.\n\nbiotin$.tw.\n\nneurobion$.tw.\n\npantothenic acid.tw.\n\npyridox$.tw.\n\nbenfotiamine.tw.\n\nvitamin b.tw.\n\n(vitamin b1 or \"vitamin b 1\").tw.\n\n(vitamin b2 or \"vitamin b 2\").tw.\n\n(vitamin b3 or \"vitamin b 3\").tw.\n\n(vitamin b5 or \"vitamin b 5\").tw.\n\n(vitamin b6 or \"vitamin b 6\").tw.\n\n(vitamin b7 or \"vitamin b 7\").tw.\n\n(vitamin b9 or \"vitamin b 9\").tw.\n\n(vitamin b12 or \"vitamin b 12\").tw.\n\nor/1-21\n\nDiabetic Nephropathies/\n\n((diabetes or diabetic) and (kidney$ or renal or nephro$ or nephriti$ or glomerulo$ or albuminur$)).tw.\n\nor/23-24\n\nand/22,25",
    "notes": "",
    "start_date": "1949-12-31",
    "end_date": "2012-10-28",
    "annotator_id": 1
  },
  {
    "id": 112,
    "document_id": 91,
    "query": "#1 \"Vestibular Diseases/nursing\"[Mesh] OR \"Vestibular Diseases/rehabilitation\"[Mesh] OR \"Vertigo/nursing\"[Mesh] OR \"Vertigo /rehabilitation\"[Mesh] OR \"Dizziness /nursing\"[Mesh] OR \"Dizziness /rehabilitation\"[Mesh]\n#2 (VESTIBULAR [tiab] AND (REHABILITATION [tiab] OR ADAPTATION [tiab] OR HABITUATION [tiab]))\n#3 “LABYRINTH DISEASES” [Mesh] OR “VESTIBULOCOCHLEAR NERVE DISEASES” OR (“PERILYMPH” [MeSH] AND “FISTULA” [Mesh])\n#4 Vertigo [tiab] OR vestibulopath* [tiab] OR dizziness [tiab] OR ((vestibular [ti] OR balance* [ti]) AND (disorder [ti] OR hypofunction* [ti] OR dysfunction* [ti] OR impair* [ti] OR disability* [ti] OR pathology* [ti] OR disturbance* [ti]))\n#5 NEUROLABYRINTHITIDES [tiab] OR NEUROLABYRINTHITIS [tiab] OR (VESTIBULAR [tiab] AND (NEURITIS [tiab] OR NEURONITIS [tiab] OR NEURITIDES[tiab]))\n#6 “VESTIBULAR NERVE” [tiab] AND (INFLAMMATION [tiab] OR COMPRESSION [tiab]))\n#7 “ACOUSTIC NEUROMA” [tiab] OR “ACOUSTIC NEURINOMA” [tiab] OR “ACOUSTIC NEURILEMOMA” [tiab] OR “ACOUSTIC NEURILEMMOMA” [tiab] OR “VESTIBULAR SCHWANNOMA” [tiab] OR “ACOUSTIC SCHWANNOMA” [tiab] OR “MOTION SENSITIVITY” [tiab] OR (VESTIBULAR [tiab] AND PERIPHERAL [tiab]) OR (PERILYMPHATIC [tiab] AND FISTULA [tiab]) OR MENIERE* [tiab] OR “ENDOLYMPHATIC HYDROPS” [tiab] OR (LABYRINTH* [tiab] AND HYDROPS [tiab]) OR (LABYRINTH* [tiab] AND SYNDROME [tiab]) OR BPV [tiab] OR BPPV [tiab] OR ANTBPPV [tiab]\n#8 #3 OR #4 OR #5 OR #6 OR #7\n#9 “OCCUPATIONAL THERAPY” [Mesh] OR “PHYSICAL THERAPY MODALITIES” [Mesh] OR “EXERCISE THERAPY” [Mesh] OR “EXERCISE” [Mesh] OR “HEAD MOVEMENTS” [Mesh] OR “VESTIBULAR FUNCTION TESTS” [Mesh]\n#10 REHABILITATION [tiab] OR PHYSIOTHERAP* [tiab] OR (PHYSICAL [tiab] AND THERAP* [tiab]) OR EXERCIS* [tiab] OR HABITUAT* [tiab] OR EPLEY [tiab] OR CANALITH [tiab] OR SEMONT [tiab] OR MANOEUVRE* [tiab] OR MANEUVER* [tiab] OR “RECONDITIONING ACTIVIT*” [tiab] OR POSTUROGRAPHY [tiab] OR “POSTURAL CONTROL” [tiab] OR PFPP [tiab] OR (SENSORY [tiab] AND RELEARN* [tiab]) OR (SENSORY [tiab] AND RETRAIN* [tiab]) OR (POSTURAL [tiab] AND RELEARN* [tiab]) OR (POSTURAL [tiab] AND RETRAIN* [tiab])\n#11 (POSITION* [tiab] AND PROCEDURE* [tiab]) OR (REPOSITION* [tiab] AND PROCEDURE* [tiab]) OR (REPOSITION* [tiab] AND PARTICLE* [tiab]) OR (VISUAL [tiab] AND VESTIBULAR [tiab]) OR (FUNCTIONAL [tiab] AND RETRAIN* [tiab]) OR (OCCUPATIONAL [tiab] AND RETRAIN* [tiab]) OR (OCCUPATIONAL [tiab] AND ADAPTATION [tiab]) OR (COOKSEY [tiab] AND CAWTHORNE [tiab])\n#12 #9 OR #10 OR #11\n#13 #8 AND #12\n#14 #1 OR #2 OR #13",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-17",
    "annotator_id": 1
  },
  {
    "id": 113,
    "document_id": 52,
    "query": "1          first-rank.mp.\n\n2          first rank.mp.\n\n3          first?rank.mp.\n\n4          FRS$.mp.\n\n5          Schneiderian.mp\n\n6          1 or 2 or 3 or 4 or 5 (2137)",
    "notes": "",
    "start_date": null,
    "end_date": "2011-04-12",
    "annotator_id": 1
  },
  {
    "id": 114,
    "document_id": 52,
    "query": "1          exp \"International Classification of Diseases\"/ (3305)\n\n2          exp \"Diagnostic and Statistical Manual of Mental Disorders\"/ (9349)\n\n3          \"Research Diagnostic Criteria\".mp. (1325)\n\n4          Feighner.mp. (147)\n\n5          ICD.mp. (13774)\n\n6          DSM.mp. (29660)\n\n7          RDC.mp. (1143)\n\n8          schneider.mp. (1529)\n\n9          bleuler.mp. (215)\n\n10        kraepelin.mp. (495)\n\n11        \"international pilot study of schizophrenia\".mp. (47)\n\n12        IPSS.mp. (1436)\n\n13        \"new haven schizophrenia index\".mp. (13)\n\n14        NHSI.mp. (14)\n\n15        \"present state examination\".mp. (412)\n\n16        PSE.mp. (1394)\n\n17        \"operational criteria\".mp. (431)\n\n18        (operation$ adj3 criteri$).mp. [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract, name of substance word, subject heading word, unique identifier] (1077)\n\n19        \"Sensitivity and Specificity\"/ (233760)\n\n20        Diagnosis/ (15703)\n\n21        1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 (303793)\n\n22        exp Schizophrenia/ (74720)\n\n23        schizophren$.mp. (93319)\n\n24        22 or 23 (93528)\n\n25        21 and 24 (7401)\n\n26        (animals not (humans and animals)).sh. (3503422)\n\n27        25 not 26 (7398)",
    "notes": "",
    "start_date": null,
    "end_date": "2011-05-31",
    "annotator_id": 1
  },
  {
    "id": 115,
    "document_id": 52,
    "query": " *schizophrenia/di [Diagnosis] (16918)",
    "notes": "",
    "start_date": null,
    "end_date": "2011-07-16",
    "annotator_id": 1
  },
  {
    "id": 116,
    "document_id": 69,
    "query": "#1 (work[tw] OR works*[tw] OR work'*[tw] OR worka*[tw] OR worke*[tw] OR workg*[tw] OR worki*[tw] OR workl*[tw] OR workp*[tw] OR occupation*[tw] OR employe*[tw])\n\n#2 (effect*[tw] OR control[tw] OR controls*[tw] OR controla*[tw] OR controle*[tw] OR controli*[tw] OR controll*[tw] OR evaluat*[tw] OR intervention*[tw] OR program*[tw] OR compare*[tw])\n\n#3 (sedentary OR sitting) OR seated posture OR chair[tiab] OR desk[tiab] OR (office AND inactiv*)\n\n#4 (animals [mh] NOT humans [mh])\n\n#5 #1 AND #2 AND #3 NOT #4",
    "notes": "",
    "start_date": null,
    "end_date": "2013-12-16",
    "annotator_id": 1
  },
  {
    "id": 117,
    "document_id": 90,
    "query": "Anemia (MeSH, ti, ab ) OR anaemia (ti, ab)\n\nMalaria (MeSH, ti,ab)\n\n1 OR 2\n\nChild* OR infant*(ti,ab)\n\n3 and 4\n\n(Intermittent preventive treatment) ti, ab\n\nIPT*(ti,ab)\n\n6 or 7\n\n5 and 8",
    "notes": "",
    "start_date": null,
    "end_date": "2014-12-03",
    "annotator_id": 1
  },
  {
    "id": 118,
    "document_id": 41,
    "query": "Arteriovenous Shunt, Surgical/\n\nArteriovenous Fistula/\n\nBlood Vessel Prosthesis/\n\n(fistula$ or AVF$ or graft or grafts or shunt or shunts).tw.\n\n(vascular access or venous access).tw.\n\n(dialysis access or hemodialysis access or haemodialysis access).tw.\n\nor/1-6\n\nRenal Dialysis/\n\nexp Hemofiltration/\n\ndialysis.tw.\n\n(predialysis or pre-dialysis).tw.\n\n(hemodialysis or haemodialysis).tw.\n\n(hemofiltration or haemofiltration).tw.\n\n(hemodiafiltration or haemodiafiltration).tw.\n\nRenal Insufficiency/\n\nexp Renal Insufficiency, Chronic/\n\n(kidney failure or kidney disease or renal failure or renal disease).tw.\n\n(CKD or CKF or CRD or CRF or ESKD or ESKF or ESRD or ESRF).tw.\n\nor/8-18\n\nConstriction, Pathologic/\n\nConstriction/\n\nGraft Occlusion Vascular/\n\nThrombosis/\n\n(stenosis or stenoses or stenosed or stenotic or restenos*).tw.\n\n(thrombosis or thrombosed or thrombotic).tw.\n\n(occlud* or occlusion or obstruct*).tw.\n\nor/20-26\n\nAngioplasty/\n\nAngioplasty, Balloon/\n\nexp Angioplasty, Laser/\n\nBalloon Dilation/\n\nangioplasty.tw.\n\nballoon dilation.tw.\n\nPTA.tw.\n\nEndovascular Procedures/\n\nexp Stents/\n\nImplants, Artificial/\n\n(endovascular treatment* or endovascular procedure* or endoluminal repair or endovascular surgery*).tw.\n\n(stent or stents or stenting).tw.\n\n(vein patch* or transposition* or interposition* or revision* or proximalization).tw.\n\n((pre-emptive or preemptive) adj (strateg* or correction*)).tw.\n\nor/28-41\n\nand/7,19,27,42",
    "notes": "",
    "start_date": null,
    "end_date": "2015-11-29",
    "annotator_id": 1
  },
  {
    "id": 119,
    "document_id": 89,
    "query": "1. Pulmonary Ventilation/ or Ventilation/ or Positive-Pressure Respiration/ or Respiration, Artificial/ or Ventilators, Mechanical/ or High-Frequency Ventilation/ or High-Frequency Jet Ventilation/\n\n2. ((Pressure-controlled or volume-controlled) and ventilat*).mp. or ventilat*.ti.\n\n3. 1 or 2\n\n4. Respiratory Distress Syndrome, Adult/ or Respiratory Insufficiency/ or exp Severe Acute Respiratory Syndrome/ or Lung Injury/\n\n5. (acute respiratory failure or acute lung injury or (acute adj3 distress syndrome)).mp. or (ALI or ARDS).ti,ab.\n\n6. 5 or 4\n\n7. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) not (animals not (humans and animals)).sh.\n\n8. 7 and 6 and 3",
    "notes": "",
    "start_date": "1949-12-31",
    "end_date": "2014-09-30",
    "annotator_id": 1
  },
  {
    "id": 120,
    "document_id": 28,
    "query": "1. randomized controlled trial.pt.\n2. (randomized or randomised).ab,ti.\n3. placebo.ab,ti.\n4. dt.fs.\n5. randomly.ab,ti.\n6. trial.ab,ti.\n7. groups.ab,ti.\n8. or/1-7\n9. exp animals/\n10. exp humans/\n11. 9 not (9 and 10)\n12. 8 not 11\n13. exp glaucoma/\n14. exp intraocular pressure/\n15. exp filtering surgery/\n16. trabeculectom$.tw.\n17. sclerostom$.tw.\n18. ((surg$ or filter$ or filtrat$) adj5 glaucoma$).tw.\n19. (surg$ adj5 intra?ocular pressure$).tw.\n20. or/13-19\n21. exp angiogenesis inhibitors/\n22. angiogenesis inducing agents/\n23. endothelial growth factors/\n24. exp vascular endothelial growth factors/\n25. (macugen$ or pegaptanib$ or lucentis$ or rhufab$ or ranibizumab$ or bevacizumab$ or avastin or or aflibercept$).tw.\n26. (anti adj2 VEGF$).tw.\n27. (endothelial adj2 growth adj2 factor$).tw.\n28. or/21-27\n29. 20 and 28\n30. 12 and 29",
    "notes": "The search filter for trials at the beginning of the MEDLINE strategy is from the published paper by Glanville (Glanville 2006).",
    "start_date": "1945-12-31",
    "end_date": "2015-11-29",
    "annotator_id": 1
  },
  {
    "id": 121,
    "document_id": 54,
    "query": "procalcitonin.tw.\n\nprocalcitonin.nm.\n\nPCT.tw.\n\nor/1-3\n\nc-Reactive Protein/\n\nc-reactive protein.tw.\n\nCRP.tw.\n\nor/5-7\n\nBlood Sedimentation/\n\nerythrocyte sedimentation rate.tw.\n\nESR.tw.\n\nblood sedimentation.tw.\n\nor/9-12\n\nor/4,8,13\n\nTechnetium Tc 99m Dimercaptosuccinic Acid/\n\nDMSA.tw.\n\ndimercaptosuccin$.tw.\n\nscintigra$.tw.\n\nRadionuclide Imaging/\n\nSuccimer/du\n\nKidney/ri\n\nor/15-21\n\nor/14,22\n\nUrinary Tract Infections/\n\nPyelonephritis/\n\nurinary tract infection$.tw.\n\npyelonephritis.tw.\n\n(UTI or UTIs).tw.\n\nor/24-28\n\nand/23,29",
    "notes": "",
    "start_date": null,
    "end_date": "2013-02-12",
    "annotator_id": 1
  },
  {
    "id": 155,
    "document_id": 120,
    "query": "1. randomised controlled trial.pt.\n\n2. controlled clinical trial.pt.\n\n3. randomised.ab.\n\n4. placebo.ab.\n\n5. clinical trials as topic.sh.\n\n6. randomly.ab.\n\n7. trial.ti.\n\n8. 1 or 2 or 3 or 4 or 5 or 6 or 7\n\n9. exp animals/ not humans.sh.\n\n10. 8 not 9\n\n11. (epilep$ or seizure$ or convuls$).tw.\n\n12. exp Epilepsy/\n\n13. exp Seizures/\n\n14. 11 or 12 or 13\n\n15.stiripentol.tw.\n\n16. Diacomit.tw.\n\n17.15 or 16\n\n18. 10 and 14 and 17",
    "notes": "This strategy is based on the Cochrane Highly Sensitive Search Strategy for identifying randomised trials (Lefebvre 2011).",
    "start_date": null,
    "end_date": "2014-01-30",
    "annotator_id": 1
  },
  {
    "id": 122,
    "document_id": 80,
    "query": "1. exp arthritis, rheumatoid/\n2. (felty$ adj2 syndrome).tw.\n3. (caplan$ adj2 syndrome).tw.\n4. rheumatoid nodule.tw.\n5. (sjogren$ adj2 syndrome).tw.\n6. (sicca adj2 syndrome).tw.\n7. still$ disease.tw.\n8. bechterew$ disease.tw.\n9. (arthritis adj2 rheumat$).tw.\n10. or/1-9\n11. Antibodies, Monoclonal/\n12. Immunologic Factors/\n13. rituximab.tw.\n14. rituxan.tw.\n15. mabthera.tw.\n16. or/11-15\n17. 10 and 16\n18. clinical trial.pt.\n19. randomized.ab.\n20. placebo.ab.\n21. dt.fs.\n22. clinical trials/\n23. randomly.ab.\n24. trial.ti.\n25. groups.ab.\n26. or/18-25\n27. animals/\n28. humans/\n29. 27 and 28\n30. 27 not 29\n31. 26 not 30\n32. 17 and 31",
    "notes": "",
    "start_date": null,
    "end_date": "2013-12-31",
    "annotator_id": 1
  },
  {
    "id": 123,
    "document_id": 37,
    "query": "1   exp Ovarian Neoplasms/\n2   (ovar* adj5 (cancer* or neoplas* or carcinom* or malignan* or tumor* or tumour*)).mp.\n3   1 or 2\n4   exp Surgical Procedures, Operative/\n5   surg*.mp.\n6   surgery.fs.\n7   4 or 5 or 6\n8   (interval or debulk* or cytoreduc* or secondary).mp.\n9   3 and 7 and 8\n10 randomized controlled trial.pt.\n11 controlled clinical trial.pt.\n12 randomized.ab.\n13 randomly.ab.\n14 trial.ab.\n15 groups.ab.\n16 10 or 11 or 12 or 13 or 14 or 15\n17 9 and 16",
    "notes": "key: mp = title, original title, abstract, name of substance word, subject heading word\nfs = floating subheading\npt = publication type\nab = abstract\nsh = subject heading",
    "start_date": "1965-12-31",
    "end_date": "2008-06-29",
    "annotator_id": 1
  },
  {
    "id": 124,
    "document_id": 66,
    "query": "#1 exp Ethanol/ad, tu [Administration & Dosage, Therapeutic Use]\n\n#2 exp Acetic Acid/ad, tu [Administration & Dosage, Therapeutic Use]\n\n#3 exp Injections/\n\n#4 (((ethanol or alcohol or acetic acid or vinegar) and (inject* or ablati*)) or PEI or PAI or PAAI).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n\n#5 #1 or #2 or #3 or #4\n\n#6 exp Liver Neoplasms/\n\n#7 (((liver or hepatic or hepatocellular or hepato-cellular) and (carcinom* or cancer* or neoplasm* or malign* or tumo*)) or HCC).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n\n#8 #6 or #7\n\n#9 #5 and #8\n\n#10 (random* or blind* or placebo* or meta-analys*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n\n#11 #9 and #10",
    "notes": "MEDLINE (Ovid SP)",
    "start_date": "1945-12-31",
    "end_date": "2014-07-30",
    "annotator_id": 1
  },
  {
    "id": 125,
    "document_id": 62,
    "query": "1. exp OSTEOARTHRITIS/\n2. osteoarthr$.tw.\n3. (degenerative adj2 arthritis).tw.\n4. or/1-3\n5. exp CHONDROITIN/\n6. chondroitin.sh,rn,tw.\n7. 5 or 6\n8. 4 and 7\n9. randomized controlled trial.pt.\n10. controlled clinical trial.pt.\n11. randomized controlled trials.sh.\n12. random allocation.sh.\n13. double blind method.sh.\n14. single-blind method.sh.\n15. clinical trial.pt.\n16. clinical trials.sh.\n17. clinical trial.tw.\n18. ((singl$ or doubl$ or trebl$ or tripl$) and (mask$ or blind$)).tw.\n19. placebos.sh.\n20. placebo$.tw.\n21. random$.tw.\n22. Research Design/\n23. comparative study.sh.\n24. evaluation studies.sh.\n25. follow-up studies.sh.\n26. prospective studies.sh.\n27. control$.tw.\n28. prospectiv$.tw.\n29. volunteer$.tw.\n30. or/9-29\n31. (animal not human).mp.\n32. 30 not 31\n33. 8 and 32",
    "notes": "No language or date restrictions were applied in the search for trials.",
    "start_date": null,
    "end_date": "2013-11-29",
    "annotator_id": 1
  },
  {
    "id": 126,
    "document_id": 102,
    "query": "1 psychotherapy/ or exp psychoanalytic therapy/ or exp psychotherapeutic processes/ or psychotherapy, brief/ or psychotherapy, multiple/ or psychotherapy, rational-emotive/ or exp socioenvironmental therapy/\n\n2 Psychoanalytic Interpretation/\n\n3 (psychotherap$ or psycho-therap$ or psychoanalytic$ or psycho-analytic$ or psychodynamic$ or psycho-dynamic$).tw.\n\n4 Family Therapy/\n\n5 or/1-4\n\n6 exp maternal behavior/ or parent-child relations/ or father-child relations/ or mother-child relations/ or parenting/ or paternal behavior/\n\n7 Mothers/px or Fathers/px or Parents/px\n\n8 Object Attachment/\n\n9 Reactive Attachment Disorder/\n\n10 ((attachment adj3 disorder$) or (insecure adj3 attachment$) or (secure adj3 attachment$) or (dysregulation adj3 disorder$)).tw.\n\n11 ((parent$ or mother$ or maternal$ or father$ or paternal$ or infant$ or child$) adj3 (attachment$ or bond$ or interaction$ or relationship$ or dyad$ or triad$)).tw.\n\n12 or/6-11\n\n13 exp infant/\n\n14 infant behavior/\n\n15 (baby or babies or infant$ or child$ or toddler$).tw.\n\n16 or/13-15\n\n17 5 and 12 and 16\n\n18 (parent$ adj3 (baby or babies or infant$ or child$ or toddler$) adj3 (psychother$ or psycho-therap$ or psychodynamic$ or psycho-dynamic$)).tw.\n\n19 (mother$ adj3 (baby or babies or infant$ or child$ or toddler$) adj3 (psychother$ or psycho-therap$ or psychodynamic$ or psycho-dynamic$)).tw.\n\n20 (maternal$ adj3 (baby or babies or infant$ or child$ or toddler$) adj3 (psychother$ or psycho-therap$ or psychodynamic$ or psycho-dynamic$)).tw.\n\n21 (father$ adj3 (baby or babies or infant$ or child$ or toddler$) adj3 (psychother$ or psycho-therap$ or psychodynamic$ or psycho-dynamic$)).tw.\n\n22 (paternal$ adj3 (baby or babies or infant$ or child$ or toddler$) adj3 (psychother$ or psycho-therap$ or psychodynamic$ or psycho-dynamic$)).tw.\n\n23 (parent$ adj3 (baby or babies or infant$ or child$ or toddler$) adj3 (psychoanalytic$ or psycho-analytic$ or psychodynamic$ or psycho-dynamic$)).tw.\n\n24 (mother$ adj3 (baby or babies or infant$ or child$ or toddler$) adj3 (psychoanalytic$ or psycho-analytic$ or psychodynamic$ or psycho-dynamic$)).tw.\n\n25 (maternal$ adj3 (baby or babies or infant$ or child$ or toddler$) adj3 (psychoanalytic$ or psycho-analytic$ or psychodynamic$ or psycho-dynamic$)).tw.\n\n26 (father$ adj3 (baby or babies or infant$ or child$ or toddler$) adj3 (psychoanalytic$ or psycho-analytic$ or psychodynamic$ or psycho-dynamic$)).tw.\n\n27 (paternal$ adj3 (baby or babies or infant$ or child$ or toddler$) adj3 (psychoanalytic$ or psycho-analytic$ or psychodynamic$ or psycho-dynamic$)).tw.\n\n28 or/18-27\n\n29 17 or 28\n\n30 randomized controlled trial.pt.\n\n31 controlled clinical trial.pt.\n\n32 randomized.ab.\n\n33 placebo.ab.\n\n34 drug therapy.fs.\n\n35 randomly.ab.\n\n36 trial.ab.\n\n37 groups.ab.\n\n38 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37\n\n39 exp animals/ not humans.sh.\n\n40 38 not 39\n\n41 29 and 40",
    "notes": "Ovid MEDLINE",
    "start_date": "1949-12-31",
    "end_date": "2014-01-09",
    "annotator_id": 1
  },
  {
    "id": 127,
    "document_id": 61,
    "query": "1. Neck Pain/\n\n2. exp Brachial Plexus Neuropathies/\n\n3. exp neck injuries/ or exp whiplash injuries/\n\n4. cervical pain.mp.\n\n5. neckache.mp.\n\n6. whiplash.mp.\n\n7. cervicodynia.mp.\n\n8. cervicalgia.mp.\n\n9. brachialgia.mp.\n\n10. brachial neuritis.mp.\n\n11. brachial neuralgia.mp.\n\n12. neck pain.mp.\n\n13. neck injur*.mp.\n\n14. brachial plexus neuropath*.mp.\n\n15. brachial plexus neuritis.mp.\n\n16. thoracic outlet syndrome/ or cervical rib syndrome/\n\n17. Torticollis/\n\n18. exp brachial plexus neuropathies/ or exp brachial plexus neuritis/\n\n19. cervico brachial neuralgia.ti,ab.\n\n20. cervicobrachial neuralgia.ti,ab.\n\n21. (monoradicul* or monoradicl*).tw.\n\n22. or/1-21\n\n23. exp headache/ and cervic*.tw.\n\n24. exp genital diseases, female/\n\n25. genital disease*.mp.\n\n26. or/24-25\n\n27. 23 not 26\n\n28. 22 or 27\n\n29. neck/\n\n30. neck muscles/\n\n31. exp cervical plexus/\n\n32. exp cervical vertebrae/\n\n33. atlanto-axial joint/\n\n34. atlanto-occipital joint/\n\n35. Cervical Atlas/\n\n36. spinal nerve roots/\n\n37. exp brachial plexus/\n\n38. (odontoid* or cervical or occip* or atlant*).tw.\n\n39. axis/ or odontoid process/\n\n40. Thoracic Vertebrae/\n\n41. cervical vertebrae.mp.\n\n42. cervical plexus.mp.\n\n43. cervical spine.mp.\n\n44. (neck adj3 muscles).mp.\n\n45. (brachial adj3 plexus).mp.\n\n46. (thoracic adj3 vertebrae).mp.\n\n47. neck.mp.\n\n48. (thoracic adj3 spine).mp.\n\n49. (thoracic adj3 outlet).mp.\n\n50. trapezius.mp.\n\n51. cervical.mp.\n\n52. cervico*.mp.\n\n53. 51 or 52\n\n54. exp genital diseases, female/\n\n55. genital disease*.mp.\n\n56. exp *Uterus/\n\n57. 54 or 55 or 56\n\n58. 53 not 57\n\n59. 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 58\n\n60. exp pain/\n\n61. exp injuries/\n\n62. pain.mp.\n\n63. ache.mp.\n\n64. sore.mp.\n\n65. stiff.mp.\n\n66. discomfort.mp.\n\n67. injur*.mp.\n\n68. neuropath*.mp.\n\n69. or/60-68\n\n70. 59 and 69\n\n71. Radiculopathy/\n\n72. exp temporomandibular joint disorders/ or exp temporomandibular joint dysfunction syndrome/\n\n73. myofascial pain syndromes/\n\n74. exp \"Sprains and Strains\"/\n\n75. exp Spinal Osteophytosis/\n\n76. exp Neuritis/\n\n77. Polyradiculopathy/\n\n78. exp Arthritis/\n\n79. Fibromyalgia/\n\n80. spondylitis/ or discitis/\n\n81. spondylosis/ or spondylolysis/ or spondylolisthesis/\n\n82. radiculopathy.mp.\n\n83. radiculitis.mp.\n\n84. temporomandibular.mp.\n\n85. myofascial pain syndrome*.mp.\n\n86. thoracic outlet syndrome*.mp.\n\n87. spinal osteophytosis.mp.\n\n88. neuritis.mp.\n\n89. spondylosis.mp.\n\n90. spondylitis.mp.\n\n91. spondylolisthesis.mp.\n\n92. or/71-91\n\n93. 59 and 92\n\n94. exp neck/\n\n95. exp cervical vertebrae/\n\n96. Thoracic Vertebrae/\n\n97. neck.mp.\n\n98. (thoracic adj3 vertebrae).mp.\n\n99. cervical.mp.\n\n100. cervico*.mp.\n\n101. 99 or 100\n\n102. exp genital diseases, female/\n\n103. genital disease*.mp.\n\n104. exp *Uterus/\n\n105. or/102-104\n\n106. 101 not 105\n\n107. (thoracic adj3 spine).mp.\n\n108. cervical spine.mp.\n\n109. 94 or 95 or 96 or 97 or 98 or 106 or 107 or 108\n\n110. Intervertebral Disk/\n\n111. (disc or discs).mp.\n\n112. (disk or disks).mp.\n\n113. 110 or 111 or 112\n\n114. 109 and 113\n\n115. herniat*.mp.\n\n116. slipped.mp.\n\n117. prolapse*.mp.\n\n118. displace*.mp.\n\n119. degenerat*.mp.\n\n120. (bulge or bulged or bulging).mp.\n\n121. 115 or 116 or 117 or 118 or 119 or 120\n\n122. 114 and 121\n\n123. intervertebral disk degeneration/ or intervertebral disk displacement/\n\n124. intervertebral disk displacement.mp.\n\n125. intervertebral disc displacement.mp.\n\n126. intervertebral disk degeneration.mp.\n\n127. intervertebral disc degeneration.mp.\n\n128. 123 or 124 or 125 or 126 or 127\n\n129. 109 and 128\n\n130. 28 or 70 or 93 or 122 or 129\n\n131. animals/ not (animals/ and humans/)\n\n132. 130 not 131\n\n133. exp *neoplasms/\n\n134. exp *wounds, penetrating/\n\n135. 133 or 134\n\n136. 132 not 135\n\n137. Neck Pain/rh [Rehabilitation]\n\n138. exp Brachial Plexus Neuropathies/rh\n\n139. exp neck injuries/rh or exp whiplash injuries/rh\n\n140. thoracic outlet syndrome/rh or cervical rib syndrome/rh\n\n141. Torticollis/rh\n\n142. exp brachial plexus neuropathies/rh or exp brachial plexus neuritis/rh\n\n143. 137 or 138 or 139 or 140 or 141 or 142\n\n144. Radiculopathy/rh\n\n145. exp temporomandibular joint disorders/rh or exp temporomandibular joint dysfunction syndrome/rh\n\n146. myofascial pain syndromes/rh\n\n147. exp \"Sprains and Strains\"/rh\n\n148. exp Spinal Osteophytosis/rh\n\n149. exp Neuritis/rh\n\n150. Polyradiculopathy/rh\n\n151. exp Arthritis/rh\n\n152. Fibromyalgia/rh\n\n153. spondylitis/rh or discitis/rh\n\n154. spondylosis/rh or spondylolysis/rh or spondylolisthesis/rh\n\n155. or/144-154\n\n156. 59 and 155\n\n157. exp Combined Modality Therapy/\n\n158. Exercise/\n\n159. Physical Exertion/\n\n160. exp Exercise Therapy/\n\n161. exp Electric Stimulation Therapy/\n\n162. exp Rehabilitation/\n\n163. exp Physical Therapy Modalities/\n\n164. Hydrotherapy/\n\n165. postur* correction.mp.\n\n166. Feldenkrais.mp.\n\n167. (alexander adj (technique or method)).tw.\n\n168. Relaxation Therapy/\n\n169. Biofeedback, Psychology/\n\n170. or/157-169\n\n171. 136 and 170\n\n172. 143 or 156 or 171\n\n173. animals/ not (animals/ and humans/)\n\n174. 172 not 173\n\n175. exp randomised controlled trials as topic/\n\n176. randomised controlled trial.pt.\n\n177. controlled clinical trial.pt.\n\n178. (random* or sham or placebo*).tw.\n\n179. placebos/\n\n180. random allocation/\n\n181. single blind method/\n\n182. double blind method/\n\n183. ((singl* or doubl* or trebl* or tripl*) adj25 (blind* or dumm* or mask*)).ti,ab.\n\n184. (rct or rcts).tw.\n\n185. (control* adj2 (study or studies or trial*)).tw.\n\n186. or/175-185\n\n187. 174 and 186\n\n188. limit 187 to yr=\"2006 -Current\"\n\n189. limit 187 to yr=\"1902 - 2005\"\n\n190. guidelines as topic/\n\n191. practice guidelines as topic/\n\n192. guideline.pt.\n\n193. practice guideline.pt.\n\n194. (guideline? or guidance or recommendations).ti.\n\n195. consensus.ti.\n\n196. or/190-195\n\n197. 174 and 196\n\n198. 136 and 196\n\n199. 197 or 198\n\n200. limit 199 to yr=\"2006 -Current\"\n\n201. limit 199 to yr=\"1902 - 2005\"\n\n202. meta-analysis/\n\n203. exp meta-analysis as topic/\n\n204. (meta analy* or metaanaly* or met analy* or metanaly*).tw.\n\n205. review literature as topic/\n\n206. (collaborative research or collaborative review* or collaborative overview*).tw.\n\n207. (integrative research or integrative review* or intergrative overview*).tw.\n\n208. (quantitative adj3 (research or review* or overview*)).tw.\n\n209. (research integration or research overview*).tw.\n\n210. (systematic* adj3 (review* or overview*)).tw.\n\n211. (methodologic* adj3 (review* or overview*)).tw.\n\n212. exp technology assessment biomedical/\n\n213. (hta or thas or technology assessment*).tw.\n\n214. ((hand adj2 search*) or (manual* adj search*)).tw.\n\n215. ((electronic adj database*) or (bibliographic* adj database*)).tw.\n\n216. ((data adj2 abstract*) or (data adj2 extract*)).tw.\n\n217. (analys* adj3 (pool or pooled or pooling)).tw.\n\n218. mantel haenszel.tw.\n\n219. (cohrane or pubmed or pub med or medline or embase or psycinfo or psyclit or psychinfo or psychlit or cinahl or science citation index).ab.\n\n220. or/202-219\n\n221. 174 and 220\n\n222. limit 221 to yr=\"2006 -Current\"\n\n223. limit 221 to yr=\"1902 - 2005\"\n\n224. (ae or to or po or co).fs.\n\n225. (safe or safety or unsafe).tw.\n\n226. (side effect* or side event*).tw.\n\n227. ((adverse or undesirable or harm* or injurious or serious or toxic) adj3 (effect* or event* or reaction* or incident* or outcome*)).tw.\n\n228. (abnormalit* or toxicit* or complication* or consequence* or noxious or tolerabilit*).tw.\n\n229. or/224-228\n\n230. 174 and 229\n\n231. limit 230 to yr=\"2006 -Current\"\n\n232. limit 230 to yr=\"1902 - 2005\"\n\n233. limit 187 to ed=20100701-20120313\n\n234. limit 199 to ed=20100701-20120313\n\n235. limit 221 to ed=20100701-20120313\n\n236. limit 230 to ed=20100701-20120313\n\n237. limit 189 to ed=20120313-20131108",
    "notes": "MEDLINE- OVID\n\n--\n\nthis one looks thorough (so many queries...)",
    "start_date": "1949-12-31",
    "end_date": "2014-04-29",
    "annotator_id": 1
  },
  {
    "id": 128,
    "document_id": 24,
    "query": "Substance-related disorders [mesh]\n\nDrinking behavior [mesh]\n\nbinge [tiab]\n\ndrink*[tiab]\n\nabus*[tiab] OR consumption[tiab] OR misuse[tiab] OR use*[tiab]\n\n#1 or #2 or #3 or #4 or #5\n\ndrug [tiab] OR substance [tiab] OR alcohol [tiab] OR cannabis[tiab] OR *amphetamine[tiab] OR cocaine[tiab] OR heroin [tiab] OR Methaqualone [tiab] OR prescription [tiab]\n\n#6 AND #7\n\n\"Brief intervention\" [tiab]\n\n\"early intervention\"[tiab]\n\n\"minimal intervention\"[tiab]\n\nBI[tiab] OR BMI[tiab]\n\nCounseling [mesh]\n\n((brief[Title/Abstract]) AND motivation*[Title/Abstract]) AND interview*[Title/Abstract]\n\nMotivation* [mesh:no exp]\n\n#9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15\n\nAdolescent [mesh]\n\n((((adolescen*[Title/Abstract]) OR teenage*[Title/Abstract]) OR young[Title/Abstract]) OR student* [Title/Abstract] OR juvenile [Title/Abstract] kid[Title/Abstract] OR kids[Title/Abstract] OR youth[Title/Abstract] OR underage[Title/Abstract]\n\nSchool* [tw] OR class* [tw]\n\n#17 OR #18 OR #19\n\nRandomized controlled trial [pt]\n\ncontrolled clinical trial [pt]\n\nrandom*[tiab]\n\nplacebo [tiab]\n\ntrial [tiab]\n\ngroups [tiab]\n\nanimals [mh] NOT humans [mh]\n\n(#26) NOT #27\n\n(((#7) AND #16) AND #17) AND #28",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2015-02-27",
    "annotator_id": 1
  },
  {
    "id": 129,
    "document_id": 95,
    "query": "1. Lung Diseases, Obstructive/\n\n2. exp Pulmonary Disease, Chronic Obstructive/\n\n3. emphysema$.mp.\n\n4. (chronic$ adj3 bronchiti$).mp.\n\n5. (obstruct$ adj3 (pulmonary or lung$ or airway$ or airflow$ or bronch$ or respirat$)).mp.\n\n6. COPD.mp.\n\n7. COAD.mp.\n\n8. COBD.mp.\n\n9. AECB.mp.\n\n10. or/1-9",
    "notes": "COPD search",
    "start_date": null,
    "end_date": "2014-08-30",
    "annotator_id": 1
  },
  {
    "id": 130,
    "document_id": 95,
    "query": "1. exp \"clinical trial [publication type]\"/\n\n2. (randomised or randomised).ab,ti.\n\n3. placebo.ab,ti.\n\n4. dt.fs.\n\n5. randomly.ab,ti.\n\n6. trial.ab,ti.\n\n7. groups.ab,ti.\n\n8. or/1-7\n\n9. Animals/\n\n10. Humans/\n\n11. 9 not (9 and 10)\n\n12. 8 not 11",
    "notes": "Filter to identify RCTs\n--\n\nboth of these sets of queries were searched 'from their inception'",
    "start_date": null,
    "end_date": "2014-08-30",
    "annotator_id": 1
  },
  {
    "id": 131,
    "document_id": 46,
    "query": "(VIN or VIN2 or VIN3).mp.\n\n(vulva* adj5 intraepithelial neoplasia).mp.\n\n1 or 2\n\nexp Vulva/\n\nvulva*.mp.\n\n4 or 5\n\nexp Precancerous Conditions/\n\n(pre-cancer* or precancer*).mp.\n\ndysplasia.mp.\n\nunifocal.mp.\n\nmultifocal.mp.\n\nexp Carcinoma in Situ/\n\ncarcinoma in situ.mp.\n\n7 or 8 or 9 or 10 or 11 or 12 or 13\n\n6 and 14\n\n3 or 15",
    "notes": "searched from the inception date\n--\nkey: mp=title, original title, abstract, name of substance word, subject heading word",
    "start_date": "1945-12-31",
    "end_date": "2015-09-29",
    "annotator_id": 1
  },
  {
    "id": 132,
    "document_id": 107,
    "query": "1 exp Neoplasms/\n2 (malignan* or neoplasm* or cancer* or carcinoma* or tumour* or tumor*).mp. \n3 1 or 2\n4 Dance Therapy/\n5 Dancing/\n6 (dance or dancing).mp. \n7 (movement adj therap*).mp. \n8 4 or 5 or 6 or 7\n9 3 and 8\n",
    "notes": "MEDLINE search strategy (OvidSp)\n--\nkey: mp = title, original title, abstract, name of substance word, subject heading word",
    "start_date": "1949-12-31",
    "end_date": "2014-06-29",
    "annotator_id": 1
  },
  {
    "id": 156,
    "document_id": 121,
    "query": "exp Progesterone/\n\nexp Obstetric Labor, Premature/\n\nexp Tocolytic Agents/\n\nexp Tocolysis/\n\n2 or 3 or 4\n\n1 and 5\n\nclinical trial.pt.\n\nrandomized.ti,ab.\n\nplacebo.ti,ab.\n\ndt.fs.\n\nrandomly.ti,ab.\n\ntrial.ti,ab.\n\ngroups.ti,ab.\n\nor/7-14\n\n6 and 14",
    "notes": "MEDLINE (1966 to August 2013) (search carried out by authors):",
    "start_date": "1965-12-31",
    "end_date": "2013-08-30",
    "annotator_id": 1
  },
  {
    "id": 133,
    "document_id": 117,
    "query": "1. exp lung neoplasms/\n\n2. carcinoma, non-small-cell lung/\n\n3. (lung adj2 cancer).tw.\n\n4. (lung adj2 carcinoma$).tw.\n\n5. (lung adj2 neoplas$).tw.\n\n6. (pulmonary adj2 neoplas$).tw.\n\n7. (lung$ adj2 metast$).tw.\n\n8. exp carcinoma,bronchogenic/\n\n9. exp bronchial neoplasms/\n\n10. (bronch$ adj2 cancer$).tw.\n\n11. (bronch$ adj2 carcinoma$).tw.\n\n12. exp pleural neoplasms/\n\n13. or/1-12\n\n14. (lung$ or bronch$ or pulmonary).tw.\n\n15. exp carcinoma, squamous cell/\n\n16. exp adenocarcinoma/\n\n17. ((round adj cell) and (carcinoma$ or cancer$)).tw.\n\n18. ((reserve adj cell) and (carcinoma$ or cancer$)).tw.\n\n19. ((large adj cell) and (carcinoma$ or cancer$)).tw.\n\n20. ((squamous adj cell) and (carcinoma$ or cancer$)).tw.\n\n21. adenocarcinoma$.tw.\n\n22. carcinoma, large cell/\n\n23. or/15-22\n\n24. 14 and 23\n\n25. 13 or 24\n\n26. exp radiotherapy/\n\n27. exp radiotherapy, computer-assisted/\n\n28. exp radiation dosage/\n\n29. exp radiotherapy dosage/\n\n30. exp radiotherapy, high-energy/\n\n31. exp radiotherapy,adjuvant/\n\n32. exp dose fractionation/\n\n33. exp brachytherapy/\n\n34. exp radiation oncology/\n\n35. radiotherap$.tw.\n\n36. (thorac$ adj2 radiotherap$).mp.\n\n37. (radiat$ adj2 therap$).mp.\n\n38. (thorac$ adj2 radiat$).mp.\n\n39. irradiation.tw.\n\n40. (endobronch$ adj2 brachytherap$).mp.\n\n41. or/26-40\n\n42. exp palliative care/\n\n43. exp terminal care/\n\n44. exp quality of life/\n\n45. (symptom$ adj2 control$).mp.\n\n46. (symptom$ adj2 relief).mp.\n\n47. (symptom$ adj2 manag$).mp.\n\n48. (palliat$ adj2 manag$).mp.\n\n49. exp appetite/\n\n50. exp fatigue/\n\n51. exp cough/\n\n52. exp dyspnea/\n\n53. dyspnoea.tw.\n\n54. exp hemoptysis/\n\n55. haemoptysis.tw.\n\n56. exp chest pain/\n\n57. exp deglutition disorders/\n\n58. exp nausea/\n\n59. exp weight loss/\n\n60. tiredness.tw.\n\n61. exp hoarseness/\n\n62. breathlessness.tw.\n\n63. (symptom$ adj2 palliat$).mp.\n\n64. (palliat$ adj2 radiat$).mp.\n\n65. (palliat$ adj2 intent$).mp.\n\n66. or/42-65\n\n67. 41 and 66\n\n68. 25 and 67\n\n69. randomized controlled trial.pt.\n\n70. controlled clinical trial.pt.\n\n71. randomized.ab.\n\n72. placebo.ab.\n\n73. drug therapy.fs.\n\n74. randomly.ab.\n\n75. trial.ab.\n\n76. groups.ab.\n\n77. or/69-76\n\n78. exp animals/ not humans.sh.\n\n79. 77 not 78\n\n80. 68 and 79\n\n81 (201112* or 2012* or 2013* or 2014*).em.\n\n80 and 81",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2013-12-31",
    "annotator_id": 1
  },
  {
    "id": 134,
    "document_id": 40,
    "query": "1. exp Dietary Fiber/\n2. roughage*.tw.\n3. prebiotic*.tw.\n4. (carbohydrate adj2 polymer*).tw.\n5. ((non-starch or nonstarch) adj (poly-saccharide* or polysaccharide*)).tw.\n6. or/1-5\n7. Diet/\n8. diet*.tw.\n9. consum*.tw.\n10. eat*.tw.\n11. food*.tw.\n12. nutri*.tw.\n13. or/7-12\n14. exp Chitin/\n15. exp Cellulose/\n16. chitin*.tw.\n17. lignin*.tw.\n18. hemicellulose*.tw.\n19. hexosane*.tw.\n20. pentosane*.tw.\n21. xanthan*.tw.\n22. exp Fructans/\n23. fructan*.tw.\n24. inulin*.tw.\n25. polyuronide*.tw.\n26. Pectins/\n27. pectin*.tw.\n28. Alginates/\n29. alginate*.tw.\n30. (alginic adj2 acid*).tw.\n31. Agar/\n32. agar*.tw.\n33. Carrageenan/\n34. carrageen*.tw.\n35. Raffinose/\n36. raffinose*.tw.\n37. Xylose/\n38. xylose*.tw.\n39. polydextrose*.tw.\n40. Lactulose/\n41. lactulose*.tw.\n42. cellulose*.tw.\n43. (fibre* or fiber* or high-fibre* or high-fiber*).tw.\n44. or/14-43\n45. 13 and 44\n46. 6 or 45\n47. exp Cardiovascular Diseases/\n48. cardio*.tw.\n49. cardia*.tw.\n50. heart*.tw.\n51. coronary*.tw.\n52. angina*.tw.\n53. ventric*.tw.\n54. myocard*.tw.\n55. pericard*.tw.\n56. isch?em*.tw.\n57. emboli*.tw.\n58. arrhythmi*.tw.\n59. thrombo*.tw.\n60. atrial fibrillat*.tw.\n61. tachycardi*.tw.\n62. endocardi*.tw.\n63. (sick adj sinus).tw.\n64. exp Stroke/\n65. (stroke or stokes).tw.\n66. cerebrovasc*.tw.\n67. cerebral vascular.tw.\n68. apoplexy.tw.\n69. (brain adj2 accident*).tw.\n70. ((brain* or cerebral or lacunar) adj2 infarct*).tw.\n71. exp Hypertension/\n72. hypertensi*.tw.\n73. peripheral arter* disease*.tw.\n74. ((high or increased or elevated) adj2 blood pressure).tw.\n75. exp Hyperlipidemias/\n76. hyperlipid*.tw.\n77. hyperlip?emia*.tw.\n78. hypercholesterol*.tw.\n79. hypercholester?emia*.tw.\n80. hyperlipoprotein?emia*.tw.\n81. hypertriglycerid?emia*.tw.\n82. exp Arteriosclerosis/\n83. exp Cholesterol/\n84. cholesterol.tw.\n85. \"coronary risk factor* \".tw.\n86. Blood Pressure/\n87. blood pressure.tw.\n88. or/47-87\n89. 46 and 88\n90. randomized controlled trial.pt.\n91. controlled clinical trial.pt.\n92. randomized.ab.\n93. placebo.ab.\n94. drug therapy.fs.\n95. randomly.ab.\n96. trial.ab.\n97. groups.ab.\n98. 90 or 91 or 92 or 93 or 94 or 95 or 96 or 97\n99. exp animals/ not humans.sh.\n100. 98 not 99\n101. 89 and 100",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2015-01-03",
    "annotator_id": 1
  },
  {
    "id": 135,
    "document_id": 111,
    "query": "#1 OBSTETRIC LABOR, PREMATURE [MeSH terms] OR PREMATURE BIRTH [MeSH terms]\n#2 premature labor OR premature labour OR preterm labor OR preterm labour OR preterm birth\n#3 #1 or #2\n# 4 home OR ambulatory OR domiciliary\n# 5 HOME CARE SERVICES [MeSH terms]\n#6 HUM OR HUAM OR HUCA\n#7 UTERINE MONITORING [MeSH terms] OR fetal monitoring OR uterine monitor$ OR uterine contraction OR uterine activity monitor$\n#8 (#4 OR #5 OR #6)\n#9 (#7 AND #8)\n#10 randomized controlled trial[Publication Type] OR controlled clinical trial[Publication Type]\n#11 RCT OR randomised OR randomized OR clinical trial$\n#12 (#10 or #11)\n#13 (#3 AND #9 AND #12)",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2014-08-30",
    "annotator_id": 1
  },
  {
    "id": 136,
    "document_id": 106,
    "query": "1 randomized controlled trial.pt. (397350)\n2 controlled clinical trial.pt. (90496)\n3 randomized.ab. (316885)\n4 placebo.ab. (162975)\n5 drug therapy.fs. (1775294)\n6 randomly.ab. (227206)\n7 trial.ab. (330636)\n8 groups.ab. (1429199)\n9 or/1-8 (3509100)\n10 exp animals/ not humans.sh. (4077582)\n11 9 not 10 (3013932)\n12 exp enteral nutrition/ (16146)\n13 (enter$ adj3 feed$).tw. (5972)\n14 (enter$ adj3 nutrit$).tw. (6942)\n15 or/12-14 (20878)\n16 exp Intubation, Gastrointestinal/ (8571)\n17 (nasoenteral$ or naso enteral$).tw. (139)\n18 (esophag$ adj3 intubat$).tw. (601)\n19 (oesophag$ adj3 intubat$).tw. (242)\n20 (duoden$ adj3 intubat$).tw. (382)\n21 (gastrointest$ adj3 intubat$).tw. (52)\n22 (gastric adj3 intubat$).tw. (984)\n23 (esophag$ adj3 catheter$).tw. (376)\n24 (oesophag$ adj3 catheter$).tw. (100)\n25 (duoden$ adj3 catheter$).tw. (260)\n26 (stomach adj3 intubat$).tw. (120)\n27 (stomach adj3 catheter$).tw. (84)\n28 (gastrointest$ adj3 catheter$).tw. (43)\n29 (gastric adj3 catheter$).tw. (259)\n30 exp gastrointestinal motility/ (33836)\n31 exp gastric emptying/ (9078)\n32 (stomach adj3 emptying).tw. (442)\n33 (gastric adj3 emptying).tw. (10373)\n34 (gastro$ adj3 motili$).tw. (4222)\n35 (gastric adj3 motili$).tw. (2905)\n36 or/16-35 (50241)\n37 exp metoclopramide/ (4635)\n38 (Metoclopramide or Cerucal or 5 Chloro 2 Methoxyprocainamide or Clodilion or Clopra or Del 1267 or Del1267 or Dibertil or Duraclamid or Emenil or Emetard or Emitasol or Encil or Gastrobid or Gastronerton or Gastrosil or Gastrotem or Gastro Timelets or Gastrotimelets or Hyrin or M 813 or M813 or Maxeran or Maxeron or Maxolan or Maxolon or Meclopamide or Meclopramide or Meclopran or Metaclopramide or Methochlopramide or Methoclopramide or Methoclopramine or Metochlopramide or Metoclopamide or Metoclopramid or Metoclopramine or Metoclopranide Hydrochloride or Metaclopromide or Metoclorpramide or Metodopramide or Metopram or Metox or Metpamid or Mygdalon or Neu Sensamide or Octamide or Paspertin or Perinorm or Plasil or Pramidin or Pramin or Primperan or Reclomide or Reglan or Rimetin or Sensamide or Tomid).tw. (5631)\n39 or/37-38 (6628)\n40 15 and 36 and 39 (63)\n41 11 and 40 (39)\n42 limit 41 to ed=20080101-20141021 (13)",
    "notes": "Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations and Ovid MEDLINE(R) <1946 to Present>",
    "start_date": "1965-12-31",
    "end_date": "2014-10-20",
    "annotator_id": 1
  },
  {
    "id": 138,
    "document_id": 71,
    "query": "1 (panbronchiolitis or pan-bronchiolitis).tw,ot.\n2 diffuse panbronchiolitis.rs.\n3 dpb.tw.\n4 or/1-3\n5 exp Macrolides/\n6 macrolide*.tw,nm.\n7 (macrolide* or clarithromycin* or troleandomycin* or erythromycin* or josamycin* or azithromycin* or roxithromycin*).tw,nm.\n8 Anti-Bacterial Agents/\n9 or/5-8\n10 4 and 9",
    "notes": "updated search strategy",
    "start_date": "1965-12-31",
    "end_date": "2014-07-05",
    "annotator_id": 1
  },
  {
    "id": 141,
    "document_id": 20,
    "query": "1. Diabetic Ketoacidosis/\n2. Diabetic Coma/\n3. ((hyperglyc?emic or diabet*) adj emergenc*).tw.\n4. (diabet* and (keto* or acidos* or coma)).tw.\n5. DKA.tw.\n6. or/1-5\n7. Insulin Lispro/\n8. Insulin Aspart/\n9. Insulin, Short-Acting/\n10. (glulisine or apidra).tw.\n11. (humulin or novolin).tw.\n12. (lispro or aspart).tw.\n13. (novolog or novorapid).tw.\n14. (insulin* adj3 analogue*).tw.\n15. acting insulin*.tw.\n16. or/7-15\n17. 6 and 16\n18. exp animals/ not humans/\n19. 17 not 18",
    "notes": "MEDLINE (Ovid SP)",
    "start_date": "1945-12-31",
    "end_date": "2015-08-26",
    "annotator_id": 1
  },
  {
    "id": 137,
    "document_id": 71,
    "query": "#1 diffuse panbronchiolitis.tw.\n#2 DPB.tw.\n#3 1 or 2\n#4 exp Macrolides/\n#5 (macrolide* or clarithromycin* or troleandomycin* or erythromycin* or josamycin* or azithromycin* or roxithromycin*).tw.\n#6 4 or 5\n#7 3 and 6",
    "notes": "previous search strategy",
    "start_date": "1965-12-31",
    "end_date": "2010-04-04",
    "annotator_id": 1
  },
  {
    "id": 139,
    "document_id": 108,
    "query": "1 exp Bronchiolitis/\n2 bronchiolit*.tw.\n3 Bronchopneumonia/\n4 bronchopneumon*.tw.\n5 exp respiratory syncytial viruses/ or exp respiratory syncytial virus, human/\n6 Respiratory Syncytial Virus Infections/\n7 (respiratory syncytial virus* or rsv).tw.\n8 or/1-7\n9 Respiratory Therapy/\n10 Respiration, Artificial/\n11 positive-pressure respiration/ or continuous positive airway pressure/\n12 (positive pressur* adj5 (ventilat* or respir* or breath* or airway*)).tw.\n13 positiv* airway* pressur*.tw.\n14 continuous distend* pressur*.tw.\n15 positive end expiratory pressure.tw.\n16 (ppv or cpap or ncpap or nm-cpap or np-cpap or peep).tw.\n17 or/9-16\n18 8 and 17",
    "notes": "",
    "start_date": "1945-12-31",
    "end_date": "2014-04-12",
    "annotator_id": 1
  },
  {
    "id": 140,
    "document_id": 72,
    "query": "#1 PREGNANCY*:ME\n#2 PREGNAN*\n#3 MATERN*\n#4 ANTEPART*\n#5 PRENATAL\n#6 ANTENATAL\n#7 PERINATAL\n#8 ((((((#1 or #2) or #3) or #4) or #5) or #6) or #7)\n#9 PNEUMOCOCC*\n#10 PNEUMOCOCCAL*:ME\n#11 (#9 or #10)\n#12 VACCIN*\n#13 VACCINE*:ME\n#14 IMMUNUNIZATION*:ME\n#15 ((#12 or #13) or #14)\n#16 (#11 and #15)\n#17 (#8 and #16)",
    "notes": "\"We adapted the above search strategy to search MEDLINE (January 1966 to June 2004) and EMBASE (January 1985 to June 2004) by selecting appropriate MeSH and/or keywords from their respective thesauri.\"",
    "start_date": "1965-12-31",
    "end_date": "2004-06-29",
    "annotator_id": 1
  },
  {
    "id": 142,
    "document_id": 20,
    "query": "#1 (hyperglycemic emergenc*[tw] OR hyperglycaemic emergenc*[tw] OR diabetic emergenc*[tw] OR (diabet*[tw] AND (ketoac*[tw] OR acidos*[tw] OR coma[tw])) OR DKA[tw])\n\n#2 (glulisine[tw] OR apidra[tw] OR humulin[tw] OR novolin[tw] OR lispro[tw] OR aspart[tw] OR novolog[tw] OR novorapid[tw] OR (insulin[tw] AND analog*[tw]) OR acting insulin*[tw])\n\n#3 #1 AND #2\n\n#4 #3 NOT medline[sb] NOT pmcbook",
    "notes": "PubMed",
    "start_date": null,
    "end_date": "2015-08-26",
    "annotator_id": 1
  },
  {
    "id": 143,
    "document_id": 26,
    "query": "STRONGYLOIDES\nSTRONGYLOIDES STERCORALIS\nstrongyloid*\nstrongyloides infection*\n1 or 2 or 3 or 4\nthiabendazole\nalbendazole\nmebendazole\nanthelmint$\nivermectin*\n6 or 7 or 8 or 9 or 10\n5 and 11",
    "notes": "",
    "start_date": "1965-12-31",
    "end_date": "2015-08-30",
    "annotator_id": 1
  },
  {
    "id": 144,
    "document_id": 29,
    "query": "1. Randomized Controlled Trial.pt.\n2. Controlled Clinical Trial.pt.\n3. (randomized or randomised).ab,ti.\n4. placebo.ab,ti.\n5. drug therapy.fs.\n6. randomly.ab,ti.\n7. trial.ab,ti.\n8. groups.ab,ti.\n9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8\n10. exp animals/ not humans.sh.\n11. 9 not 10\n12. exp Onchocerciasis/\n13. exp Onchocerca/\n14. exp Microfilaria/\n15. (Onchocerc* or Oncocerc*).tw.\n16. (river adj2 blindness).tw.\n17. (Robles* disease or \"O volvulus\" or volvulosis or craw-craw or sowdah).tw.\n18. or/12-17\n19. exp Ivermectin/\n20. (Ivermec* or Ivermek* or Ivomec* or \"Ablaze-IM\" or \"ABZ Plus\" or \"Albacos-IR\" or \"Albosym-IR\" or Alvect or \"Anthel-UP\" or \"Ariban Plus\" or Ascapil or \"Bandy Plus\" or \"Benrod-I\" or Benzole or Cardomec or \"Dermoper IV\" or Dermopero or Detebencil or Diapec or Ectin or Ectover or \"Elect-A\" or Epimek or Eqvalan or Eqvalen or \"Eris Plus\" or \"Getrid-I\" or \"Hymin Plus\" or Ifact or Imectin or Ivecop or \"Ivecop-AB\" or Ivercid or \"Ivercid-A\" or Ivermin or Iversan or \"Iver-Sol\" or Iverstar or Ivertal or Iverx or Iverzole or Ivexterm or Ivor or Ivoral or Ivori or Kaonol or Kidi or Kilox or Leverctin or Macbi or Maikeding or Mectin or Mectizan or Mediderm or \"MK 933\" or MK933 or Networm or Oramec or Plurimec or Quamox or \"Quanox Gotas\" or Revectina or Sanifer or Securo or Simpiox or Sklice or Stromectol or Vermectil or Vermectin or Vermokill or Yvermil).tw.\n21. 70288-86-7.rn.\n22. or/19-21\n23. exp Doxycycline/\n24. (Abadox or Abraxil or \"Acnedox-LB\" or Actidox or Adoxa or \"Ai Rui De An\" or \"Aknefug Doxy\" or \"Ak-Ramycin\" or \"Ak-Ratabs\" or Aliudox or Alodox or \"Alpha 6 Deoxyoxytetracycline\" or \"Alpha-6-Deoxyoxytetracycline\" or Ambrodoxy or \"Ambroxol AL comp\" or \"Ambroxol comp\" or \"Amdox-Puren\" or Amermycin or Anfadox or \"Antodox Apidox\" or Apociclina or Apodoxin or Apodoxy or \"Apo-Doxy\" or Apprilon or Atridox or \"Avidox-LB\" or \"Avidox-OZ\" or \"Avidox-SP\" or Avidoxy or \"Azudoxat-T\" or Bactidox or \"Bidox-DT\" or Biocin or Biodoxi or Bioximicina or \"BMY 28689\" or BMY28689 or \"BU 3839T\" or \"Chemedox-HT\" or Ciclidoxan or Clifordin or Codox or Cyclodox).tw.\n25. (Dedoxyn or Dentarec or Dobid or Docdoxyc or Docyl or \"Doksiciklinas monohidratas\" or Doksisiklin or Doksisykliini or Doksisykliinimonohydraatti or Doksycyklina or \"Dom-Doxycycline\" or Doranbax or Doryx or Dosyklin or Dotur or Doxacin or Doxakne or Doxat or Doxibiot or Doxiciclina or Doxiciklin or Doxicip or Doxicor or Doxilegrand or Doxilina or Doximed or Doxina or Doxipil or Doxitab or Doxithal or Doxitidin or Doxitin or \"Dox-M DT\" or \"Dox-M ST\" or \"Dox-M TZ\" or \"Dox-M-A\" or \"Dox-M-OZ\" or \"Doxodin-TR\" or Doxt or Doxy or \"Doxy-1 L-DR Forte\" or \"Doxy-100\" or Doxybene or Doxycap or Doxycin or Doxycline or Doxycyclin or Doxycycline or Doxycyclinum or \"Doxycyklin monohydrate\" or Doxycyklinmonohydrat or Doxyderma or Doxydoc or Doxyferm or Doxyguard or Doxyhexal or \"Doxy-HP\" or Doxylan or Doxyleb or Doxylin or \"Doxylin-DT\" or \"Doxylin-TZ\" or Doxylis or \"Doxy-M\" or Doxyman or Doxymerck or Doxymono or Doxymycin or \"Doxy-N-Tablinen\" or Doxypalu or Doxyprotect or \"Doxyratio M\" or Doxyremed or Doxyric or Doxysol or Doxystad or Doxytab or \"Doxy-Tabs\" or Doxytop or \"Doxy-Wolff\" or Dumoxin or Duradox or Duradoxal or \"DX-24\").tw.\n26. (Efracea or Emdox or \"Emdox-TZ\" or Frakas or Geeox or Ginadox or \"Glodox-LB\" or Granudoxy or \"GS-3065\" or Hydramycin or Ibimycin or Idocyklin or Ivamycin or Jenacyclin or LAA or Lentomyk or Lupidox or Madoxy or \"Martidox-M\" or \"M-Dox\" or Microdox or Minicycline or Monodox or Morgidox or \"Nab-DT\" or Nee or Novadox or \"Novo-Doxylin\" or Novum or Nudoxy or NutriDox or Ocudox or Oracea or Oraxyl or Oraycea or Periosan or Periostat or \"PHL-Doxycycline\" or Plemex or \"PMS-Doxycycline\" or Pondoxcycline or Randoclin or Remycin or Sigadoxin or Supracyclin or Supracycline or Synvibra or \"Tasmacyclin Akne\" or Tetradox or Tolexine or Tremesal or Unidox or \"Vibra Tabs\" or Vibradox or Vibradoxin or Vibramicina or Vibramycin or Vibramycine or \"Vibra-S\" or Vibratab or \"Vibra-Tabs\" or Vibravenos or Vivradoxil or Xedocine).tw.\n27. (564-25-0 or 17086-28-1).rn.\n28. 23 or 24 or 25 or 26 or 27\n29. 22 or 28\n30. 11 and 18 and 29",
    "notes": "MEDLINE (Ovid) search strategy",
    "start_date": "1945-12-31",
    "end_date": "2015-07-30",
    "annotator_id": 1
  },
  {
    "id": 145,
    "document_id": 53,
    "query": "1. exp Elasticity Imaging Techniques/\n2. (transient elastograph* or fibroscan).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n3. 1 or 2\n4. exp liver cirrhosis/\n5. ((hepatic or liver) and (fibrosis or cirrhosis)).mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n6. 4 or 5\n7. exp Biopsy, Needle/\n8. liver biops*.mp. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier]\n9. 7 or 8\n10. 3 and 6 and 9",
    "notes": "MEDLINE (OvidSP)",
    "start_date": "1945-12-31",
    "end_date": "2014-08-30",
    "annotator_id": 1
  },
  {
    "id": 147,
    "document_id": 73,
    "query": "1. exp Blood Transfusion, Autologous/\n2. exp Blood Loss, Surgical/\n3. exp Blood Transfusion/\n4. (Autohaemotransfusion* or Auto-haemotransfusion* or Autohemotransfusion* or Auto-hemotransfusion* or Autotransfusion* or Auto-transfusion* or (Autologous adj5 (Blood or Plasma))).ab,ti.\n5. ((cell* or blood) adj5 (transfusion* or salvage or save*)).ab,ti.\n6. 1 or 2 or 3 or 4 or 5\n7. exp Abdominal Injuries/\n8. exp thoracic injuries/\n9. exp Wounds, Penetrating/\n10. (abdominal or abdomen or chest or thoracic or trunk).ab,ti.\n11. 9 and 10\n12. ((abdominal or abdomen or chest or thoracic or trunk) adj3 (trauma* or injur* or penetrat* or stab*)).ab,ti.\n13. ((Splenic or spleen or stomach or gastric) adj3 (rupture* or burst*)).ab,ti.\n14. ((heart or cardiac or aortic or aorta*) adj3 rupture*).ab,ti.\n15. 7 or 8 or 11 or 12 or 13 or 14\n16. 6 and 15\n17. randomized.ab,ti.\n18. randomized controlled trial.pt.\n19. controlled clinical trial.pt.\n20. placebo.ab.\n21. clinical trials as topic.sh.\n22. randomly.ab.\n23. trial.ti.\n24. or/17-23\n25. (animals not (humans and animals)).sh.\n26. 24 not 25\n27. 26 and 16",
    "notes": "Ovid MEDLINE, Ovid MEDLINE In-Process & Other Non-Indexed Citations, Ovid MEDLINE Daily and Ovid OLDMEDLINE",
    "start_date": "1945-12-31",
    "end_date": "2014-11-29",
    "annotator_id": 1
  },
  {
    "id": 149,
    "document_id": 100,
    "query": "1. (zentralveno?s* kathet* or (venostrom* or venenkathe*) or hickman line* or central line* insertion* or pulmonary arter* flotation* or ((venous or vein*) adj4 (cannulation or access or catheter* puncture)) or central venous line* or central venous pressure).mp. or exp Venous Cutdown/ or Central Venous Pressure/ or exp Catheterization Central Venous/\n2. (ultrasound* or ultrasonic* or Doppler or echography or ultrasonograpgh*).mp. or exp Ultrasonography Doppler Color/ or exp Echocardiography Doppler/ or exp Ultrasonography/ or exp Ultrasonics/\n3. 1 and 2\n4. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or drug therapy.fs. or randomly.ab. or trial.ab. or groups.ab.) not (animals not (humans and animals)).sh.\n5. 3 and 4",
    "notes": "MEDLINE (Ovid SP)",
    "start_date": "1965-12-31",
    "end_date": "2013-01-14",
    "annotator_id": 1
  },
  {
    "id": 146,
    "document_id": 56,
    "query": "1. randomized controlled trial.pt.\n2. (randomized or randomised).ab,ti.\n3. placebo.ab,ti.\n4. dt.fs.\n5. randomly.ab,ti.\n6. trial.ab,ti.\n7. groups.ab,ti.\n8. or/1-7\n9. exp animals/\n10. exp humans/\n11. 9 not (9 and 10)\n12. 8 not 11\n13. exp diabetic retinopathy/\n14. retinopath$.tw.\n15. (vitre$ adj3 detach$).tw.\n16. (retina$ adj3 detach$).tw.\n17. (diabet$ adj3 maculopath$).tw.\n18. or/13-17\n19. exp blood pressure/\n20. exp blood glucose/\n21. exp hypertension/\n22. ((pressure or glucose or glycem$) adj3 blood$).tw.\n23. hypertens$.tw.\n24. or/19-23\n25. exp antihypertensive agents/\n26. exp angiotensin converting enzyme inhibitors/\n27. (ACE adj1 inhibitor$).tw.\n28. (antihypertensive adj2 (agent$ or drug$ or medicat$)).tw.\n29. exp calcium channel blockers/\n30. (calcium adj1 channel adj1 blocker$).tw.\n31. (calcium adj1 channel adj1 antagonist$).tw.\n32. exp diuretics/\n33. diuretic$.tw.\n34. exp adrenergic beta antagonists/\n35. (adrenergic adj1 beta adj1 antagonist$).tw.\n36. (beta adj1 blocker$).tw.\n37. exp adrenergic alpha antagonist/\n38. (adrenergic adj1 alpha adj1 antagonist$).tw.\n39. exp vasodilator agents/\n40. exp angiotensin II type 1 receptor blockers/\n41. (angiotensin adj3 blocker$).tw.\n42. acebutolol.tw.\n43. amiloride.tw.\n44. amlodipine.tw.\n45. atorvastin.tw.\n46. benazepril.tw.\n47. atenolol.tw.\n48. bendroflumethiazide.tw.\n49. nadolol.tw.\n50. betaxolol.tw.\n51. bisoprolol.tw.\n52. bosentan.tw.\n53. bucindolol.tw.\n54. bumetanide.tw.\n55. candesartan.tw.\n56. captopril.tw.\n57. carteolol.tw.\n58. carvedilol.tw.\n59. chlorothiazide.tw.\n60. chlorthalidone.tw.\n61. clonidine.tw.\n62. diazoxide.tw.\n63. diltiazem.tw.\n64. diltiazem.tw.\n65. doxazosin.tw.\n66. enalapril.tw.\n67. enalapril$.tw.\n68. felodipine.tw.\n69. eplerenone.tw.\n70. epoprostenol.tw.\n71. eprosartan.tw.\n72. esmolol.tw.\n73. (ethacrynic adj1 acid).tw.\n74. fenoldopam.tw.\n75. fosinopril.tw.\n76. furosemide.tw.\n77. guanabenz.tw.\n78. guanadrel.tw.\n79. guanfacine.tw.\n80. hydralazine.tw.\n81. irbesartan.tw.\n82. lisinopril.tw.\n83. losartan.tw.\n84. methyldopa.tw.\n85. metoprolol.tw.\n86. moexipril.tw.\n87. olmesartan.tw.\n88. propranolol.tw.\n89. quinapril.tw.\n90. spironolactone.tw.\n91. telmisartan.tw.\n92. timolol.tw.\n93. triamterene.tw.\n94. valsartan.tw.\n95. hydrochlorothiazide.tw.\n96. iloprost.tw.\n97. indapamide.tw.\n98. isoxsuprine.tw.\n99. isradipine.tw.\n100. labetalol.tw.\n101. lercanidipine.tw.\n102. mecamylamine.tw.\n103. methyclothiazide.tw.\n104. metolazone.tw.\n105. mibefradil.tw.\n106. minoxidil.tw.\n107. nicardipine.tw.\n108. nifedipine.tw.\n109. nisoldipine.tw.\n110. exp nitric oxide/\n111. exp nitroprusside/\n112. nitroprusside.tw.\n113. omapatrilat.tw.\n114. penbutolol.tw.\n115. perindopril.tw.\n116. phenylbutazone.tw.\n117. phenoxybenzamine.tw.\n118. phentolamine.tw.\n119. pindolol.tw.\n120. polythiazide.tw.\n121. prazosin.tw.\n122. prostacyclin.tw.\n123. ramipril.tw.\n124. reserpine.tw.\n125. sildenafil.tw.\n126. spirapril.tw.\n127. terazosin.tw.\n128. torsemide.tw.\n129. trandolapril.tw.\n130. verapamil.tw.\n131. trepostinil.tw.\n132. triamterene.tw.\n133. trichlormethiazide.tw.\n134. or/25-133\n135. 18 and 24 and 12\n136. 18 and 134 and 12\n137. 135 or 136",
    "notes": "MEDLINE (OvidSP) ",
    "start_date": "1945-12-31",
    "end_date": "2014-04-29",
    "annotator_id": 1
  },
  {
    "id": 148,
    "document_id": 94,
    "query": "1 exp Angiotensin-Converting Enzyme Inhibitors/\n2 ((angiotensin$ or dipeptidyl$ or kininase ii) adj3 (convert$ or enzyme or inhibit$ or recept$ or block$)).tw.\n3 (ace adj inhibit$).tw.\n4 acei.tw.\n5 (alacepril or altiopril or ancovenin or benazepril or captopril or ceranapril or ceronapril or cilazapril or deacetylalacepril or delapril or derapril or enalapril or epicaptopril or fasidotril or fosinopril or foroxymithine or gemopatrilat or idapril or imidapril or indolapril or libenzapril or lisinopril or moexipril or moveltipril or omapatrilat or pentopril$ or perindopril$ or pivopril or quinapril$ or ramipril$ or rentiapril or saralasin or s nitrosocaptopril or spirapril$ or temocapril$ or teprotide or trandolapril$ or utibapril$ or zabicipril$ or zofenopril$ or Aceon or Accupril or Altace or Capoten or Lotensin or Mavik or Monopril or Prinivil or Univas or Vasotec or Zestril).tw.\n6 or/1-5\n7 exp Angiotensin Receptor Antagonists/\n8 (angiotensin adj3 (receptor antagon$ or receptor block$)).tw.\n9 arb?.tw.\n10 (abitesartan or azilsartan or candesartan or elisartan or embusartan or eprosartan or forasartan or irbesartan or KT3-671 or losartan or milfasartan or olmesartan or saprisartan or tasosartan or telmisartan or valsartan or zolasartan).tw.\n11 or/7-10\n12 renin/ai\n13 (aliskiren or ciprokiren or ditekiren or enalkiren or remikiren or rasilez or tekturna or terlakiren or zankiren).mp.\n14 renin inhibit$.tw.\n15 or/12-14\n16 6 or 11 or 15\n17 exp calcium channel blockers/\n18 (amlodipine or aranidipine or barnidipine or bencyclane or benidipine or bepridil or cilnidipine or cinnarizine or clentiazem or darodipine or diltiazem or efonidipine or elgodipine or etafenone or fantofarone or felodipine or fendiline or flunarizine or gallopamil or isradipine or lacidipine or lercanidipine or lidoflazine or lomerizine or manidipine or mibefradil or nicardipine or nifedipine or niguldipine or nilvadipine or nimodipine or nisoldipine or nitrendipine or perhexiline or prenylamine or semotiadil or terodiline or tiapamil or verapamil or Cardizem CD or Dilacor XR or Tiazac or Cardizem Calan or Isoptin or Calan SR or Isoptin SR Coer or Covera HS or Verelan PM).tw.\n19 (calcium adj2 (antagonist? or block$ or inhibit$)).tw.\n20 or/17-19\n21 (methyldopa or alphamethyldopa or amodopa or dopamet or dopegyt or dopegit or dopegite or emdopa or hyperpax or hyperpaxa or methylpropionic acid or dopergit or meldopa or methyldopate or medopa or medomet or sembrina or aldomet or aldometil or aldomin or hydopa or methyldihydroxyphenylalanine or methyl dopa or mulfasin or presinol or presolisin or sedometil or sembrina or taquinil or dihydroxyphenylalanine or methylphenylalanine or methylalanine or alpha methyl dopa).mp.\n22 (reserpine or serpentina or rauwolfia or serpasil).mp.\n23 (clonidine or adesipress or arkamin or caprysin or catapres$ or catasan or chlofazolin or chlophazolin or clinidine or clofelin$ or clofenil or clomidine or clondine or clonistada or clonnirit or clophelin$ or dichlorophenylaminoimidazoline or dixarit or duraclon or gemiton or haemiton or hemiton or imidazoline or isoglaucon or klofelin or klofenil or m-5041t or normopresan or paracefan or st-155 or st 155 or tesno timelets).mp.\n24 exp hydralazine/\n25 (dihydralazine or hydralazin$ or hydrallazin$ or hydralizine or hydrazinophtalazine or hydrazinophthalazine or hydrazinophtalizine or dralzine or hydralacin or hydrolazine or hypophthalin or hypoftalin or hydrazinophthalazine or idralazina or 1-hydrazinophthalazine or apressin or nepresol or apressoline or apresoline or apresolin or alphapress or alazine or idralazina or lopress or plethorit or praeparat).tw.\n26 or/21-25\n27 exp adrenergic beta-antagonists/\n28 (acebutolol or adimolol or afurolol or alprenolol or amosulalol or arotinolol or atenolol or befunolol or betaxolol or bevantolol or bisoprolol or bopindolol or bornaprolol or brefonalol or bucindolol or bucumolol or bufetolol or bufuralol or bunitrolol or bunolol or bupranolol or butofilolol or butoxamine or carazolol or carteolol or carvedilol or celiprolol or cetamolol or chlortalidone cloranolol or cyanoiodopindolol or cyanopindolol or deacetylmetipranolol or diacetolol or dihydroalprenolol or dilevalol or epanolol or esmolol or exaprolol or falintolol or flestolol or flusoxolol or hydroxybenzylpinodolol or hydroxycarteolol or hydroxymetoprolol or indenolol or iodocyanopindolol or iodopindolol or iprocrolol or isoxaprolol or labetalol or landiolol or levobunolol or levomoprolol or medroxalol or mepindolol or methylthiopropranolol or metipranolol or metoprolol or moprolol or nadolol or oxprenolol or penbutolol or pindolol or nadolol or nebivolol or nifenalol or nipradilol or oxprenolol or pafenolol or pamatolol or penbutolol or pindolol or practolol or primidolol or prizidilol or procinolol or pronetalol or propranolol or proxodolol or ridazolol or salcardolol or soquinolol or sotalol or spirendolol or talinolol or tertatolol or tienoxolol or tilisolol or timolol or tolamolol or toliprolol or tribendilol or xibenolol).tw.\n29 (beta adj2 (adrenergic? or antagonist? or block$ or receptor?)).tw.\n30 or/27-29\n31 exp adrenergic alpha antagonists/ae, tu\n32 (alfuzosin or bunazosin or doxazosin or metazosin or neldazosin or prazosin or silodosin or tamsulosin or terazosin or tiodazosin or trimazosin).tw.\n33 (adrenergic adj2 (alpha or antagonist?)).tw.\n34 ((adrenergic or alpha or receptor?) adj2 block$).tw.\n35 or/31-34\n36 exp thiazides/ae, tu\n37 exp sodium potassium chloride symporter inhibitors/ae, tu\n38 ((loop or ceiling) adj diuretic?).tw.\n39 (amiloride or benzothiadiazine or bendroflumethiazide or bumetanide or chlorothiazide or cyclopenthiazide or furosemide or hydrochlorothiazide or hydroflumethiazide or methyclothiazide or metolazone or polythiazide or trichlormethiazide or veratide or thiazide?).tw.\n40 (chlorthalidone or chlortalidone or phthalamudine or chlorphthalidolone or oxodoline or thalitone or hygroton or indapamide or metindamide).tw.\n41 or/36-40\n42 hypertension/\n43 hypertens$.tw.\n44 ((high or elevat$ or rais$) adj2 blood pressure).tw.\n45 or/42-44\n46 randomized controlled trial.pt.\n47 controlled clinical trial.pt.\n48 randomized.ab.\n49 placebo.ab.\n50 clinical trials as topic/\n51 randomly.ab.\n52 trial.ti.\n53 or/46-52\n54 animals/ not (humans/ and animals/)\n55 Pregnancy/ or Hypertension, Pregnancy-Induced/ or Pregnancy Complications, Cardiovascular/ or exp Ocular Hypertension/\n56 (pregnancy-induced or ocular hypertens$ or preeclampsia or pre-eclampsia).ti.\n57 53 not (54 or 55 or 56)\n58 16 and 45 and 57 and (20 or 26 or 30 or 35 or 41)",
    "notes": "Database: Ovid MEDLINE(R) 1946 to Present with Daily Update\nSearch Date: 19 November 2014",
    "start_date": "1945-12-31",
    "end_date": "2014-10-18",
    "annotator_id": 1
  },
  {
    "id": 150,
    "document_id": 118,
    "query": "medulloblastoma OR medulloblastomas OR circumscribed arachnoidal cerebellar sarcoma OR desmoplastic medulloblastoma OR desmoplastic medulloblastomas OR childhood medulloblastoma OR childhood medulloblastomas OR medullomyoblastoma OR medullomyoblastomas OR melanocytic medulloblastoma OR melanocytic medulloblastomas OR medulloblast* OR medullomyoblast* OR large cell medulloblastoma OR large cell medulloblastomas OR brain neoplasm OR brain neoplasms OR intracranial neoplasm OR intracranial neoplasms OR cerebellar neoplasm OR cerebellar neoplasms OR brain tumor OR brain tumors OR cerebellar tumors OR cerebellar tumor OR primitive neuroepithelial tumor OR primitive neuroepithelial tumors OR primitive neuroectodermal tumor OR primitive neuroectodermal tumors OR primitive neuroepithelial neoplasm OR primitive neuroepithelial neoplasms OR primitive neuroectodermal neoplasms OR primitive neuroectodermal neoplasm OR PNET OR PNETs OR cerebral primitive neuroectodermal tumor OR ependymoblastoma OR ependymoblastomas OR ependymoblast* OR medulloepithelioma OR medulloepitheliomas OR medulloepitheliom* OR spongioblastoma OR spongioblastomas OR spongioblast* OR germ cell neoplasm OR embryonal neoplasm OR large cell anaplastic medulloblastoma OR large cell anaplastic medulloblastomas OR nodular desmoplastic medulloblastoma OR nodular desmoplastic medulloblastomas",
    "notes": "For medulloblastoma, we used the following MeSH headings and text words",
    "start_date": "1965-12-31",
    "end_date": "2003-08-05",
    "annotator_id": 1
  },
  {
    "id": 151,
    "document_id": 118,
    "query": "survival OR survival rate OR rate, survival OR rates, survival OR survival rates OR cumulative survival rate OR cumulative survival rates OR rate, cumulative survival OR rates, cumulative survival OR survival rate, cumulative OR survival rates, cumulative OR survivorship OR mean survival time OR mean survival times OR survival time, mean OR survival times, mean OR time, mean survival OR times, mean survival OR survival time OR surviv* OR median survival time OR median survival times OR survival time, median OR survival times, median OR time, median survival OR times, median survival OR overall survival OR analysis, survival OR analyses, survival OR survival analysis OR survival analyses OR disease-free survival OR disease free survival OR survival, disease-free OR disease-free survivals OR survival, disease free OR survivals, disease-free OR event-free survival OR event-free survivals OR event free survival OR survival, event-free OR survivals, event-free OR progression-free survival OR progression free survival OR progression-free survivals OR survival, progression-free OR survivals, progression-free OR event-free OR event free OR progression free OR progression-free OR time to progression OR treatment outcome OR treatment effectiveness OR treatment efficacy OR neoplasm recurrence OR neoplasm recurrences",
    "notes": "For survival, we used the following MeSH headings and text words",
    "start_date": "1965-12-31",
    "end_date": "2003-08-05",
    "annotator_id": 1
  },
  {
    "id": 152,
    "document_id": 118,
    "query": "chemotherapy OR chemotherapies OR chemotherap* OR antineoplastic protocol OR antineoplastic protocols OR protocol, antineoplastic OR protocols, antineoplastic OR cancer treatment protocols OR cancer treatment protocol OR protocol, cancer treatment OR protocols, cancer treatment OR treatment protocol, cancer OR treatment protocols, cancer OR antineoplastic combined chemotherapy protocols OR antineoplastic agents, combined OR agent, combined antineoplastic OR agents, combined antineoplastic OR antineoplastic agent, combined OR combined antineoplastic agent OR antineoplastic drug combinations OR antineoplastic drug combination OR combinations, antineoplastic drug OR drug combination, antineoplastic OR anticancer drug combinations OR anticancer drug combination OR drug combination, anticancer OR drug combinations, anticancer OR Combined antineoplastic agents OR antineoplastic combined chemotherapy regimens OR drug combinations, antineoplastic OR antineoplastic chemotherapy protocols OR antineoplastic chemotherapy protocol OR chemotherapy protocol, antineoplastic OR protocol, antineoplastic chemotherapy OR protocols, antineoplastic chemotherapy OR cancer chemotherapy protocols OR cancer chemotherapy protocol OR chemotherapy protocol, cancer OR chemotherapy protocols, cancer OR protocol, cancer chemotherapy OR protocols, cancer chemotherapy OR chemotherapy protocols, antineoplastic",
    "notes": "For chemotherapy, we used the following MeSH headings and text words",
    "start_date": "1965-12-31",
    "end_date": "2003-08-05",
    "annotator_id": 1
  },
  {
    "id": 153,
    "document_id": 118,
    "query": "infant OR infan* OR newborn OR newborn* OR new-born* OR baby OR baby* OR babies OR neonat* OR child OR child* OR schoolchild* OR schoolchild OR school child OR school child* OR kid OR kids OR toddler* OR adolescent OR adoles* OR teen* OR boy* OR girl* OR minors OR minors* OR underag* OR under ag* OR juvenil* OR youth* OR kindergar* OR puberty OR puber* OR pubescen* OR prepubescen* OR prepuberty* OR pediatrics OR pediatric* OR paediatric* OR peadiatric* OR schools OR nursery school* OR preschool* OR pre school* OR primary school* OR secondary school* OR elementary school* OR elementary school OR high school* OR highschool* OR school age OR schoolage OR school age* OR schoolage* OR infancy OR schools, nursery OR infant, newborn",
    "notes": "For children, we used the following MeSH headings and text words",
    "start_date": "1965-12-31",
    "end_date": "2003-08-05",
    "annotator_id": 1
  },
  {
    "id": 154,
    "document_id": 119,
    "query": "1. (tuberculosis or TB).tw\n2. Mycobacterium tuberculosis/\n3. Tuberculosis, Multidrug-Resistant/ or Tuberculosis/ or Tuberculosis, Pulmonary/\n4.  1 or 2 or 3\n5. (Xpert or GeneXpert or cepheid or( near* patient)). tw.\n4 and 5",
    "notes": "Search strategy: Medline (OVID) and Embase (OVID)",
    "start_date": "2006-12-31",
    "end_date": "2007-01-20",
    "annotator_id": 1
  },
  {
    "id": 157,
    "document_id": 122,
    "query": "1 randomized controlled trial.pt. (389866)\n2 controlled clinical trial.pt. (89904)\n3 randomized.ab. (287333)\n4 placebo.ab. (156850)\n5 drug therapy.fs. (1767223)\n6 randomly.ab. (199448)\n7 trial.ab. (302482)\n8 groups.ab. (1276425)\n9 or/1-8 (3299027)\n10 exp animals/ not humans.sh. (4060470)\n11 9 not 10 (2809295)\n12 Carpal Tunnel Syndrome.mp. or Carpal Tunnel Syndrome/ (7915)\n13 (carp$ tunn$ or tunn$ syndrom$ or carp$ syndrom$).mp. (9575)\n14 (nerve entrapment or nerve compression or entrapment neuropath$).mp. (11216)\n15 median nerve entrapment.mp. (99)\n16 nerve compression syndromes/ (9072)\n17 or/12-16 (19390)\n18 endoscop$.mp. (159054)\n19 OCTR.mp. (35)\n20 ECTR.mp. (59)\n21 releas$.mp. (600120)\n22 or/18-21 (757515)\n23 11 and 17 and 22 (328)",
    "notes": "Database: Ovid MEDLINE(R) <1946 to November Week 1 2013>\nSearch Strategy:\n--------------------------------------------------------------------------------",
    "start_date": "1945-12-31",
    "end_date": "2013-11-08",
    "annotator_id": 1
  },
  {
    "id": 158,
    "document_id": 123,
    "query": "1. Delirium/\n\n2. deliri*.mp.\n\n3. \"acute confusion*\".ti,ab.\n\n4. \"acute organic psychosyndrome\".ti,ab.\n\n5. \"acute brain syndrome\".ti,ab.\n\n6. \"metabolic encephalopathy\".ti,ab.\n\n7. \"acute psycho-organic syndrome\".ti,ab.\n\n8. \"clouded state\".ti,ab.\n\n9. \"clouding of consciousness\".ti,ab.\n\n10. \"exogenous psychosis\".ti,ab.\n\n11. \"toxic psychosis\".ti,ab.\n\n12. \"toxic confusion\".ti,ab.\n\n13. Delirium, Dementia, Amnestic, Cognitive Disorders/su [Surgery]\n\n14. obnubilat*.ti,ab.\n\n15. or/1-14\n\n16. Primary Prevention/\n\n17. prevent*.mp.\n\n18. reduc*.ti,ab.\n\n19. stop*.ti,ab.\n\n20. taper*.ti,ab.\n\n21. avoid*.ti,ab.\n\n22. \"cut* down\".ti,ab.\n\n23. or/16-22\n\n24. 15 and 23\n\n25. randomized controlled trial.pt.\n\n26. controlled clinical trial.pt.\n\n27. randomi?ed.ab.\n\n28. placebo.ab.\n\n29. drug therapy.fs.\n\n30. randomly.ab.\n\n31. trial.ab.\n\n32. groups.ab.\n\n33. or/25-32\n\n34. (animals not (humans and animals)).sh.\n\n35. 33 not 34\n\n36. 24 and 35",
    "notes": "MEDLINE In-process and other non-indexed citations and MEDLINE 1950 - present (Ovid SP)",
    "start_date": "1949-12-31",
    "end_date": "2013-03-31",
    "annotator_id": 1
  },
  {
    "id": 159,
    "document_id": 124,
    "query": "1 foster home care/\n2 ((kin or kinship) adj3 (care$ or caring)).tw.\n3 ((kin or kinship) adj3 foster$).tw.\n4 ((kin or kinship) adj3 placement$).tw.\n5 ((family or families) adj3 foster$).tw.\n6 ((family or families) adj3 placement$).tw.\n7 ((family or families) adj3 substitute$).tw.\n8 (relative$ adj3 substitute$).tw.\n9 (relative$ adj3 foster$).tw.\n10 custodial grandparent$.tw.\n11 Infant/\n12 exp Child/\n13 adolescent/\n14 (baby or babies or infant$ or toddler$ or PRESCHOOL$ or PRE-SCHOOL$ or CHILD$ or BOY$ or GIRL$ or preteen or teen$ or adolescen$ or youth$ or young person$ or young people).tw.\n15 or/11-14\n16 or/1-10\n17 15 and 16",
    "notes": "Ovid MEDLINE(R),1948 to March Week 1 2011, last searched 14 March 2011",
    "start_date": "1947-12-31",
    "end_date": "2011-04-08",
    "annotator_id": 1
  },
  {
    "id": 160,
    "document_id": 125,
    "query": "1 exp Anovulation/ (1994)\n2 anovulat$.tw. (4604)\n3 amenorrhea/ or oligomenorrhea/ (9395)\n4 amenorrh$.tw. (12096)\n5 oligomenorrh$.tw. (1173)\n6 Polycystic Ovary Syndrome/ (10275)\n7 pcos.tw. (6166)\n8 Polycystic Ovar$.tw. (10552)\n9 pcod.tw. (261)\n10 or/1-9 (31138)\n11 trigger$.tw. (180779)\n12 exp Chorionic Gonadotropin/ (29316)\n13 HCG.tw. (21316)\n14 uhcg.tw. (19)\n15 rhcg.tw. (173)\n16 exp Luteinizing Hormone/ (44744)\n17 Human Chorionic Gonadotrop?in$.tw. (15232)\n18 rLH.tw. (281)\n19 recombinant LH.tw. (128)\n20 Recombinant Luteini?ing Hormone$.tw. (50)\n21 GnRH A.tw. (935)\n22 buserelin.tw. (1271)\n23 leuprorelin.tw. (352)\n24 nafarelin.tw. (253)\n25 triptorelin.tw. (587)\n26 gnrh agonist$.tw. (3620)\n27 gonadotrop?in releasing hormone agonist$.tw. (2158)\n28 or/11-27 (261679)\n29 10 and 28 (5873)\n30 randomized controlled trial.pt. (390648)\n31 controlled clinical trial.pt. (89952)\n32 randomized.ab. (306122)\n33 randomised.ab. (67265)\n34 placebo.tw. (168269)\n35 clinical trials as topic.sh. (175506)\n36 randomly.ab. (216624)\n37 trial.ti. (132003)\n38 (crossover or cross-over or cross over).tw. (63117)\n39 or/30-38 (980010)\n40 exp animals/ not humans.sh. (4062546)\n41 39 not 40 (905465)\n42 29 and 41 (562)\n43 (2012$ or 2013$).ed. (2071776)\n44 42 and 43 (51)\n",
    "notes": "",
    "start_date": null,
    "end_date": "2014-03-20",
    "annotator_id": 1
  },
  {
    "id": 161,
    "document_id": 127,
    "query": "1 randomized controlled trial.pt.\n2 controlled clinical trial.pt.\n3 randomized.ab.\n4 placebo.ab.\n5 drug therapy.fs.\n6 randomly.ab.\n7 trial.ab.\n8 groups.ab.\n9 or/1-8\n10 exp animals/ not humans.sh.\n11 9 not 10\n12 polyneuropathies/\n13 muscle Weakness/\n14 rhabdomyolysis/\n15 quadriplegia/\n16 paresis/\n17 neuromuscular manifestation$1.tw.\n18 (polyneuropath$ or myopath$).tw.\n19 polyneuromyopath$.tw.\n20 neuromuscular disorder$.tw.\n21 neuromuscular disease$.tw.\n22 paresis.tw.\n23 quadriplegia.tw.\n24 weakness.tw.\n25 neuromyopath$.tw.\n26 motor syndrome.tw.\n27 muscle function.tw.\n28 muscle strength/\n29 (muscle strength or respiratory failure).tw.\n30 or/12-29\n31 intensive Care/\n32 critical Illness/\n33 intensive care.tw.\n34 critical$ ill$.tw.\n35 ventilator weaning/\n36 respiration, artificial/\n37 or/31-36\n38 therapeutics/\n39 enteral nutrition/ or enter$ feed$.tw. or enter$ nutrition.tw.\n40 parenteral nutrition/ or parenter$ feed$.tw. or parenter$ nutrition.tw.\n41 glucocorticoids/ or glucocorticoids.tw.\n42 exercise therapy/ or kinesiotherap$.tw.\n43 diet therapy/\n44 pc.fs.\n45 rh.fs.\n46 therapies investigational/ or experimental therap$.tw. or investigational therap$.tw.\n47 amino acids/ or amino acids.tw.\n48 arginine/ or arginine.tw. or arg.tw.\n49 glutamine/ or glutamine.tw. or glu.tw.\n50 antioxidants/ or antioxidant$.tw. or anti oxidant$.tw.\n51 acetylcysteine/ or n-acetylcycteine.tw. or NAC.tw. or glutathione.tw.\n52 growth hormone/ or growth hormone.tw. or GH.tw.\n53 androgens/ or androgen$.tw. or testosterone.tw. or oxandrolone.tw.\n54 Insulin-Like Growth Factor I/ or insulin-like growth factor.tw. or igf-1.tw.\n55 immunoglobulins/ or immunoglobulin$.tw.\n56 insulin/ or insulin.tw.\n57 iit.mp.\n58 (insulin adj5 therapy).tw.\n59 (insulin adj5 treatment).tw.\n60 physical therapy modalities/ or physiotherap$.tw. or physical therap$.tw.\n61 electric stimulation therapy/ or electrostimulation.mp. or (electric$ adj2 stimulation).tw.\n62 rehabilitation.tw. or rehabilitation/\n63 breathing exercises/\n64 breathing exercise$.tw.\n65 magnesium.mp.\n66 or/38-65\n67 11 and 30 and 37 and 66",
    "notes": "",
    "start_date": null,
    "end_date": "2011-10-03",
    "annotator_id": 1
  },
  {
    "id": 162,
    "document_id": 130,
    "query": "(\"Contraceptive Agents, Female\"[Mesh] OR \"Contraceptive Devices, Female\"[Mesh] OR contracept*[tiab]) AND (\"Body Weight\"[Mesh] OR weight[tiab] OR \"Body Mass Index\"[Mesh]) NOT (cancer*[ti] OR polycystic [ti] OR exercise [ti] OR physical activity[ti] OR postmenopaus*[ti])",
    "notes": "MEDLINE via PubMed (01 Jan 2011 to 01 Jan 2014)\nFilter Activated: Clinical Trial\n",
    "start_date": "2010-12-31",
    "end_date": "2013-12-31",
    "annotator_id": 1
  },
  {
    "id": 163,
    "document_id": 131,
    "query": "1. randomized controlled trial.pt.\n2. (randomized or randomised).ab,ti.\n3. placebo.ab,ti.\n4. dt.fs.\n5. randomly.ab,ti.\n6. trial.ab,ti.\n7. groups.ab,ti.\n8. or/1-7\n9. exp animals/\n10. exp humans/\n11. 9 not (9 and 10)\n12. 8 not 11\n13. exp cataract/\n14. cataract extraction/\n15. exp lens crystalline/\n16. exp lenses intraocular/\n17. lens implantation intraocular/\n18. (intraocular lens$ or intra ocular lens$ or IOL$).tw.\n19. or/13-18\n20. phacoemulsification/\n21. pha?oemulsif$.tw.\n22. (phaco or phako).tw.\n23. or/20-22\n24. (extracapsular adj2 cataract$).tw.\n25. (extra capsular adj2 cataract$).tw.\n26. ECCE.tw.\n27. or/24-26\n28. 19 and 23 and 27\n29. 12 and 28",
    "notes": "The search filter for trials at the beginning of the MEDLINE strategy is from the published paper by Glanville et al (Glanville 2006).",
    "start_date": null,
    "end_date": "2014-01-28",
    "annotator_id": 1
  },
  {
    "id": 174,
    "document_id": 145,
    "query": "1. cerebrovascular disorders/ or basal ganglia cerebrovascular disease/ or exp brain ischemia/ or carotid artery diseases/ or carotid artery thrombosis/ or intracranial arterial diseases/ or cerebral arterial diseases/ or exp \"intracranial embolism and thrombosis\"/ or exp stroke/\n2. (isch?emi$ adj6 (stroke$ or apoplex$ or cerebral vasc$ or cerebrovasc$ or cva or attack$)).tw.\n3. ((brain or cerebr$ or cerebell$ or vertebrobasil$ or hemispher$ or intracran$ or intracerebral or infratentorial or supratentorial or middle cerebr$ or mca$ or anterior circulation) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$ or hypoxi$)).tw.\n4. 1 or 2 or 3\n5. exp insulins/ or insulin infusion systems/\n6. (insulin$ or novolin or humulin or iletin or velosulin).tw.\n7. insulin$.nm.\n8. 5 or 6 or 7\n9. 4 and 8\n10. exp animals/ not humans.sh\n11. 9 not 10",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-22",
    "annotator_id": 1
  },
  {
    "id": 177,
    "document_id": 150,
    "query": "malaria\narte*\ndihydroarte*\namodiaq*\nlumefantrine\nCoartem*\nmefloquine\n2 or 3\n4 or 5 or 6 or 7\n1 and 8 and 9",
    "notes": "Search terms used in combination with the search strategy for retrieving trials developed by The Cochrane Collaboration (Lefebvre 2008); upper case: MeSH or EMTREE heading; lower case: free text term.",
    "start_date": null,
    "end_date": "2013-07-28",
    "annotator_id": 1
  },
  {
    "id": 165,
    "document_id": 132,
    "query": "1   exp Central Nervous System Neoplasms/\n2   ((central nervous system or CNS) adj5 (cancer* or tumor* or tumour* or neoplas* or carcinoma* or metastat* or malignan*)).mp.\n3   ((brain or intracranial or intra-cranial or cerebr*) adj5 (cancer* or tumor* or tumour* or neoplas* or carcinoma* or metastat* or malignan*)).mp.\n4   exp neoplasms, neuroepithelial/\n5   (glioma* or astrocytoma* or xanthoastrocytoma* or glioblastoma* or gliosarcoma* or oligodendrogli* or oligoastrocyt* or ependym* or subependym* or astroblastoma* or ganglioglioma* or gangliocytoma* or neurocytoma* or liponeurocytoma* or pineocytoma* or pineoblastoma* or medulloblastoma* or neuroblastoma* or ganglioneuroblastoma*or medulloepithelioma*).mp.\n6   ((glioneural or neuroectodermal or embryonal or neuroepithelial or pineal or choroid plexus or teratoid or rhabdoid) adj5 (tumor* or tumour*)).mp.\n7   1 or 2 or 3 or 4 or 5 or 6\n8   Fluorescence/\n9   Aminolevulinic Acid/\n10 fluorescen*.mp.\n11 (aminolevulinic acid or 5-aminolevulinic acid).mp.\n12 ALA.mp.\n13 exp Magnetic Resonance Imaging/\n14 (MRI or magnetic resonance imag*).mp.\n15 exp Ultrasonography/\n16 (ultrasound or ultrasonography).mp.\n17 3D.mp.\n18 Neuronavigation/\n19 Surgery, Computer-Assisted/\n20 (navigat* or neuronavigat* or neuro-navigat*).mp.\n21 ((intra-operative or intraoperative) adj5 (technolog* or modalit*)).mp.\n22 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21\n23 7 and 22\n24 randomized controlled trial.pt.\n25 controlled clinical trial.pt.\n26 randomized.ab.\n27 placebo.ab.\n28 clinical trials as topic.sh.\n29 randomly.ab\n30 trial.ti.\n31 24 or 25 or 26 or 27 or 28 or 29 or 30\n32 23 and 31\n33 exp animals/ not humans.sh.\n34 32 not 33",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-27",
    "annotator_id": 1
  },
  {
    "id": 167,
    "document_id": 133,
    "query": "1. (exp Anesthesia/ or exp Perioperative care/ or an?esthe*.mp. or perioperative.ti,ab.) and (exp child/ or child*.af. or exp Pediatrics/ or p?ediatric*.af.) \n2. exp Pain, Postoperative/ or exp Postoperative Complications/ or exp \"Postoperative Nausea and Vomiting\"/ or (postoperative adj5 (pain or nausea or vomiting or analgesia)).mp. or (delirium or agitation or pruritus or itch* or sedation or hypotensi* or bradycardi*).mp.\n3. exp Clonidine/ or clonidin*.af. \n4. 1 and 2 and 3",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-27",
    "annotator_id": 1
  },
  {
    "id": 169,
    "document_id": 135,
    "query": "tuberculosis\nANTITUBERCULAR AGENTS/ADMINISTRATION AND DOSAGE\nSTREPTOMYCIN\nISONIAZID\nRIFAMPIN\nrifampicin\nPYRAZINAMIDE\nethambutol\nintermittent\n2-9/OR\nChild*\nPediatr*\nInfant*\n11 or 12 or 13\n1 and 10 and 14",
    "notes": "Search terms used in combination with the search strategy for retrieving trials developed by The Cochrane Collaboration (Lefebvre 2008); upper case: MeSH or EMTREE heading; lower case: free text term.",
    "start_date": null,
    "end_date": "2014-01-27",
    "annotator_id": 1
  },
  {
    "id": 170,
    "document_id": 136,
    "query": "kidney transplantation/\n\nexp Hydroxymethylglutaryl-CoA Reductase Inhibitors/\n\n\"hydroxymethylglutaryl-CoA reductase inhibitor$\".tw.\n\n(\"HMG CoA reductase inhibitor$\" or \"HMG Co A reductase inhibitor$\").tw.\n\nstatin$.tw.\n\natorvastatin.tw.\n\ncerivastatin.tw.\n\ndalvastatin.tw.\n\nfluindostatin.tw.\n\nfluvastatin.tw.\n\nlovastatin.tw.\n\npitavastatin.tw.\n\npravastatin.tw.\n\nrosuvastatin.tw.\n\nsimvastatin.tw.\n\nmeglutol.tw.\n\nmevinolin$.tw.\n\nmonacolin$.tw.\n\nPravachol.tw.\n\nLipex.tw.\n\nLipitor.tw.\n\nZocor.tw.\n\nLescol.tw.\n\nMevacor.tw.\n\nBaycol.tw.\n\nor/2-25\n\nand/1,26",
    "notes": "",
    "start_date": null,
    "end_date": "2012-02-19",
    "annotator_id": 1
  },
  {
    "id": 171,
    "document_id": 137,
    "query": "1. exp Asthma/\n\n2. asthma$.mp.\n\n3. (antiasthma$ or anti-asthma$).mp.\n\n4. Respiratory Sounds/\n\n5. wheez$.mp.\n\n6. Bronchial Spasm/\n\n7. bronchospas$.mp.\n\n8. (bronch$ adj3 spasm$).mp.\n\n9. bronchoconstrict$.mp.\n\n10. exp Bronchoconstriction/\n\n11. (bronch$ adj3 constrict$).mp.\n\n12. Bronchial Hyperreactivity/\n\n13. Respiratory Hypersensitivity/\n\n14. ((bronchial$ or respiratory or airway$ or lung$) adj3 (hypersensitiv$ or hyperreactiv$ or allerg$ or insufficiency)).mp.\n\n15. ((dust or mite$) adj3 (allerg$ or hypersensitiv$)).mp.\n\n16. or/1-15",
    "notes": "",
    "start_date": null,
    "end_date": "2012-12-12",
    "annotator_id": 1
  },
  {
    "id": 172,
    "document_id": 138,
    "query": "(((laparoscop* OR coelioscop* OR celioscop* OR peritoneoscop*) AND (cholecystectom*)) OR “cholecystectomy, laparoscopic”[MeSH]) AND (\"Ambulatory Surgical Procedures\"[Mesh] OR \"Day Care\"[Mesh] OR \"Ambulatory Care\"[Mesh] OR (day case) OR day-case OR (day surgery) or day-surgery OR (day care) OR day-care OR (day stay) OR day-stay OR (day procedure) OR day-procedure OR ambulatory OR outpatient OR out-patient OR (an?esth* AND regimen*)) AND ((randomized controlled trial [pt] OR controlled clinical trial [pt] OR randomized [tiab] OR placebo [tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals [mh] NOT humans [mh]))",
    "notes": "",
    "start_date": "1986-12-31",
    "end_date": "2013-10-31",
    "annotator_id": 1
  },
  {
    "id": 173,
    "document_id": 143,
    "query": "1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or exp intracranial arterial diseases/ or exp \"intracranial embolism and thrombosis\"/ or exp intracranial hemorrhages/ or stroke/ or exp brain infarction/ or stroke, lacunar/ or vasospasm, intracranial/ or vertebral artery dissection/\n2. (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or SAH).tw.\n3. ((brain$ or cerebr$ or cerebell$ or intracran$ or intracerebral) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$)).tw.\n4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracranial or subarachnoid) adj5 (haemorrhage$ or hemorrhage$ or haematoma$ or hematoma$ or bleed$)).tw.\n5. hemiplegia/ or exp paresis/\n6. (hemipleg$ or hemipar$ or paresis or paretic).tw.\n7. exp gait disorders, neurologic/\n8. 1 or 2 or 3 or 4 or 5 or 6 or 7\n9. exercise/ or exercise test/ or exercise therapy/ or motion therapy, continuous passive/\n10. body weight/ or weight-bearing/\n11. (treadmill$ or tread mill$ or running wheel$ or running machine$).tw.\n12. ((walking or walk or exercise) adj5 (machine$ or device$)).tw.\n13. ((walking or gait or locomotor or ambulation) adj5 (train$ or re-train$ or retrain$)).tw.\n14. exp walking/ and (machine$ or device$ or train$ or re-train$ or retrain$).tw.\n15. ((weight or body-weight or bodyweight) adj5 (support$ or suspen$ or relief)).tw.\n16. ((walk or walking or ambulat$ or locomot$ or gait or overhead) adj5 support$).tw.\n17. harness$.tw.\n18. 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17\n19. exp walking/ or gait/ or mobility limitation/ or locomotion/\n20. (walk$ or gait$ or ambulat$ or mobil$ or locomot$ or stride).tw.\n21. 19 or 20\n22. Randomized Controlled Trials as Topic/\n23. random allocation/\n24. Controlled Clinical Trials as Topic/\n25. control groups/\n26. clinical trials as topic/\n27. double-blind method/\n28. single-blind method/\n29. Placebos/\n30. placebo effect/\n31. cross-over studies/\n32. Therapies, Investigational/\n33. Research Design/\n34. randomized controlled trial.pt.\n35. controlled clinical trial.pt.\n36. clinical trial.pt.\n37. (random$ or RCT or RCTs).tw.\n38. (controlled adj5 (trial$ or stud$)).tw.\n39. (clinical$ adj5 trial$).tw.\n40. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.\n41. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.\n42. ((control or experiment$ or conservative) adj5 (treatment or therapy or procedure or manage$)).tw.\n43. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.\n44. (cross-over or cross over or crossover).tw.\n45. (placebo$ or sham).tw.\n46. trial.ti.\n47. (assign$ or allocat).tw.\n48. or/22-47\n49. 8 and 18 and 21 and 48\n50. exp animals/ not humans.sh.\n51. 49 not 50",
    "notes": "",
    "start_date": null,
    "end_date": "2014-02-22",
    "annotator_id": 1
  },
  {
    "id": 175,
    "document_id": 146,
    "query": "1. exp Dementia/\n\n2. Delirium/\n\n3. Wernicke Encephalopathy/\n\n4. Delirium, Dementia, Amnestic, Cognitive Disorders/\n\n5. dement*.\n\n6. alzheimer*.mp.\n\n7. (lewy* adj2 bod*).mp.\n\n8. deliri*.mp.\n\n9. (chronic adj2 cerebrovascular).mp.\n\n10. (\"organic brain disease\" or \"organic brain syndrome\").mp.\n\n11. (\"normal pressure hydrocephalus\" and \"shunt*\").mp.\n\n12. \"benign senescent forgetfulness\".mp.\n\n13. (cerebr* adj2 deteriorat*).mp.\n\n14. (cerebral* adj2 insufficient*).mp.\n\n15. (pick* adj2 disease).mp.\n\n16. (or jcd or cjd).mp.\n\n17. huntington*.mp.\n\n18. binswanger*.mp.\n\n19. korsako*.mp.\n\n20. or/1-19\n\n21. \"cognit* impair*\".mp.\n\n22. exp *Cognition Disorders/\n\n23. MCI.ti,ab.\n\n24. ACMI.ti,ab.\n\n25. ARCD.ti,ab.\n\n26. SMC.ti,ab.\n\n27. CIND.ti,ab.\n\n28. BSF.ti,ab.\n\n29. AAMI.ti,ab.\n\n30. MD.ti,ab.\n\n31. LCD.ti,ab.\n\n32. QD.ti,ab.\n\n33. AACD.ti,ab.\n\n34. MNCD.ti,ab.\n\n35. MCD.ti,ab.\n\n36. (\"N-MCI\" or \"A-MCI\" or \"M-MCI\").ti,ab.\n\n37. ((cognit* or memory or cerebr* or mental*) adj3 (declin* or impair* or los* or deteriorat* or degenerat* or complain* or disturb* or disorder*)).ti,ab.\n\n38. \"preclinical AD\".mp.\n\n39. \"pre-clinical AD\".mp.\n\n40. (\"preclinical alzheimer*\" or \"pre-clinical alzheimer*\").mp.\n\n41. (aMCI or MCIa).ti,ab.\n\n42. (\"CDR 0.5\" or \"clinical dementia rating scale 0.5\").ti,ab.\n\n43. (\"GDS 3\" or \"stage 3 GDS\").ti,ab.\n\n44. (\"global deterioration scale\" and \"stage 3\").mp.\n\n45. \"Benign senescent forgetfulness\".ti,ab.\n\n46. \"mild neurocognit* disorder*\".ti,ab.\n\n47. (prodrom* adj2 dement*).ti,ab.\n\n48. or/21-47\n\n49. 20 or 48\n\n50. depress*.ti,ab.\n\n51. dysthymi*.ti,ab.\n\n52. \"adjustment disorder*\".mp.\n\n53. \"mood disorder*\".mp.\n\n54. \"affective disorder*\".mp.\n\n55. \"affective symptom*\".mp.\n\n56. anxiety.mp.\n\n57. anxious.mp.\n\n58. ?phobi*.mp.\n\n59. \"panic disorder\".mp.\n\n60. BPSD.ti,ab.\n\n61. \"behavioural and psychological symptoms of dementia\".mp.\n\n62. (\"neuropsychiatric symptom*\" or NPS).mp.\n\n63. exp Behavioral Symptoms/ or Psychomotor Agitation/\n\n64. Depression/\n\n65. Anxiety/ or Anxiety Disorders/\n\n66. or/50-65\n\n67. 49 and 66\n\n68. (psychotherapy or \"cognitive therap*\").mp.\n\n69. \"behaviour*\".mp.\n\n70. counselling.ti,ab.\n\n71. \"cognitive analytic therapy\".mp.\n\n72. \"interpersonal therap*\".mp.\n\n73. relaxation.mp.\n\n74. (\"non-pharmacological intervention*\" or \"non-pharmacological treatment*\").mp.\n\n75. \"psychodynamic therap*\".mp.\n\n76. (behavi* adj2 therap*).ti,ab.\n\n77. \"rational insight therap*\".mp.\n\n78. \"problem-solving therap*\".mp.\n\n79. CBT.ti,ab.\n\n80. psychosocial.ti,ab.\n\n81. psycho-social.ti,ab.\n\n82. exp Psychotherapy/ or Psychotherapy, Multiple/ or Psychotherapy, Group/ or Psychotherapy, Brief/ or Psychotherapy, Rational-Emotive/\n\n83. or/68-82\n\n84. 67 and 83\n\n85. randomized controlled trial.pt.\n\n86. controlled clinical trial.pt.\n\n87. random*.ab.\n\n88. trial.ab.\n\n89. groups.ab.\n\n90. or/85-89\n\n91. (animals not (humans and animals)).sh.\n\n92. 90 not 91\n\n93. 84 and 92",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-21",
    "annotator_id": 1
  },
  {
    "id": 176,
    "document_id": 147,
    "query": "1 exp Wound Closure Techniques/ (38162)\n2 exp Sutures/ (12060)\n3 (closure or close or closing or sutur*).tw. (300829)\n4 or/1-3 (324065)\n5 exp Subcutaneous Tissue/ (1703)\n6 (((subcutaneous or sub-cutaneous) adj5 (fat or adipose or tissue*)) or superficial fascia or hypdermis).tw. (18170)\n7 or/5-6 (19321)\n8 4 and 7 (937)\n9 randomized controlled trial.pt. (338195)\n10 controlled clinical trial.pt. (85043)\n11 randomized.ab. (241810)\n12 placebo.ab. (134534)\n13 clinical trials as topic.sh. (162087)\n14 randomly.ab. (173722)\n15 trial.ti. (103477)\n16 or/9-15 (782338)\n17 (animals not (humans and animals)).sh. (3663525)\n18 16 not 17 (720068)\n19 8 and 18 (66)\n",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-20",
    "annotator_id": 1
  },
  {
    "id": 178,
    "document_id": 151,
    "query": "(laparoscop* OR coelioscop* OR celioscop* OR peritoneoscop* OR \"Laparoscopy\"[Mesh]) AND (video OR mirror OR box OR simulat*) AND train* AND ((randomised controlled trial [pt] OR controlled clinical trial [pt] OR randomised [tiab] OR placebo [tiab] OR drug therapy [sh] OR randomly [tiab] OR trial [tiab] OR groups [tiab]) NOT (animals [mh] NOT humans [mh]))",
    "notes": "",
    "start_date": "1986-12-31",
    "end_date": "2013-04-30",
    "annotator_id": 1
  },
  {
    "id": 180,
    "document_id": 154,
    "query": "1 exp Measles/\n2 exp Measles virus/\n3 measles.tw.\n4 rubeola.tw.\n5 morbilli*.tw.\n6 or/1-5\n7 exp Vitamin A/\n8 vitamin a.tw,nm.\n9 retinol.tw,nm.\n10 exp Dietary Supplements/\n11 or/7-10\n12 exp Blindness/\n13 Xerophthalmia/\n14 Night Blindness/\n15 (bitot* adj1 spot*).tw.\n16 xerosis*.tw.\n17 keratomalacia.tw.\n18 blind*.tw.\n19 xerophthalmia*.tw.\n20 exp Vision Disorders/\n21 (vision* or visual* or eye* or sight*).tw.\n22 or/12-21\n23 6 and 11 and 22",
    "notes": "We searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2013, Issue 2, part of The Cochrane Library, www.thecochranelibrary.com (accessed 18 March 2013), which includes the Cochrane Acute Respiratory Infections Group Specialised Register, MEDLINE (1950 to March week 1, 2013), EMBASE (1974 to March 2013) and LILACS (1985 to March 2013). We used the following search strategy to search MEDLINE and CENTRAL. We did not use a filter to identify randomised trials in MEDLINE as there were too few studies. We adapted the search terms accordingly for EMBASE (Appendix 1) and LILACS (Appendix 2).",
    "start_date": "1949-12-31",
    "end_date": "2013-02-28",
    "annotator_id": 1
  },
  {
    "id": 182,
    "document_id": 157,
    "query": "1. exp osteoarthritis/\n\n2. osteoarthr$.tw.\n\n3. (degenerative adj2 arthritis).tw.\n\n4. or/1-3\n\n5. exp Self Care/\n\n6. ((self or symptom$) adj (care or help or manag$ or directed or monitor$ or efficacy or admin$)).tw.\n\n7. Patient Education as Topic/\n\n8. ((health or patient$) adj2 (educat$ or information)).tw.\n\n9. exp Consumer Participation/\n\n10. ((patient$ or consumer$) adj part$).tw.\n\n11. \"power (psychology)\"/\n\n12. empower$.tw.\n\n13. Holistic Health/\n\n14. (holistic or wholistic).tw.\n\n15. exp Rehabilitation/\n\n16. rehab$.tw.\n\n17. \"Activities of Daily Living\"/\n\n18. (activit$ adj2 daily adj living).tw.\n\n19. social support/\n\n20. (social adj (support or network$)).tw.\n\n21. (support adj system$).tw.\n\n22. exp Adaptation, Psychological/\n\n23. (psychologic$ adj (adjust$ or adapt$)).tw.\n\n24. (cope or copes or coping).tw.\n\n25. exp Behavior Therapy/\n\n26. (adapt$ adj behav$).tw.\n\n27. (behav$ adj (therap$ or intervention$)).tw.\n\n28. or/5-27\n\n29. 4 and 28\n\n30. randomized controlled trial.pt.\n\n31. controlled clinical trial.pt.\n\n32. randomized.ab.\n\n33. placebo.ab.\n\n34. drug therapy.fs.\n\n35. randomly.ab.\n\n36. trial.ab.\n\n37. groups.ab.\n\n38. or/30-37\n\n39. (animals not (humans and animals)).sh.\n\n40. 38 not 39\n\n41. 29 and 40",
    "notes": "MEDLINE (Ovid) 2005 to January Week 2, 2013",
    "start_date": "2004-12-31",
    "end_date": "2013-01-11",
    "annotator_id": 1
  },
  {
    "id": 184,
    "document_id": 160,
    "query": "1. exp Asthma/\n\n2. asthma$.mp.\n\n3. (antiasthma$ or anti-asthma$).mp.\n\n4. Respiratory Sounds/\n\n5. wheez$.mp.\n\n6. Bronchial Spasm/\n\n7. bronchospas$.mp.\n\n8. (bronch$ adj3 spasm$).mp.\n\n9. bronchoconstrict$.mp.\n\n10. exp Bronchoconstriction/\n\n11. (bronch$ adj3 constrict$).mp.\n\n12. Bronchial Hyperreactivity/\n\n13. Respiratory Hypersensitivity/\n\n14. ((bronchial$ or respiratory or airway$ or lung$) adj3 (hypersensitiv$ or hyperreactiv$ or allerg$ or insufficiency)).mp.\n\n15. ((dust or mite$) adj3 (allerg$ or hypersensitiv$)).mp.\n\n16. or/1-15",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-12",
    "annotator_id": 1
  },
  {
    "id": 186,
    "document_id": 163,
    "query": "1. exp Vitamin D/\n2. exp Cholecalciferol/\n3. exp ergocalciferols/ or exp dihydrotachysterol/ or exp 25-hydroxyvitamin d 2/\n4. exp Hydroxycholecalciferols/\n5. vitamin D?.tw,ot.\n6. (cholecalciferol$ or calcifediol$ or calcitriol$ or dihydrotachysterol$ or hydroxyvitamin$ d?).tw,ot.\n7. (alfacalcidol$ or alphacalcidol$ or colecalciferol$).tw,ot.\n8. or/1-7\n9. exp Mortality/\n10. mortality.tw,ot.\n11. mortaliti$.tw,ot.\n12. or/9-11\n13. exp Primary Prevention/\n14. (prevention$ or prevent$).tw,ot.\n15. exp Neoplasm/\n16. (cancer$ or neoplasm$ or tumo?r$).tw,ot.\n17. or/13-16\n18. exp Randomized Controlled Trials as topic/\n19. Randomized Controlled Trial.pt.\n20. exp Controlled Clinical Trials as topic/\n21. Controlled Clinical Trial.pt.\n22. exp Random Allocation/\n23. exp Double-Blind Method/\n24. exp Single-Blind Method/\n25. or/18-24\n26. exp \"Review Literature as topic\"/\n27. exp Technology Assessment, Biomedical/\n28. exp Meta-analysis as topic/\n29. Meta-analysis.pt.\n30. hta.tw,ot.\n31. (health technology adj6 assessment$).tw,ot.\n32. (meta analy$ or metaanaly$ or meta?analy$).tw,ot.\n33. ((review$ or search$) adj10 (literature$ or medical database$ or medline or pubmed or embase or cochrane or cinahl or psycinfo or psyclit or healthstar or biosis or current\ncontent$ or systemat$)).tw,ot.\n34. or/26-33\n35. 25 or 34\n36. 8 and 17 and 35\n37. 8 and 12 and 35\n38 36 or 37\n39. limit 38 to animals\n40. limit 38 to humans\n41. 39 not 40\n42 38 not 41",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-09",
    "annotator_id": 1
  },
  {
    "id": 181,
    "document_id": 155,
    "query": "1. exp Epilepsy/\n\n2. (epilepsy adj4 surg$).tw.\n\n3. exp Seizures/\n\n4. seizure$.tw.\n\n5. or/1-4\n\n6. high frequency oscillation$.tw.\n\n7. ripple$.tw.\n\n8. 6 or 7\n\n9. 5 and 8",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-14",
    "annotator_id": 1
  },
  {
    "id": 183,
    "document_id": 158,
    "query": "1   exp Neoplasms/\n2   (neoplasm* or tumor* or tumour* or cancer* or malignan* or carcinoma* or adenocarcinoma* or lymphoma* or leukem* or luekaem*).mp.\n3   1 or 2\n4   Neutropenia/\n5   neutropeni*.mp.\n6   (granulop?en* or granulocytop?en*).mp.\n7   (immunosuppress* or immuno-suppress*).mp.\n8   4 or 5 or 6 or 7\n9   exp Gram-Positive Bacterial Infections/dt [Drug Therapy]\n10  exp Anti-Bacterial Agents/\n11  (antibiotic* or anti-bacterial or antibacterial).mp.\n12  (vancomycin or teicoplanin or oxacillin or cloxacillin or dicloxacillin or flucloxacillin or nafcillin or cefazolin or clindamycin or quinupristin-dalfopristin or linezolid or trimethoprim-sulphamethoxazole or daptomycin or tigecycline).mp.\n13  9 or 10 or 11 or 12\n14  3 and 8 and 13\n15  randomized controlled trial.pt.\n16  controlled clinical trial.pt.\n17  randomized.ab.\n18  placebo.ab.\n19  clinical trials as topic.sh.\n20  randomly.ab.\n21  trial.ti.\n22  15 or 16 or 17 or 18 or 19 or 20 or 21\n23  14 and 22 ",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-13",
    "annotator_id": 1
  },
  {
    "id": 185,
    "document_id": 162,
    "query": "1 exp Anti-Infective Agents/ (614173)\n2 exp Penicillins/ (16923)\n3 exp Cephalosporins/ (12724)\n4 exp Aminoglycosides/ (48702)\n5 exp Quinolones/ (22074)\n6 exp Clindamycin/ (2024)\n7 exp Metronidazole/ (4816)\n8 exp Trimethoprim/ (3822)\n9 exp Mupirocin/ (640)\n10 exp Neomycin/ (1890)\n11 exp Fusidic Acid/ (473)\n12 exp Framycetin/ (166)\n13 exp Polymyxins/ (2141)\n14 exp Chlortetracycline/ (351)\n15 (antibiotic$ or antimicrobial$ or antibacterial$ or penicillin$ or cephalosporin$ or aminoglycoside$ or quinolone$ or clindamycin or metronidazole or trimethoprim or mupirocin or pseudomonic acid or neomycin or fusidic acid or framycetin or polymyxin$ or chlortetracycline).ti,ab. (191275)\n16 exp Antisepsis/ (710)\n17 antiseptic$.ti,ab. (2623)\n18 exp Soaps/ (697)\n19 exp Iodophors/ (1188)\n20 exp Chlorhexidine/ (3330)\n21 exp Alcohols/ (210358)\n22 exp Hydrogen Peroxide/ (28460)\n23 exp Benzoyl Peroxide/ (498)\n24 exp Gentian Violet/ (991)\n25 exp Hypochlorous Acid/ (3254)\n26 exp Hexachlorophene/ (30)\n27 exp Potassium Permanganate/ (526)\n28 exp Silver/ (7101)\n29 exp Silver Sulfadiazine/ (434)\n30 exp Honey/ (1518)\n31 (soap$1 or iodophor$ or povidone or iodine or chlorhexidine or betadine or alcohol$1 or disinfectant$ or hydrogen peroxide or benzoyl peroxide or gentian violet or hypochlorit$ or eusol or dakin$ or hexachlorophene or benzalkonium or potassium permanganate or silver sulfadiazine or silver sulphadiazine or honey$).ti,ab. (159344)\n32 or/1-31 (982110)\n33 exp Leg Ulcer/ (10032)\n34 (varicose ulcer$ or venous ulcer$ or leg ulcer$ or stasis ulcer$ or (lower extremit$ adj ulcer$) or crural ulcer$ or ulcus cruris).ti,ab. (3777)\n35 or/33-34 (10770)\n36 32 and 35 (1383)\n37 randomized controlled trial.pt. (248241)\n38 controlled clinical trial.pt. (40205)\n39 randomized.ab. (202576)\n40 placebo.ab. (93758)\n41 clinical trials as topic.sh. (81126)\n42 randomly.ab. (139357)\n43 trial.ti. (75545)\n44 or/37-43 (560427)\n45 (animals not (humans and animals)).sh. (1653788)\n46 44 not 45 (509737)\n47 36 and 46 (165)",
    "notes": "Ovid MEDLINE - 1950 to September Week 3 2009",
    "start_date": "1949-12-31",
    "end_date": "2009-09-15",
    "annotator_id": 1
  },
  {
    "id": 187,
    "document_id": 165,
    "query": "1. cerebrovascular disorders/ or exp basal ganglia cerebrovascular disease/ or exp brain ischemia/ or exp carotid artery diseases/ or exp cerebrovascular trauma/ or exp intracranial arterial diseases/ or exp intracranial arteriovenous malformations/ or exp \"intracranial embolism and thrombosis\"/ or exp intracranial hemorrhages/ or stroke/ or exp brain infarction/ or vasospasm, intracranial/\n2. (stroke or poststroke or post-stroke or cerebrovasc$ or brain vasc$ or cerebral vasc$ or cva$ or apoplex$ or SAH).tw.\n3. ((brain$ or cerebr$ or cerebell$ or intracran$ or intracerebral) adj5 (isch?emi$ or infarct$ or thrombo$ or emboli$ or occlus$)).tw.\n4. ((brain$ or cerebr$ or cerebell$ or intracerebral or intracranial or subarachnoid) adj5 (haemorrhage$ or hemorrhage$ or haematoma$ or hematoma$ or bleed$)).tw.\n5. ((transi$ adj3 isch?em$ adj3 attack$) or TIA$1).tw.\n6. 1 or 2 or 3 or 4 or 5\n7. PPAR gamma/ag, de, me, pd, tu\n8. Peroxisome Proliferator-Activated Receptors/ag, de, me, pd, tu or Transcription Factors/ag, de, me, pd, tu\n9. Thiazolidinediones/\n10. ((peroxisome proliferator-activated receptor gamma or PPAR gamma or PPAR-gamma or PPARgamma or PPARG or NR1C3) adj5 (agonist$ or modulator$ or stimulat$ or stimulant$ or activat$)).tw.\n11. (thiazolidinedione$ or glitazone$ or pioglitazone or rosiglitazone or troglitazone or netoglitazone or rivoglitazone or ciglitazone or balaglitazone or darglitazone or edaglitazone or englitazone or lobeglitazone).tw,nm.\n12. 7 or 8 or 9 or 10 or 11\n13. Randomised Controlled Trials as Topic/\n14. random allocation/\n15. Controlled Clinical Trials as Topic/\n16. control groups/\n17. clinical trials as topic/ or clinical trials, phase i as topic/ or clinical trials, phase ii as topic/ or clinical trials, phase iii as topic/ or clinical trials, phase iv as topic/\n18. double-blind method/\n19. single-blind method/\n20. Placebos/\n21. placebo effect/\n22. Drug Evaluation/\n23. Research Design/\n24. randomised controlled trial.pt.\n25. controlled clinical trial.pt.\n26. (clinical trial or clinical trial phase i or clinical trial phase ii or clinical trial phase iii or clinical trial phase iv).pt.\n27. random$.tw.\n28. (controlled adj5 (trial$ or stud$)).tw.\n29. (clinical$ adj5 trial$).tw.\n30. ((control or treatment or experiment$ or intervention) adj5 (group$ or subject$ or patient$)).tw.\n31. (quasi-random$ or quasi random$ or pseudo-random$ or pseudo random$).tw.\n32. ((singl$ or doubl$ or tripl$ or trebl$) adj5 (blind$ or mask$)).tw.\n33. placebo$.tw.\n34. controls.tw.\n35. (RCT or RCTs).tw. or trial.ti.\n36. or/13-35\n37. 6 and 12 and 36\n38. exp animals/ not humans.sh.\n39. 37 not 38",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-07",
    "annotator_id": 1
  },
  {
    "id": 179,
    "document_id": 153,
    "query": "1. exp Dementia/\n\n2. Delirium/\n\n3. Wernicke Encephalopathy/\n\n4. Delirium, Dementia, Amnestic, Cognitive Disorders/\n\n5. dement*.mp.\n\n6. alzheimer*.mp.\n\n7. (lewy* adj2 bod*).mp.\n\n8. deliri*.mp.\n\n9. (chronic adj2 cerebrovascular).mp.\n\n10. (\"organic brain disease\" or \"organic brain syndrome\").mp.\n\n11. (\"normal pressure hydrocephalus\" and \"shunt*\").mp.\n\n12. \"benign senescent forgetfulness\".mp.\n\n13. (cerebr* adj2 deteriorat*).mp.\n\n14. (cerebral* adj2 insufficient*).mp.\n\n15. (pick* adj2 disease).mp.\n\n16. (creutzfeldt or jcd or cjd).mp.\n\n17. huntington*.mp.\n\n18. binswanger*.mp.\n\n19. korsako*.mp.\n\n20. or/1-19\n\n21. respite.ti,ab.\n\n22. daycare.ti,ab.\n\n23. (\"caregiver* relief\" or \"carer* relief\").ti,ab.\n\n24. Respite Care/\n\n25. (care adj3 relief).ti,ab.\n\n26. or/21-25\n\n27. 20 and 26\n\n28. (2007* or 2008* or 2009* or 2010* or 2011* or 2012*).ed.\n\n29. 27 and 28",
    "notes": "121 hits retrieved",
    "start_date": "2007-01-01",
    "end_date": "2012-11-29",
    "annotator_id": 1
  },
  {
    "id": 188,
    "document_id": 166,
    "query": "#1 Mucopolysaccharidosis II [mh]\n\n#2 Mucopolysaccharidosis IIs\n\n#3 Mucopolysaccharidoses IIs\n\n#4 Hunter Syndrome Gargoylism\n\n#5 Hunter Syndrome Gargoylisms\n\n#6 Hunter's Syndrome\n\n#7 Hunters Syndrome\n\n#8 Hunter Syndrome\n\n#9 MPSII\n\n#10 MPS II\n\n#11 Mucopolysaccharidosis 2\n\n#12 Mucopolysaccharidoses 2\n\n#13 Mucopolissacaridose II\n\n#14 Mucopolissacaridosis II\n\n#15 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14\n\n#16 Iduronate Sulfatase [Mh]\n\n#17 Sulfoiduronate Sulfatase\n\n#18 Iduronatesulfate Sulfohydrolase\n\n#19 Hunter Corrective Factor\n\n#20 Iduronate Sulfate Sulfatase\n\n#21 Iduronato Sulfatasa\n\n#22  Iduronato Sulfatase\n\n#23 #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22\n\n# 24 randomized controlled trial [pt]\n\n# 25 controlled clinical trial [pt]\n\n#26 randomized [tiab]\n\n#27 placebo [tiab]\n\n#28 drug therapy [sh]\n\n#29 randomly [tiab]\n\n#30 trial [tiab]\n\n#31 groups [tiab]\n\n#32 #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #29 OR #30 OR #31\n\n#33#15 AND #23 AND #32\n",
    "notes": "",
    "start_date": null,
    "end_date": "2014-01-07",
    "annotator_id": 1
  },
  {
    "id": 189,
    "document_id": 168,
    "query": "1. exp Sleep Apnea Syndromes/\n\n2. (sleep$ adj3 (apnea$ or apnoea$)).mp.\n\n3. (hypopnoea$ or hypopnoea$).mp.\n\n4. OSA.mp.\n\n5. SHS.mp.\n\n6. OSAHS.mp.\n\n7. or/1-6",
    "notes": "",
    "start_date": null,
    "end_date": "2013-01-16",
    "annotator_id": 1
  },
  {
    "id": 190,
    "document_id": 169,
    "query": "1. exp \"Substance-Related-Disorders\"/\n2. ((drug or substance) adj (abuse* or addict* or dependen* or misuse*)).ti,ab\n3. (drug* adj (treat* or intervention* or program*)\n4. substance near (treat* or intervention* or program*)\n5.(detox* or methadone) in ti,ab\n6. narcotic* near (treat* or intervention* or program*)\n7. 1 or 2 or 3 or 4 or 5 or 6\n8. prison*. ti,ab\n9. exp \"Prisoners\"/\n10. offender* or criminal* or inmate* or convict* or probation* or remand or felon*).ti,ab\n11. exp \"Prisons\"/\n12. 8 or 9 or 10 or 11\n13. 7 and 12",
    "notes": "",
    "start_date": null,
    "end_date": "2013-03-01",
    "annotator_id": 1
  },
  {
    "id": 191,
    "document_id": 170,
    "query": "1. Beta-Lactams/ or Penicillins/ or Cephalosporins/ or Carbapenems/ or Imipenem/ or Ceftazidime/ or Cefotaxime/ or Amoxicillin-Potassium Clavulanate Combination/ or beta-lactam*.ti,ab. or (co?amoxiclav* or cephalosporin* or ceftazidim* or cefotaxim* or carbapenem* or imipenem* or meropenem*).mp. or (beta-lactam* adj5 (combin* or mono*)).mp. \n2. Aminoglycosides/ or (aminoglycoside* or netilmicin* or gentamicin* or amikacin* or tobramycin* or streptomycin* or isepamicin* or sisomicin* or combinat*).ti,ab. or Drug-Therapy-Combination/ \n3. 1 or (1 and 2) \n4. pneumonia/ or exp Sepsis/ or Shock, Septic/ or exp Bacteremia/ or Infection/ or exp Endocarditis, Bacterial/ or Endocarditis/ or exp Endocarditis, Subacute Bacterial/ or Staphylococcus/ or Streptococcus/ or (pneumonia* or infect* or sepsis* or septic* or bacter*).ti,ab.\n5. 3 and 4 \n6. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) not (animals not (humans and animals)).sh. \n7. 6 and 5",
    "notes": "",
    "start_date": null,
    "end_date": "2013-12-19",
    "annotator_id": 1
  },
  {
    "id": 192,
    "document_id": 171,
    "query": "1. exp Eczema/ or eczema.mp.\n2. exp Dermatitis, Atopic/\n3. neurodermatitis.mp. or exp Neurodermatitis/\n4. exp Dermatitis/ or dermatitis.mp.\n5. or/1-4\n6. exp Psychotherapy/\n7. exp Patient Education Handout/\n8. exp Education/\n9. exp Health Education/\n10. exp Psychology/\n11. exp Behavior Therapy/\n12. exp Cognitive Therapy/\n13. exp Autogenic Training/\n14. exp Suggestion/\n15. exp Hypnosis/\n16. exp Counseling/\n17. exp Relaxation/\n18. exp Relaxation Therapy/\n19. exp \"Imagery (Psychotherapy)\"/\n20. exp Biofeedback, Psychology/\n21. exp Family Therapy/\n22. exp Health Promotion/\n23. exp Patient Education as Topic/\n24. exp Parent-Child Relations/\n25. exp Skin Care/\n26. exp Self-Help Groups/\n27. exp Psychiatry/\n28. psychodynamic therap$.ti,ab.\n29. behavio$ management.ti,ab.\n30. behavio$ therapy.ti,ab.\n31. autogenic training.ti,ab.\n32. counsel$.ti,ab.\n33. psychotherapy.ti,ab.\n34. suggestion.ti,ab.\n35. (hypnosis or hypnotherapy).ti,ab.\n36. cognitive therap$.ti,ab.\n37. relaxation.ti,ab.\n38. psychotherapeutic technique$.ti,ab.\n39. self help.ti,ab.\n40. support.ti,ab.\n41. mindfulness.ti,ab.\n42. imagery.ti,ab.\n43. biofeedback.ti,ab.\n44. family therap$.ti,ab.\n45. health promotion.ti,ab.\n46. health education.ti,ab.\n47. patient education.ti,ab.\n48. patient teaching.ti,ab.\n49. patient training.ti,ab.\n50. or/6-49\n51. exp Eczema/px [Psychology]\n52. exp Dermatitis, Atopic/px [Psychology]\n53. exp Neurodermatitis/px [Psychology]\n54. exp Dermatitis/px [Psychology]\n55. 51 or 52 or 53 or 54\n56. randomized controlled trial.pt.\n57. controlled clinical trial.pt.\n58. randomized.ab.\n59. placebo.ab.\n60. clinical trials as topic.sh.\n61. randomly.ab.\n62. trial.ti.\n63. 56 or 57 or 58 or 59 or 60 or 61 or 62\n64. (animals not (humans and animals)).sh.\n65. 63 not 64\n66. 5 and 50 and 65\n67. 55 and 65\n68. 66 or 67",
    "notes": "",
    "start_date": null,
    "end_date": "2013-12-19",
    "annotator_id": 1
  },
  {
    "id": 193,
    "document_id": 173,
    "query": "1 randomized controlled trial.pt. (389866)\n2 controlled clinical trial.pt. (89904)\n3 randomized.ab. (287333)\n4 placebo.ab. (156850)\n5 drug therapy.fs. (1767223)\n6 randomly.ab. (199448)\n7 trial.ab. (302482)\n8 groups.ab. (1276425)\n9 or/1-8 (3299027)\n10 exp animals/ not humans.sh. (4060470)\n11 9 not 10 (2809295)\n12 exp herpes zoster/ (9764)\n13 herpes zoster.mp. (11326)\n14 shingle$.mp. (867)\n15 exp neuralgia, postherpetic/ (718)\n16 postherpetic neuralgia.mp. (1429)\n17 post-herpetic neuralgia.mp. (574)\n18 post-herpetic pain.mp. (21)\n19 postherpetic pain.mp. (52)\n20 PHN.tw. (1202)\n21 trigeminal neuralgia.mp. (6283)\n22 exp Trigeminal Neuralgia/ (5589)\n23 fibromyalgia.mp. (7494)\n24 exp pain/ or (pain or painful).mp. (545148)\n25 or/12-24 (561051)\n26 (duloxetine or cymbalta).mp. (1506)\n27 11 and 25 and 26 (486)\n28 remove duplicates from 27 (396)",
    "notes": "Database: Ovid MEDLINE(R) <1946 to November Week 1 2013>",
    "start_date": "1945-12-31",
    "end_date": "2013-11-08",
    "annotator_id": 1
  },
  {
    "id": 194,
    "document_id": 174,
    "query": "1. Shock, Cardiogenic/\n2. cardiogenic* shock*.tw.\n3. Cardiac Output, Low/\n4. (low adj2 cardiac output).tw.\n5. ((instab* or unstab*) adj h?emodynamic*).tw.\n6. or/1-5\n7. Drug Therapy/\n8. ((drug or medica* or pharmacological) adj (therap* or treatment)).tw.\n9. exp Drug Administration Routes/\n10. drug administ*.tw.\n11. Drug Administration Schedule/\n12. or/7-11\n13. exp Cardiotonic Agents/\n14. cardiotonic.tw.\n15. ((myocardial or cardiac) adj stimula*).tw.\n16. inotrope*.tw.\n17. inotropic agent*.tw.\n18. cardioprotective agent*.tw.\n19. acetyldigitoxin*.tw.\n20. acetyldigoxin*.tw.\n21. adrenomedullin.tw.\n22. aminophylline.tw.\n23. amrinone.tw.\n24. bufanolide*.tw.\n25. carbachol.tw.\n26. cardiac glycoside*.tw.\n27. cymarine.tw.\n28. deslanoside.tw.\n29. digitalis glycoside*.tw.\n30. digitoxin.tw.\n31. digoxin.tw.\n32. dobutamine.tw.\n33. dopamine.tw.\n34. enoximone.tw.\n35. etilefrine.tw.\n36. isoproterenol.tw.\n37. lisinopril.tw.\n38. medigoxin.tw.\n39. milrinone.tw.\n40. ouabain.tw.\n41. oxyfedrine.tw.\n42. phenylephrine.tw.\n43. phosphocreatine.tw.\n44. potassium magnesium aspartate.tw.\n45. prenalterol.tw.\n46. proscillaridin.tw.\n47. strophanthin*.tw.\n48. or/12-47\n49. exp Vasodilator Agents/\n50. vasodilators.tw.\n51. vasodilator drug*.tw.\n52. vasodilator agent*.tw.\n53. vasorelaxant*.tw.\n54. vasoactive antagonist*.tw.\n55. acetylcholine.tw.\n56. adenosine*.tw.\n57. adrenomedullin.tw.\n58. alprostadil.tw.\n59. amiodarone.tw.\n60. amlodipine.tw.\n61. amyl nitrite.tw.\n62. bencyclane.tw.\n63. bepridil.tw.\n64. betahistine.tw.\n65. bradykinin.tw.\n66. calcitonin.tw.\n67. celiprolol.tw.\n68. chromonar.tw.\n69. cromakalim.tw.\n70. cyclandelate.tw.\n71. diazoxide.tw.\n72. dihydroergocristine.tw.\n73. dihydroergocryptine.tw.\n74. dilazep.tw.\n75. diltiazem.tw.\n76. dipyridamole.tw.\n77. dyphylline.tw.\n78. ergoloid mesylate*.tw.\n79. erythritol.tw.\n80. erythrityl tetranitrate.tw.\n81. felodipine.tw.\n82. fenoldopam.tw.\n83. flunarizine.tw.\n84. hexobendine.tw.\n85. hydralazine.tw.\n86. iloprost.tw.\n87. isosorbide dinitrate.tw.\n88. isoxsuprine.tw.\n89. isradipine.tw.\n90. kallidin.tw.\n91. khellin.tw.\n92. lidoflazine.tw.\n93. mibefradil.tw.\n94. minoxidil.tw.\n95. molsidomine.tw.\n96. moxisylyte.tw.\n97. nafronyl.tw.\n98. niacin.tw.\n99. nicardipine.tw.\n100. nicergoline.tw.\n101. nicorandil.tw.\n102. nicotinyl alcohol.tw.\n103. nifedipine.tw.\n104. nimodipine.tw.\n105. nisoldipine.tw.\n106. nitrendipine.tw.\n107. nitroglycerin.tw.\n108. nitroprusside.tw.\n109. nonachlazine.tw.\n110. nylidrin.tw.\n111. oxprenolol.tw.\n112. oxyfedrine.tw.\n113. papaverine.tw.\n114. pentaerythritol tetranitrate.tw.\n115. pentoxifylline.tw.\n116. perhexiline.tw.\n117. phenoxybenzamine.tw.\n118. pinacidil.tw.\n119. pindolol.tw.\n120. Pituitary Adenylate Cyclase-Activating Polypeptide.tw.\n121. polymethyl methacrylate.tw.\n122. prenylamine.tw.\n123. propranolol.tw.\n124. S-Nitroso-N-Acetylpenicillamine.tw.\n125. S-Nitrosoglutathione.tw.\n126. S-Nitrosothiols.tw.\n127. Sodium Azide.tw.\n128. Suloctidil.tw.\n129. Theobromine.tw.\n130. Theophylline.tw.\n131. Thiouracil.tw.\n132. Tolazoline.tw.\n133. Trapidil.tw.\n134. Trimetazidine.tw.\n135. Vasoactive Intestinal Peptide.tw.\n136. Verapamil.tw.\n137. Vincamine.tw.\n138. Xanthinol Niacinate.tw.\n139. or/49-138\n140. exp Vasoconstrictor Agents/\n141. vasopressor*.tw.\n142. vasoconstrictor*.tw.\n143. vasoactive agonist*.tw.\n144. Angiotensin Amide.tw.\n145. Angiotensin II.tw.\n146. Arginine Vasopressin.tw.\n147. Cocaine.tw.\n148. Dihydroergotamine.tw.\n149. Ephedrine.tw.\n150. Epinephrine.tw.\n151. Ergotamine.tw.\n152. Etilefrine.tw.\n153. Felypressin.tw.\n154. Lypressin.tw.\n155. Mephentermine.tw.\n156. Metaraminol.tw.\n157. Methoxamine.tw.\n158. Methysergide.tw.\n159. Midodrine.tw.\n160. Nordefrin.tw.\n161. Norepinephrine.tw.\n162. Octopamine.tw.\n163. Ornipressin.tw.\n164. Phenylephrine.tw.\n165. Sumatriptan.tw.\n166. Synephrine.tw.\n167. Vasopressin*.tw.\n168. Vasotocin.tw.\n169. or/140-168\n170. exp Anticoagulants/\n171. anticoagulant*.tw.\n172. 4-Hydroxycoumarins.tw.\n173. Acenocoumarol.tw.\n174. Ancrod.tw.\n175. Citric Acid.tw.\n176. Coumarin*.tw.\n177. Dalteparin.tw.\n178. Dermatan Sulfate.tw.\n179. Dextrans.tw.\n180. Dicumarol.tw.\n181. Edetic Acid.tw.\n182. Enoxaparin.tw.\n183. Ethyl Biscoumacetate.tw.\n184. Gabexate.tw.\n185. Heparin.tw.\n186. Heparin*.tw.\n187. Nadroparin.tw.\n188. Pentosan Sulfuric Polyester.tw.\n189. Phenindione.tw.\n190. Phenprocoumon.tw.\n191. Protein C.tw.\n192. Protein S.tw.\n193. Warfarin.tw.\n194. beta 2-Glycoprotein I.tw.\n195. antithrombin*.tw.\n196. thrombin inhibitor*.tw.\n197. Hirudin*.tw.\n198. or/170-197\n199. exp Platelet Aggregation Inhibitors/\n200. antiplatelet.tw.\n201. platelet antagonist*.tw.\n202. (platelet adj2 inhibitor*).tw.\n203. platelet antiaggregant*.tw.\n204. Aspirin.tw.\n205. Disintegrin*.tw.\n206. Epoprostenol.tw.\n207. Ketanserin.tw.\n208. Ticlopidine.tw.\n209. or/199-208\n210. Phosphodiesterase Inhibitors/\n211. ((phosphodiesterase2 or phosphodiesterase-2 or phosphodiesteraseII or phosphodiesterase-II) adj (antagonist* or inhibitor*)).tw.\n212. antiphosphodiesterase*.tw.\n213. ((pde2 or pde-2 or pdeII or pde-II) adj (antagonist* or inhibitor*)).tw.\n214. Caffeine/\n215. Caffeine.tw.\n216. Etazolate/\n217. Etazolate.tw.\n218. calcium sensitiser*.tw.\n219. Levosimendan.tw.\n220. or/210-219\n221. exp Anti-Inflammatory Agents/\n222. anti-inflammatories.tw.\n223. anti-inflammatory agent*.tw.\n224. antiinflammatories.tw.\n225. antiinflammatory agent*.tw.\n226. Algestone Acetophenide.tw.\n227. Beclomethasone.tw.\n228. Benzydamine.tw.\n229. Betamethasone.tw.\n230. Budesonide.tw.\n231. Clobetasol.tw.\n232. Corticosterone.tw.\n233. Cortisone.tw.\n234. Desonide.tw.\n235. Desoximetasone.tw.\n236. Dexamethasone.tw.\n237. Diflucortolone.tw.\n238. Fludrocortisone.tw.\n239. Flufenamic Acid.tw.\n240. Flumethasone.tw.\n241. Fluocinonide.tw.\n242. Fluocortolone.tw.\n243. Fluorometholone.tw.\n244. Fluprednisolone.tw.\n245. Flurandrenolone.tw.\n246. Glycyrrhetinic Acid.tw.\n247. Glycyrrhizic Acid.tw.\n248. Halcinonide.tw.\n249. Heparinoids.tw.\n250. Hydrocortisone.tw.\n251. Methylprednisolone.tw.\n252. Nedocromil.tw.\n253. Paramethasone.tw.\n254. Prednisolone.tw.\n255. Prednisone.tw.\n256. Tilorone.tw.\n257. Triamcinolone.tw.\n258. Ampyrone.tw.\n259. Antipyrine.tw.\n260. Apazone.tw.\n261. Bufexamac.tw.\n262. Clofazimine.tw.\n263. Clonixin.tw.\n264. Curcumin.tw.\n265. Diclofenac.tw.\n266. Diflunisal.tw.\n267. Dipyrone.tw.\n268. Epirizole.tw.\n269. Fenoprofen.tw.\n270. Flurbiprofen.tw.\n271. Ibuprofen.tw.\n272. Indomethacin.tw.\n273. Ketoprofen.tw.\n274. Ketorolac.tw.\n275. Meclofenamic Acid.tw.\n276. Mefenamic Acid.tw.\n277. Mesalamine.tw.\n278. Naproxen.tw.\n279. Niflumic Acid.tw.\n280. Oxyphenbutazone.tw.\n281. Phenylbutazone.tw.\n282. Piroxicam.tw.\n283. Prenazone.tw.\n284. Salicylate.tw.\n285. Sulfasalazine.tw.\n286. Sulindac.tw.\n287. Suprofen.tw.\n288. Tolmetin.tw.\n289. or/221-288\n290. tilarginine.tw.\n291. 12 or 48 or 139 or 169 or 198 or 209 or 220 or 289 or 290\n292. 6 and 291\n293. randomized controlled trial.pt.\n294. controlled clinical trial.pt.\n295. randomized.ab.\n296. placebo.ab.\n297. drug therapy.fs.\n298. randomly.ab.\n299. trial.ab.\n300. groups.ab.\n301. 293 or 294 or 295 or 296 or 297 or 298 or 299 or 300\n302. exp animals/ not humans.sh.\n303. 301 not 302\n304. 292 and 303",
    "notes": "",
    "start_date": null,
    "end_date": "2012-12-31",
    "annotator_id": 1
  },
  {
    "id": 195,
    "document_id": 176,
    "query": "typhoid*\ntyphoid fever\nTYPHOID FEVER\nsalmonell*\n1 or 2 or 3 or 4\nvaccine*\n5 and 6\nTYPHOID-PARATYPHOID VACCINES\nTY21 TYPHOID VACCINE\nVI POLYSACCHARIDE VACCINE, TYPHOID\n7 or 8 or 9 or 10",
    "notes": "Search terms used in combination with the search strategy for retrieving trials developed by The Cochrane Collaboration (Higgins 2006); upper case: MeSH or EMTREE heading; lower case: free text term.",
    "start_date": null,
    "end_date": "2013-01-16",
    "annotator_id": 1
  },
  {
    "id": 196,
    "document_id": 177,
    "query": "1. exp \"Substance-Related-Disorders\"/\n2. ((drug or substance) adj (abuse* or addict* or dependen* or misuse*)).ti,ab\n3. (drug* adj (treat* or intervention* or program*)\n4. substance near (treat* or intervention* or program*)\n5.(detox* or methadone) in ti,ab\n6. narcotic* near (treat* or intervention* or program*)\n7. 1 or 2 or 3 or 4 or 5 or 6\n8. prison*. ti,ab\n9. exp \"Prisoners\"/\n10. offender* or criminal* or inmate* or convict* or probation* or remand or felon*).ti,ab\n11. exp \"Prisons\"/\n12. 8 or 9 or 10 or 11\n13. 7 and 12",
    "notes": "",
    "start_date": null,
    "end_date": "2012-05-27",
    "annotator_id": 1
  },
  {
    "id": 168,
    "document_id": 134,
    "query": "1. decision support techniques/\n\n2. decision support systems clinical/\n\n3. decision trees/\n\n4. (decision making or choice behavior).mp. and informed consent.sh.\n\n5. ((decision* or decid*) adj4 (support* or aid* or tool* or instrument* or technolog* or technique* or system* or program* or algorithm* or process* or method* or intervention* or material*)).tw.\n\n6. (decision adj (board* or guide* or counseling)).tw.\n\n7. ((risk communication or risk assessment or risk information) adj4 (tool* or method*)).tw.\n\n8. decision-making computer assisted/\n\n9. (computer* adj2 decision making).tw.\n\n10. interactive health communication*.tw.\n\n11. (interactive adj (internet or online or graphic* or booklet*)).tw.\n\n12. (interacti* adj4 tool*).tw.\n\n13. ((interactiv* or evidence based) adj3 (risk information or risk communication or risk presentation or risk graphic*)).tw.\n\n14. shared decision making.tw.\n\n15. (informed adj (choice* or decision*)).tw.\n\n16. adaptive conjoint analys#s.tw.\n\n17. or/1-16\n\n18. randomized controlled trial.pt.\n\n19. controlled clinical trial.pt.\n\n20. randomized.ab.\n\n21. placebo.ab.\n\n22. clinical trials as topic.sh.\n\n23. randomly.ab.\n\n24. trial.ti.\n\n25. or/18-24\n\n26. exp animals/ not humans.sh.\n\n27. 25 not 26\n\n28. 17 and 27",
    "notes": "",
    "start_date": "2009-01-01",
    "end_date": "2012-05-31",
    "annotator_id": 1
  }
]